ChEMBL_ID,canonical_smiles,IC50,IC50_units,Assay_Description
CHEMBL281525,CCC(C)(O)C#Cc1nc(NCc2ccc(OC)c(OC)c2)c2ncn(C(C)C)c2n1,600.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL336776,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CC3(O)CCCC3)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085240,COc1cccc(CNc2nc(N3CCC[C@@H]3CO)nc3c2ncn3C(C)C)c1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085235,COc1cc(CNc2nc(N3CCC[C@@H]3CO)nc3c2ncn3C(C)C)cc(OC)c1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL130161,COc1cc(CNc2nc(I)nc3c2ncn3C(C)C)cc(OC)c1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085244,CC(C)n1cnc2c(NCc3ccccc3C(F)(F)F)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL26513,CCC(C)(O)C#Cc1nc(Nc2ccc(Cl)c(Cl)c2)c2ncn(C(C)C)c2n1,500.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL2111870,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@H](CO)Cc3ccccc3)nc21,2000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL132948,Ic1nc(NCc2ccccc2)c2ncn(C3CCCC3)c2n1,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL130315,CC(C)n1cnc2c(NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085241,CC(C)n1cnc2c(NCc3ccc(Cl)cc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL134239,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CC3(O)CCCCC3)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085249,CC(C)n1cnc2c(N(Cc3ccccc3)Cc3ccccc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085248,CC(C)n1cnc2c(Nc3ccc(Cl)c(Cl)c3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL335743,Nc1nc(Cl)c2ncn(C3CCCC3)c2n1,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085251,OC[C@H]1CCCN1c1nc(NCc2ccccc2)c2ncn(C3CCCC3)c2n1,500.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085252,CC(C)n1cnc2c(NCc3cccc(I)c3)nc(N3CCC[C@@H]3CO)nc21,160.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL134003,CC(C)n1cnc2c(NCc3ccccc3)nc(CCCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL133242,CC(C)n1cnc2c(NCc3ccccc3)nc(/C=C/CCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL130903,CC(C)n1cnc2c(Nc3cccc(Br)c3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL77369,CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085238,COc1ccc(CNc2nc(N3CCC[C@@H]3CO)nc3c2ncn3C(C)C)cc1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL26564,CCC(C)(O)C#Cc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,340.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL2112682,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@@H](CO)Cc3ccccc3)nc21,1300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL335966,CC(C)n1cnc2c(NCc3ccccc3)nc(N3CCC(O)C3)nc21,2400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL337715,CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL2112683,CC(C)n1cnc2c(NCc3ccccc3)nc(N3CCC[C@H]3CO)nc21,2400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL286491,CCC(C)(O)C#Cc1nc(NCc2ccc3c(c2)OCO3)c2ncn(C(C)C)c2n1,300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL282193,CCC(C)(O)C#Cc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,500.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL337411,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL130904,CC(C)n1cnc2c(Nc3ccccc3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL336995,CC(C)n1cnc2c(NCc3ccccc3C(F)(F)F)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085231,CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)nc(N3CCC[C@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085232,CC(C)n1cnc2c(NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL130597,CC(C)n1cnc2c(NCc3ccccc3)nc(N(CCO)Cc3ccccc3)nc21,8000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL132687,CC(C)n1cnc2c(NCc3ccccc3)nc(CCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085234,COc1ccccc1CNc1nc(N2CCC[C@@H]2CO)nc2c1ncn2C(C)C,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL133740,CC(C)n1cnc2c(N3CC=CCC3)nc(NCCO)nc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL2112678,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@H](C)CO)nc21,700.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL131031,C=CCN(C)c1nc(I)nc2c1ncn2C(C)C,14000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085242,OC[C@H]1CCCN1c1nc(NCc2ccccc2)c2ncn(C3CCCCC3)c2n1,13000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL131083,CC(C)n1cnc2c(NCc3ccc(C(F)(F)F)cc3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085243,CC(C)n1cnc2c(Nc3ccccc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL129973,C=CCN(C)c1nc(NCCO)nc2c1ncn2C,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL134233,CCC(O)CCc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL338924,CCC(C)(O)CCc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL440717,CC(C)n1cnc2c(NCc3ccccc3)nc(NCC(O)c3ccccc3)nc21,2300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085239,CC(C)[C@H](CO)Nc1nc(NCc2ccc3c(c2)OCO3)c2ncn(C(C)C)c2n1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL336351,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CC(C)(O)c3ccccc3)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL336176,C=CCN(C)c1nc(NCCO)nc2c1ncn2C(C)C,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL25840,CCC(C)(O)C#Cc1nc(NCc2ccc(Cl)c(Cl)c2)c2ncn(C(C)C)c2n1,500.0,nM,Compound was tested for its inhibitory activity against cyclin-dependent kinase 5
CHEMBL3085233,CC(C)n1cnc2c(NCc3ccc(C(F)(F)F)cc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL133461,CCCCNc1nc(C#CC(C)(O)Cc2ccccc2)nc2c1ncn2C(C)C,340.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL336537,CCCCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,2300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL335069,CC(C)n1cnc2c(NCc3ccccc3)nc(CCC(C)(O)c3ccccc3)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL2112679,CC(C)n1cnc2c(NC(CO)c3ccccc3)nc(N3CCC[C@H]3CO)nc21,,nM,Inhibition of cyclin-dependent kinase 5 (Not determined)
CHEMBL3085250,OC[C@H]1CCCN1c1nc(NCc2ccccc2)c2ncn(Cc3ccccc3)c2n1,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL280623,CCOc1ccc(Nc2nc(C#CC(C)(O)CC)nc3c2ncn3C(C)C)cc1,400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085246,CC(C)(C)n1cnc2c(NCc3ccccc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL2111871,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@H](CO)c3ccccc3)nc21,3500.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL2111872,CC(C)n1cnc2c(NCc3ccccc3)nc(N3CCC[C@@H]3CO)nc21,1300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085237,CC(C)n1cnc2c(NCc3ccc4c(c3)OCO4)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL130175,COc1ccc(CNc2nc(I)nc3c2ncn3C(C)C)cc1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL445125,CCC(O)C#Cc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,,nM,Inhibition of cyclin-dependent kinase 5 (Not determined)
CHEMBL132243,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL337291,CC(C)n1cnc2c(Cl)nc(I)nc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL134080,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CCCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL132469,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CCCCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL131697,CCCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL335852,CC(C)n1cnc2c(NCc3ccccc3)nc(CCCCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL2112681,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@@H](CO)c3ccccc3)nc21,6000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL133477,Ic1nc(NCc2ccccc2)c2ncn(Cc3ccccc3)c2n1,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL336117,C=CCN(C)c1nc(I)nc2c1ncn2C,40000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL334507,CC(C)n1cnc2c(Nc3ccc(Br)cc3)nc(N3CCCC3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL24484,CCC(C)(O)C#Cc1nc(NCc2ccc(Cl)cc2)c2ncn(C(C)C)c2n1,230.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL280074,Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21,3000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL2111873,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@@H](C)CO)nc21,35000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085245,CC(C)n1cnc2c(NCc3ccc(Cl)c(Cl)c3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL284899,CCC(C)(O)C#Cc1nc(Nc2ccccc2)c2ncn(C(C)C)c2n1,300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL23317,CCC(C)(O)C#Cc1nc(Nc2ccc(OC)cc2)c2ncn(C(C)C)c2n1,300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL436368,COc1ccc(CNc2nc(C#CC3(O)CCCCCC3)nc3c2ncn3C(C)C)cc1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL440163,CC(C)n1cnc2c(Nc3ccc(Br)cc3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL133533,CC(C)n1cnc2c(NCc3ccccc3)nc(I)nc21,13000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL133055,COc1cccc(CNc2nc(I)nc3c2ncn3C(C)C)c1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL2111869,CC(C)n1cnc2c(NC(CO)c3ccccc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL422759,CCC(C)(O)C#Cc1nc(NCc2ccc(OC)cc2)c2ncn(C(C)C)c2n1,400.0,nM,Compound was tested for its inhibitory activity against cyclin-dependent kinase 5
CHEMBL23525,CCC(C)(O)C#Cc1nc(NCc2ccc(N(C)C)cc2)c2ncn(C(C)C)c2n1,260.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL336283,CCC(C)(O)C#Cc1nc(NCCc2ccc(OC)cc2)c2ncn(C(C)C)c2n1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL335938,Ic1nc(NCc2ccccc2)c2ncn(C3CCCCC3)c2n1,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085236,CC(C)n1cnc2c(NCc3cccc(Br)c3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL282330,CCOc1ccc(CNc2nc(C#CC(C)(O)CC)nc3c2ncn3C(C)C)cc1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL52387,CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,160.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL338617,COc1ccccc1CNc1nc(I)nc2c1ncn2C(C)C,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL363711,CC(C)C(=O)Nc1ncc(C(C)C)s1,321.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL188172,CC(C)c1cnc(NC(=O)c2ccccc2)s1,1150.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186120,CC(C)c1cnc(NC(=O)Oc2ccccc2)s1,1600.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL434917,CC(C)c1cnc(NC(=O)C(=O)c2ccccc2)s1,4580.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186510,CC(C)c1cnc(NC(=O)Nc2ccccc2)s1,102.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL426972,CC(C)c1cnc(NC(=O)Cc2ccccc2)s1,64.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL185498,CCc1cnc(NC(=O)Cc2ccccc2)s1,621.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL365855,O=C(Cc1ccccc1)Nc1ncc(C2CCC2)s1,25.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186511,O=C(Cc1ccccc1)Nc1ncc(C2CCCC2)s1,64.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186846,O=C(Cc1ccccc1)Nc1ncc(C2CCCCC2)s1,390.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186847,O=C(Cc1ccccc1)Nc1ncc(C2=CCCC2)s1,6530.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186932,CCCCCc1cnc(NC(=O)Cc2ccccc2)s1,3270.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186934,O=C(Cc1ccccc1)Nc1ncc(-c2ccccc2)s1,1570.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL362369,CC(=O)c1cnc(NC(=O)Cc2ccccc2)s1,7670.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL185734,CSc1cnc(NC(=O)Cc2ccccc2)s1,91.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186201,O=C(Cc1ccccc1)Nc1ncc(Br)s1,900.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL363252,CN(C)c1cnc(NC(=O)Cc2ccccc2)s1,3990.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186898,O=C(Cc1ccc2[nH]cnc2c1)Nc1ncc(C2CCC2)s1,7.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL363954,O=C(Cc1ccc2ncccc2c1)Nc1ncc(C2CCC2)s1,10.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186470,Cc1nc2ccc(CC(=O)Nc3ncc(C4CCC4)s3)cc2s1,12.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL184404,O=C(Cc1cccc2cnccc12)Nc1ncc(C2CCC2)s1,13.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186240,O=C(Cc1c[nH]c2ccccc12)Nc1ncc(C2CCC2)s1,16.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL187903,Cc1cc2ncn(CC(=O)Nc3ncc(C4CCC4)s3)c2cc1C,13.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL364338,O=C(Cn1ccc2ccccc21)Nc1ncc(C2CCC2)s1,48.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL185470,O=C(Nc1ccccc1)Nc1ncc(C2CCC2)s1,183.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL187015,O=C(Nc1ccc2ncccc2c1)Nc1ncc(C2CCC2)s1,44.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL359591,O=C(Nc1ccc2cnccc2c1)Nc1ncc(C2CCC2)s1,44.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL187256,O=C(Nc1ncc(C2CCC2)s1)Nc1cccc2ncccc12,13.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL364213,O=C(Nc1ncc(C2CCC2)s1)Nc1cccc2cnccc12,8.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186342,O=C(Nc1ncc(C2CCC2)s1)Nc1cccc2ccncc12,5.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL363283,O=C(Nc1ncc(C2CCC2)s1)Nc1cccc2c[nH]nc12,190.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186371,O=C(Nc1ncc(C2CCC2)s1)Nc1cccc2[nH]nnc12,41.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL210540,Cc1cc(-c2cnc(Nc3cnc(CN4CCN(C)CC4)cn3)s2)nc(OC2CCCCC2)n1,3000.0,nM,Inhibition of CDK5
CHEMBL427045,Cc1cc(-c2cnc(Nc3ccccn3)s2)nc(OC2CCCCC2)n1,10000.0,nM,Inhibition of CDK5
CHEMBL212049,Cc1cnc(OC2CCCCC2)nc1-c1cnc(Nc2ccccn2)s1,10000.0,nM,Inhibition of CDK5
CHEMBL424696,c1ccc(Nc2ncc(-c3ccnc(OC4CCCCC4)n3)s2)nc1,34.0,nM,Inhibition of CDK5
CHEMBL386661,CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1,25000.0,nM,Inhibition of CDK5 by HTRF kinase assay
CHEMBL215943,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1,25000.0,nM,Inhibition of CDK5 by HTRF kinase assay
CHEMBL373882,CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1,100000.0,nM,Inhibition of CDK5
CHEMBL386637,CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1,100000.0,nM,Inhibition of CDK5
CHEMBL410295,Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12,10000.0,nM,Inhibition of CDK5 by HTRF assay
CHEMBL272888,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1,25000.0,nM,Inhibition of CDK5 by HTRF assay
CHEMBL427901,CCNC(=O)O[C@@H](C)[C@H]1c2ccccc2-c2c3c(c4c([nH]c5ccccc54)c21)CNC3=O,4329.0,nM,Inhibition of CDK5
CHEMBL505896,COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,100000.0,nM,Inhibition of CDK5
CHEMBL453737,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,100000.0,nM,Inhibition of CDK5
CHEMBL447602,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1,100000.0,nM,Inhibition of CDK5
CHEMBL516901,O=c1[nH]c2[nH]cc(-c3ccc(Cl)cc3)c2n2cccc12,50000.0,nM,Inhibition of CDK5
CHEMBL453402,COc1ccc(-c2c[nH]c3[nH]c(=O)c4cccn4c23)cc1OC,50000.0,nM,Inhibition of CDK5
CHEMBL477954,O=c1[nH]c2occ(-c3ccc(Br)cc3)c2n2cccc12,50000.0,nM,Inhibition of CDK5
CHEMBL517818,O=c1[nH]c2occ(-c3ccc(F)cc3)c2n2cccc12,50000.0,nM,Inhibition of CDK5
CHEMBL517669,Cc1ccc(-c2coc3[nH]c(=O)c4cccn4c23)cc1,50000.0,nM,Inhibition of CDK5
CHEMBL478516,COc1ccc(-c2coc3[nH]c(=O)c4cccn4c23)cc1,50000.0,nM,Inhibition of CDK5
CHEMBL478517,O=c1[nH]c2occ(-c3ccc(Cl)c(Cl)c3)c2n2cccc12,50000.0,nM,Inhibition of CDK5
CHEMBL478704,COc1ccc(-c2coc3[nH]c(=O)c4cccn4c23)cc1OC,50000.0,nM,Inhibition of CDK5
CHEMBL34267,COc1ccc(-c2csc3c2-n2cccc2C3=O)cc1OCc1ccccc1,,,Inhibition of CDK5
CHEMBL287508,COc1ccc(-c2csc3c2-n2cccc2C3=O)cc1O,,,Inhibition of CDK5
CHEMBL476236,O=C1c2[nH]cc(-c3ccc(Cl)cc3)c2-n2cccc21,50000.0,nM,Inhibition of CDK5
CHEMBL35864,COc1ccc(-c2c[nH]c3c2-n2cccc2C3=O)cc1OC,50000.0,nM,Inhibition of CDK5
CHEMBL507162,COc1ccc(-c2c[nH]c3c2-n2cccc2C3=O)cc1OCc1ccccc1,50000.0,nM,Inhibition of CDK5
CHEMBL518732,COc1ccc(-c2c[nH]c3c2-n2cccc2C3=O)cc1O,30000.0,nM,Inhibition of CDK5
CHEMBL286423,COc1ccc(-c2coc3c2-n2cccc2C3=O)cc1OC,50000.0,nM,Inhibition of CDK5
CHEMBL476851,COc1ccc(-c2c[nH]c3c2-n2cccc2/C3=N/O)cc1OCc1ccccc1,14000.0,nM,Inhibition of CDK5
CHEMBL444169,COc1ccc(-c2c[nH]c3c2-n2cccc2/C3=N/O)cc1O,3200.0,nM,Inhibition of CDK5
CHEMBL221959,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,10000.0,nM,Inhibition of Cdk5
CHEMBL516640,COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1,10000.0,nM,Inhibition of CDK5
CHEMBL574588,Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1,10000.0,nM,Inhibition of CDK5 by [gamma-33-P]ATP based assay
CHEMBL574613,CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1,10000.0,nM,Inhibition of CDK5 by [gamma-33-P]ATP based assay
CHEMBL240799,O=C1Nc2ccccc2CN1c1csc(-c2ccncc2)n1,79.0,nM,Inhibition of human CDK5
CHEMBL235764,O=c1[nH]c2ccccc2cc1-c1csc(-c2ccncc2)n1,54.0,nM,Inhibition of human CDK5
CHEMBL577030,CCOC(=O)c1cc(-c2csc(-c3ccncc3)n2)c(=O)[nH]c1C,131.0,nM,Inhibition of human CDK5
CHEMBL1077347,N#Cc1c(N)cc2[nH]nc(N)c2c1-c1ccccc1,11000.0,nM,Inhibition of CDK5
CHEMBL1080583,CCC(CO)Nc1nc(Nc2cccc(-c3ccccn3)c2)c2ncn(C(C)C)c2n1,80.0,nM,Inhibition of CDK5
CHEMBL409450,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,83.0,nM,Inhibition of CDK5
CHEMBL373834,O=Nc1c(-c2c(O)[nH]c3c(Br)cccc23)[nH]c2ccccc12,33000.0,nM,Inhibition of CDK5
CHEMBL1081198,O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1,50000.0,nM,Inhibition of CDK5 after 1 hr
CHEMBL1090360,O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1,1000.0,nM,Inhibition of CDK5
CHEMBL225519,O=C1NCCc2[nH]c(-c3ccncc3)cc21,460.0,nM,Inhibition of cdk5
CHEMBL1242977,CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1,8000.0,nM,Inhibition of CDK5 by HTRF assay
CHEMBL1243200,CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)cc2)n1,1000.0,nM,Inhibition of CDK5 by HTRF assay
CHEMBL1243326,CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1,25000.0,nM,Inhibition of CDK5 by HTRF assay
CHEMBL1242367,CCNc1cc(N[C@H]2CC[C@@H](O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1,25000.0,nM,Inhibition of CDK5
CHEMBL258805,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,65.0,nM,Inhibition of CDK5
CHEMBL50894,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,40.0,nM,Inhibition of CDK5
CHEMBL1241758,O=C(Nc1cc(C2CCC2)c[nH]1)Nc1cccc2ccncc12,5.0,nM,Inhibition of CDK5
CHEMBL362560,COc1ccc(-c2[nH]nc3c2C(=O)c2c(NC(=O)NNC(=O)c4ccc(O)cc4)cccc2-3)cc1,5.0,nM,Inhibition of CDK5
CHEMBL115220,O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1,114.0,nM,Inhibition of CDK5
CHEMBL1241935,CC1(C)CC2(C)Nc3cc(-c4ccc5c(c4)NC4(C)CC(C)(C)NC(=S)N54)ccc3N2C(=S)N1,25000.0,nM,Inhibition of CDK5
CHEMBL259850,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,100000.0,nM,Inhibition of CDK5 at 10 mM
CHEMBL50498,Nc1nccc(-c2c[nH]c3cccc(O)c23)n1,3500.0,nM,Inhibition of CDK5
CHEMBL1173442,C[C@H]1C/C=C/[C@@H](O)[C@@H](O)CC/C=C/c2cc(O)cc(O)c2C(=O)O1,6000.0,nM,Inhibition of CDK5
CHEMBL2205766,CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1,10000.0,nM,Inhibition of CDK5
CHEMBL605320,c1ccc2c(c1)nc(NCCN1CCOCC1)c1c3ccccc3[nH]c21,50000000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2297165,CCN(Cc1cn2ccccc2n1)Cc1nc2cc(OC)c(OC)cc2c(=O)[nH]1,50000000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL361708,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1,30.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL464381,CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O,25118.86,nM,Inhibition of human recombinant CDK5 using histone H1 as substrate and [gamma33P]-ATP after 20 mins by scintillation counting
CHEMBL2321962,O=C1Nc2c(Br)cccc2/C1=C1/Nc2cc(C(=O)O)ccc2/C1=N\O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321960,COC(=O)c1ccc2c(c1)NC(=C1\C(=O)Nc3c(Br)cccc31)/C2=N/O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321957,COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)N(C)c3c(Br)cccc31)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL1233659,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(C(=O)O)cc2/C1=N\O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321956,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccc(-c3nnn[nH]3)cc2/C1=N\O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321955,N#Cc1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321954,COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321953,COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3c(Br)cccc31)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL213454,Cn1c(O)c(-c2[nH]c3ccccc3c2N=O)c2cccc(Br)c21,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321949,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccccc2/C1=N\O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321947,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(CO)cc2C1=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321946,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2cc(C(=O)O)ccc2C1=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321945,O=C1Nc2c(Br)cccc2/C1=C1/Nc2cc(C(=O)O)ccc2C1=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2322019,COC(=O)c1ccc2c(c1)N/C(=C1\C(=O)Nc3c1cccc3C(F)(F)F)C2=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321975,COC(=O)c1ccc2c(c1)N/C(=C1\C(=O)Nc3c(Br)cccc31)C2=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321974,O=C1Nc2ccccc2/C1=C1/Nc2cc(C(=O)O)ccc2C1=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321973,COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)N(C)c3c(Br)cccc31)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321972,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccc(-c3nnn[nH]3)cc2C1=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321971,N#Cc1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321970,COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321969,COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3c(Br)cccc31)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321967,COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3ccccc31)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL375870,Cn1c(O)c(C2=Nc3ccccc3C2=O)c2cccc(Br)c21,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321968,O=C1Nc2ccccc2/C1=C1/Nc2ccc(C(=O)O)cc2C1=O,3400.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321959,O=C1Nc2ccccc2/C1=C1/Nc2cc(C(=O)O)ccc2/C1=N\O,3300.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321963,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2cc(C(=O)O)ccc2/C1=N\O,3100.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321961,COC(=O)c1ccc2c(c1)NC(=C1\C(=O)Nc3c1cccc3C(F)(F)F)/C2=N/O,1700.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321878,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccc(C(=O)O)cc2/C1=N\O,1600.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321965,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(/C=N\O)cc2/C1=N\O,600.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321952,O=C1Nc2ccccc2/C1=C1/Nc2ccc(C(=O)O)cc2/C1=N\O,530.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321951,COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3ccccc31)N2,520.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321964,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(CO)cc2/C1=N\O,400.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321958,CN1C(=O)/C(=C2\Nc3ccc(C(=O)O)cc3\C2=N/O)c2cccc(Br)c21,200.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321948,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(/C=N/O)cc2C1=O,200.0,nM,Inhibition of human recombinant CDK5
CHEMBL2391102,CC(=O)Nc1cc(-c2nnc(SCc3ccc(-c4ccccc4C#N)cc3)o2)ccn1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391101,CC(=O)Nc1cc(-c2nnc(SCc3cccc(C#N)c3)o2)ccn1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391100,CC(=O)Nc1cc(-c2nnc(SCc3ccccc3)o2)ccn1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391099,c1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391098,N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391131,COc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2390958,N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391132,N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391133,O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391117,Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391118,COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c(C#N)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391119,COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391120,O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391121,N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391122,O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391123,c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391124,Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391125,COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c(C#N)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391126,COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391127,N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391128,O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391130,N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391129,O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL191003,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,12.59,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2426395,COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(OC)cc2)cc1,1093.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP
CHEMBL2426391,COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(F)cc2)cc1,1178.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP
CHEMBL2426387,COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(Cl)cc2)cc1,1356.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP
CHEMBL2426383,COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(C)cc2)cc1,1420.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP
CHEMBL2426399,COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccccc2)cc1,1502.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP
CHEMBL3219057,COc1ccc2[nH]c(-c3ccccc3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219058,COc1ccc2[nH]c(-c3ccccc3O)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219059,COc1ccc2[nH]c(-c3cccc(O)c3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219060,COc1ccc2[nH]c(-c3ccc(O)cc3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219061,COc1ccc2[nH]c(-c3cccc(F)c3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219062,COc1ccc2[nH]c(-c3ccc4cc(O)ccc4c3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219063,COc1ccc2[nH]c(-c3cc(O)cc(O)c3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219064,COc1ccc2[nH]c(-c3cccc(O)c3)c(-c3cccnc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219065,COc1ccc2[nH]c(-c3cccc(O)c3)c(-c3ccccn3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3297830,Cn1c2c(O)cccc2c(=O)c2c3c(c4c(c21)C=CC(C)(C)O4)C=C(O)C(C)(C)O3,10000.0,nM,Inhibition of CDK5 (unknown origin) assessed as inhibition of phosphate incorporation into substrate in presence of radiolabeled ATP
CHEMBL3297831,Cn1c2c(O)cccc2c(=O)c2c3occc3c3c(c21)C=CC(C)(C)O3,10000.0,nM,Inhibition of CDK5 (unknown origin) assessed as inhibition of phosphate incorporation into substrate in presence of radiolabeled ATP
CHEMBL452220,CC1(C)C=Cc2c(cc(O)c3c(=O)c4cccc(O)c4[nH]c23)O1,10000.0,nM,Inhibition of CDK5 (unknown origin) assessed as inhibition of phosphate incorporation into substrate in presence of radiolabeled ATP
CHEMBL3297832,COc1c(O)ccc2c(=O)c3c(O)cc4c(c3[nH]c12)C=CC(C)(C)O4,9000.0,nM,Inhibition of CDK5 (unknown origin) assessed as inhibition of phosphate incorporation into substrate in presence of radiolabeled ATP
CHEMBL3589653,O=C(O)c1nc2ccccc2c2[nH]c3ccccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589654,CC(C)(C)c1ccc2[nH]c3c4ccccc4nc(C(=O)O)c3c2c1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589655,O=C(O)c1nc2ccccc2c2[nH]c3ccc(C(F)(F)F)cc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589656,O=C(O)c1nc2ccccc2c2[nH]c3ccc([N+](=O)[O-])cc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589657,Cc1ccc2[nH]c3c4ccccc4nc(C(=O)O)c3c2c1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589658,O=C(O)c1ccc2[nH]c3c4ccccc4nc(C(=O)O)c3c2c1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589659,O=C(O)c1nc2ccc(I)cc2c2[nH]c3ccc(Cl)cc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589660,O=C(O)c1nc2ccccc2c2[nH]c3c(Cl)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589661,O=C(O)c1nc2ccccc2c2[nH]c3c(Br)cccc3c12,100000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589662,O=C(O)c1nc2ccccc2c2[nH]c3c(I)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589663,COc1cccc2c1[nH]c1c3ccccc3nc(C(=O)O)c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589664,COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(F)c3[nH]c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589665,COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Cl)c3[nH]c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589666,COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Br)c3[nH]c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589667,COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(I)c3[nH]c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589668,O=C(O)c1nc2cc(Cl)ccc2c2[nH]c3c(Cl)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589669,CCOc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Cl)c3[nH]c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589670,O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(F)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589671,O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(Cl)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589672,O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(Br)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589673,COc1ccc2nc(C(=O)O)c3c4cccc(Cl)c4[nH]c3c2c1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589674,COc1cccc(-c2ccc3nc(C(=O)O)c4c5cccc(Cl)c5[nH]c4c3c2)c1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589675,COc1ccc(-c2ccc3nc(C(=O)O)c4c5cccc(Cl)c5[nH]c4c3c2)cc1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589774,O=C(O)c1nc2ccsc2c2[nH]c3c(Cl)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589775,O=C(O)c1nc2cccnc2c2[nH]c3c(Br)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3673435,COc1cc(F)ccc1-c1ccnc(NC(=O)C2CCC(NC(C)=O)C2)c1,1337.0,nM,"In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well)."
CHEMBL3673434,COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)c1,1077.0,nM,"In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well)."
CHEMBL3651158,COc1cc2cc3c(nc2cc1OC)C1=C([Si](C)(C)C)C(=O)CC1CC3O,3300.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL3651154,C[Si](C)(C)C1=C2c3nc4ccccc4cc3C(O)CC2CC1=O,1950.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL3651155,C[Si](C)(C)C1=C2c3nc4ccccc4cc3C(Cl)CC2CC1=O,63000.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL3651156,COc1ccc2nc3c(cc2c1)C(O)CC1CC(=O)C([Si](C)(C)C)=C31,4000.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL3651157,COc1ccc2cc3c(nc2c1)C1=C([Si](C)(C)C)C(=O)CC1CC3O,4800.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL189963,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,10000.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL1801932,CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12,3700.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,45.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775861,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCc3ccc(-c4ccccn4)cc3)nc12,3600.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774636,COc1ccc(CNc2nc(NCc3ccc(-c4ccccn4)cc3)c3[nH]nc(C(C)C)c3n2)cc1,4415.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775467,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCN(CCO)CC3)nc12,422.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774503,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12,179.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775657,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCCN(C)C)nc12,2136.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774949,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCNCC3)nc12,119.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775608,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCC(N)CO)nc12,17.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775223,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N[C@@H]3CCCC[C@H]3N)nc12,44.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775470,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCCN)nc12,8.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774979,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCCCC3CCO)nc12,37.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775681,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCSCC3)nc12,114.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775509,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCOCC3)nc12,5.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775677,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCC(O)CO)nc12,21.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774932,CCC(CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1,9.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775792,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCC(C)(C)O)nc12,1.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774632,CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1,5.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775502,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCCO)nc12,49.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775606,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(S(C)(=O)=O)nc12,165.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775479,CSc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1,229.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774434,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)ncnc12,183.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL518800,CC[C@H](CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1,225.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL1944698,CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1,3.0,nM,Inhibition of human GST-tagged CDK5
CHEMBL269881,Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1,97000.0,nM,Inhibition of human CDK5 (unknown origin)
CHEMBL319467,NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,480.0,nM,Inhibition of human CDK5 (unknown origin)
CHEMBL4092981,NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nn[nH]c3n2)cc1,3300.0,nM,Inhibition of human CDK5 (unknown origin)
CHEMBL4085238,NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3cn[nH]c3n2)cc1,5900.0,nM,Inhibition of human CDK5 (unknown origin)
CHEMBL4062554,NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3cc[nH]c3n2)cc1,4400.0,nM,Inhibition of human CDK5 (unknown origin)
CHEMBL3334979,COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC,,,Inhibition of human CDK5
CHEMBL4087337,COc1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(O)c1)O2,8840.0,nM,Inhibition of human CDK5
CHEMBL490355,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21,1500.0,nM,Inhibition of human CDK5
CHEMBL4098016,COc1ccc(-c2ccnc(Nc3cccc(N)c3)n2)cc1,81000.0,nM,Inhibition of human CDK5
CHEMBL4245507,O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4294760,CSc1ncc2c(n1)CCc1cnc(Nc3ccc(C(=O)N(C)CCN(C)C)cc3)nc1-2,680.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4292930,Cc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@@H]3CCO)nc12,1.0,nM,Inhibition of recombinant CDK5 (unknown origin) expressed in Sf9 cells using histone H1 derived biotinylated peptide and 33P-ATP incubated for 1 hr by liquid scintillation counting method
CHEMBL4579344,Cc1cc(C)c(CNc2nc(N[C@@H](C)[C@@H](C)O)nc3c2ncn3C(C)C)cn1,232.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL428690,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,170.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4459754,CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@@H]3CCNC[C@H]3O)nc12,9000.0,nM,Inhibition of CDK5 (unknown origin) by luciferase reporter gene assay
CHEMBL4303287,CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1,222.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4297488,CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12,9400.0,nM,Competitive reversible inhibition of CDK5 (unknown origin)
CHEMBL3655762,CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O,23.0,nM,Competitive reversible inhibition of CDK5 (unknown origin)
CHEMBL1234833,CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12,30.0,nM,Competitive reversible inhibition of CDK5 (unknown origin)
CHEMBL103667,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,1000.0,nM,Inhibition of human CDK5
CHEMBL4462530,CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1,1270.0,nM,Inhibition of CDK5 (unknown origin) in presence of 5 mM ATP
CHEMBL4754081,CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(F)cn2)C1,2780.0,nM,Inhibition of CDK5 (unknown origin) in presence of 5 mM ATP
CHEMBL4754399,CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4)c(Cl)cn2)C1,4100.0,nM,Inhibition of CDK5 (unknown origin) in presence of 5 mM ATP
CHEMBL4442620,C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F,10.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4764173,CC[C@H](Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1)[C@@H](C)O,21.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL445813,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,13.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4864688,O=C(CCCOc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1)NCCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,7.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4846069,COc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1,32.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5083646,COc1cc(/C=C2\S/C(=N/c3ccc(C)c(C)c3)NC2=O)ccc1OCc1ccc2ccccc2c1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL1496098,O=C1Nc2ccccc2/C1=C1\Nc2ccccc2\C1=N/O,,,Inhibition of CDK5 (unknown origin)
CHEMBL5191815,C.O=c1oc2cc(O)ccc2c2c1[nH]c1ccccc12,2700.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL1946917,O=c1oc2cc(O)ccc2c2c1[nH]c1ccc(O)cc12,720.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5184492,C[C@H]1C[C@@H]2CN1CCn1[nH]c3c(cccc3c1=O)-c1nc3c(cccc3[nH]c1=O)O2,4500.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2386753,COC(=N)c1nc2ccc3ncnc(Nc4ccc5c(c4)OCO5)c3c2s1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2386761,COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4)c3c2s1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2386744,COC(=N)c1nc2ccc3ncnc(Nc4ccc(Br)cc4F)c3c2s1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL384304,COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,0.1,nM,Inhibition of CDK5 (unknown origin) by kinase selectivity assay
CHEMBL5171657,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(C3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of recombinant CDK5 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated-histone H1 as substrate incubated for 1 hr in presence of 33P-ATP by liquid scintillation counter method
CHEMBL133342,CC[C@@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,200.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5178166,O=C1NC(=O)C(c2cn3c4c(cc(F)cc24)CN(C(=O)N2CCCCC2)CC3)=C1c1cn2ccccc2n1,79.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3905910,CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO,210.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL1922219,CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)[C@@H](C)O,70.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL296468,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,340.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3656841,COC[C@@H](C)N[C@H]1CC[C@H](Nc2cc(-c3cccc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,1050.0,nM,Inhibition of CDK5 (unknown origin) by Kinomescan method
CHEMBL5199065,CCC(CC)c1cc(N[C@H]2CC[C@H](N)C2)n2nccc2n1,1200.0,nM,Inhibition of CDK5 (unknown origin) incubated for 120 mins in presence of ATP by HotSpot kinase assay
CHEMBL5285499,CCCc1cc(N[C@@H]2CC[C@@H](N)C2)n2nccc2n1,1200.0,nM,Inhibition of CDK5 (unknown origin) incubated for 120 mins in presence of ATP by HotSpot kinase assay
CHEMBL1230607,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,5.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL269538,COc1ccc2c(c1)[nH]c1c(C)nccc12,8000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5200447,Cc1[nH]cnc1-c1nccc2c1[nH]c1ccccc12,5000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5288241,C=CC(=O)Nc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cncc(NC[C@@H](O)c5ccccc5)c4)cc23)cc1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5266005,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@@H]3CCO)nc12,1.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5270781,CC1CN(c2ccncc2NC(=O)c2ccnn3cc(-c4ccccc4)nc23)CCO1,6400.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL440411,O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O,7.0,nM,Inhibition of Cdk5
CHEMBL337300,O=Nc1c(-c2c(O)[nH]c3ccc(I)cc23)[nH]c2ccccc12,20.0,nM,Inhibition of Cdk5
CHEMBL261425,O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12,25000.0,nM,Inhibition of Cdk5
CHEMBL126077,O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,100.0,nM,Inhibition of Cdk5
CHEMBL1933576,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1,10000.0,nM,Inhibition of CDK5/P25
CHEMBL1933582,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1,10000.0,nM,Inhibition of CDK5/P25
CHEMBL460989,COc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O,10000.0,nM,Inhibition of human CDK expressed in baculovirus insect cell system
CHEMBL460990,CC(C)Oc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O,10000.0,nM,Inhibition of human CDK expressed in baculovirus insect cell system
CHEMBL1276127,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O,2200.0,nM,Inhibition of recombinant human CDK expressed in baculovirus infected sf9 cells after 10 mins by SDS-PAGE based autoradiography
CHEMBL5285373,COc1ccc(CCNc2nc(N)c(C(=O)c3cc(OC)c(OC)c(OC)c3)s2)cc1,10000.0,nM,Inhibition of CDK (unknown origin)
CHEMBL174068,CC(=O)O/N=C1/C(c2c(O)[nH]c3cc(Cl)ccc23)=Nc2ccccc21,200.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL435707,Cn1c(O)c(C2=Nc3ccccc3C2=O)c2ccccc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL176904,O=C1C(c2c(O)[nH]c3cc(Br)ccc23)=Nc2ccccc21,53000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL173040,O=Nc1c(-c2c(O)[nH]c3cc(Cl)ccc23)[nH]c2ccccc12,100.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL176896,CC(=O)O/N=C1/C(c2c(O)[nH]c3ccccc23)=Nc2ccccc21,700.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL173171,Cn1c(O)c(-c2[nH]c3ccccc3c2N=O)c2ccc(Br)cc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL354276,CO/N=C1/C(c2c(O)[nH]c3cc(Br)ccc23)=Nc2ccccc21,2200.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL368954,C=Cc1ccc2c(C3=Nc4ccccc4/C3=N\OC(C)=O)c(O)[nH]c2c1,400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL172547,CC(=O)O/N=C1/C(c2c(O)[nH]c3cc(Br)c([N+](=O)[O-])cc23)=Nc2ccccc21,31000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL353554,CC(=O)O/N=C1/C(c2c(O)[nH]c3cc(I)ccc23)=Nc2ccccc21,1300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL174292,O=Nc1c(-c2c(O)[nH]c3cc(F)ccc23)[nH]c2ccccc12,150.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL352781,CC(=O)O/N=C1/C(c2c(O)[nH]c3cc(F)ccc23)=Nc2ccccc21,300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL369823,C=Cc1ccc2c(-c3[nH]c4ccccc4c3N=O)c(O)[nH]c2c1,420.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL176306,O=C1C(c2c(O)[nH]c3cccc(Cl)c23)=Nc2ccccc21,10000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL170347,O=C1C(c2c(O)[nH]c3cc(Br)ccc23)=Nc2cc(Br)ccc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL354042,O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2cc(Br)ccc12,1200.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL170138,CO/N=C1/C(c2c(O)[nH]c3ccccc23)=Nc2ccccc21,400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL175053,C=Cc1ccc2c(C3=Nc4ccccc4C3=O)c(O)[nH]c2c1,2400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL174473,Cn1c(O)c(C2=Nc3ccccc3C2=O)c2ccc(Br)cc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL175155,Cc1cc2c(-c3[nH]c4ccccc4c3N=O)c(O)[nH]c2cc1Br,130.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL253769,CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Cl)c(Cl)cc32)/Nc2ccccc2/1,100.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL368112,O=C1C(c2c(O)[nH]c3cc(Br)c([N+](=O)[O-])cc23)=Nc2ccccc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL174343,O=C1C(c2c(O)[nH]c3cc(I)ccc23)=Nc2ccccc21,5300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL173178,Cc1cc2c(C3=Nc4ccccc4C3=O)c(O)[nH]c2cc1Br,60000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL177146,O=Nc1c(-c2c(O)[nH]c3cc(I)ccc23)[nH]c2ccccc12,300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL369220,O=C1C(c2c(O)[nH]c3cc(Cl)ccc23)=Nc2ccccc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL174612,CC(=O)O/N=C1/C(c2c(O)[nH]c3cc(Br)c(C)cc23)=Nc2ccccc21,30000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL367687,O=C1C(c2c(O)[nH]c3ccccc23)=Nc2cc(Br)ccc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL172540,O=C1C(c2c(O)[nH]c3cc(F)ccc23)=Nc2ccccc21,1000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL367664,O=C1C(c2c(O)[nH]c3cc(Cl)c(Cl)cc23)=Nc2ccccc21,60000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL366414,O=Nc1c(-c2c(O)[nH]c3cc(Cl)c(Cl)cc23)[nH]c2ccccc12,60.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL441109,O=Nc1c(-c2c(O)[nH]c3cc(Br)ccc23)[nH]c2cc(Br)ccc12,1300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL430226,CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1,2400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL366438,Cn1c(O)c(-c2[nH]c3ccccc3c2N=O)c2ccccc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL170640,O=Nc1c(-c2c(O)[nH]c3cc(Br)c([N+](=O)[O-])cc23)[nH]c2ccccc12,150.0,nM,Inhibitory activity against Cyclin-dependent kinase 5-p35nck5a
CHEMBL308293,CCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,500.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL76741,CCCCCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77264,COc1ccc(-c2[nH]c3nccnc3c2C)cc1,800.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL75680,CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,200.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL307941,Clc1ccc(C2(c3cc4[nH]ccnc-4n3)CC2)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL305627,c1coc(-c2cc3[nH]ccnc-3n2)c1,9300.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL310036,Clc1ccc(-c2[nH]c3nccnc3c2Cc2ccccc2)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77267,c1c[nH]c2cc(-c3ccc(C4OCCO4)cc3)nc-2n1,15000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL76942,COc1ccc(-c2[nH]c3nccnc3c2CCCCl)cc1,3000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL76740,COc1ccc(-c2[nH]c3nccnc3c2CC2CC2)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77584,Oc1ccccc1-c1cc2[nH]ccnc-2n1,3000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL80785,Oc1ccc(-c2cc3[nH]ccnc-3n2)cc1,1000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL335027,CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1C,,nM,Inhibition of Cyclin-dependent kinase 5 (CDK5) (Not Determined)
CHEMBL77416,c1ccc(-c2cc3[nH]ccnc-3n2)nc1,53000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77066,COc1ccc(-c2cc3[nH]ccnc-3n2)cc1,4000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77002,COc1cc(OC)cc(-c2cc3[nH]ccnc-3n2)c1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL76941,C=CCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,2000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL306498,CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,1500.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77540,Cc1c(-c2ccc(OS(=O)(=O)N(C)C)cc2)[nH]c2nccnc12,900.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL170774,CCOC(=O)c1cnc2oc3ccc(OC(C)=O)cc3c2c1-c1ccccc1,,nM,Inhibition of Cyclin-dependent kinase 5 (CDK5)
CHEMBL305901,c1ccc(-c2cc3[nH]ccnc-3n2)cc1,4000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77469,c1ccc(Cc2c(-c3ccccc3)[nH]c3nccnc23)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL76660,Clc1cc(Cl)cc(-c2cc3[nH]ccnc-3n2)c1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77210,FC(F)(F)c1ccc(-c2cc3[nH]ccnc-3n2)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL306263,Fc1ccc(-c2cc3[nH]ccnc-3n2)cc1,1000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL296586,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,850.0,nM,Inhibition of Cyclin-dependent kinase 5 (CDK5)
CHEMBL312065,COc1cc(-c2cc3[nH]ccnc-3n2)cc(OC)c1OC,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77095,CCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,1200.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL74015,c1csc(-c2cc3[nH]ccnc-3n2)c1,2000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL78264,c1ccc2c(-c3cc4[nH]ccnc-4n3)cccc2c1,80000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL419273,COc1ccc(-c2[nH]c3nccnc3c2C)cc1OC,1000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL311935,Cc1c[nH]c2cc(-c3ccccc3)nc-2n1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77697,N#Cc1ccc(-c2cc3[nH]ccnc-3n2)cc1,13000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77217,CC(C)c1c(-c2ccc(Cl)cc2)[nH]c2nccnc12,13000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL76427,Cc1c(C2(c3ccc(Cl)cc3)CC2)[nH]c2nccnc12,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL306347,Clc1ccc(-c2[nH]c3nccnc3c2CC2CCCCC2)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL306355,CCCCc1c(-c2ccc(Cl)cc2)[nH]c2nccnc12,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL335518,CC(=O)c1cnc2oc3ccc(O)cc3c2c1C,,nM,Inhibition of Cyclin-dependent kinase 5 (CDK5) (Not Determined)
CHEMBL78165,Cc1c(-c2ccc(Cl)cc2)[nH]c2nccnc12,5000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL74133,Oc1ccc(-c2[nH]c3nccnc3c2CC2CC2)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL80644,COc1cccc(-c2cc3[nH]ccnc-3n2)c1,10000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77458,CN(C)c1ccc(-c2cc3[nH]ccnc-3n2)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL78232,Cn1c(-c2ccccc2)cc2nccnc21,7000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77947,COc1ccc(-c2[nH]c3nccnc3c2CC2CCCCC2)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL307943,Cc1ccc(-c2cc3[nH]ccnc-3n2)cc1,10000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL132904,CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1,,nM,Inhibition of Cyclin-dependent kinase 5 (CDK5) (Not Determined)
CHEMBL77590,COc1ccccc1-c1cc2[nH]ccnc-2n1,23000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL309347,COc1ccc(-c2[nH]c3nccnc3c2C(C)C)cc1,2000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77641,Cc1c(-c2ccc(O)cc2)[nH]c2nccnc12,200.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL307392,c1ccc(-c2cc3[nH]c4ccccc4nc-3n2)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL133712,CC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1,,nM,Inhibition of Cyclin-dependent kinase 5 (CDK5) (Not Determined)
CHEMBL76559,c1c[nH]c2cc(-c3ccsc3)nc-2n1,1000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL77211,Brc1ccc(-c2cc3[nH]ccnc-3n2)cc1,100000.0,nM,Inhibitory activity against recombinant mammalian cyclin-dependent kinase 5 (p35 NCK5a) expressed in Escherichia coli
CHEMBL321192,COc1ccc2c(c1)C(=O)C(c1c(O)[nH]c3ccccc13)=N2,1200.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL111624,COc1ccc2[nH]c(O)c(C3=Nc4ccccc4C3=O)c2c1,1200.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL326919,Cc1ccc2c(c1)C(=O)C(c1c(O)[nH]c3ccccc13)=N2,1900.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL109622,COc1ccc2c(c1)C(=O)C(c1[nH]c3ccccc3c1O)=N2,100000.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL114396,COc1ccc2c(c1)C(=O)C(c1[nH]c3ccc(OC)cc3c1O)=N2,26000.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL599552,O=C1/C(=C2\Nc3ccccc3C2=O)Nc2ccccc21,100000.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL111433,Cc1ccc2[nH]c(O)c(C3=Nc4ccccc4C3=O)c2c1,5000.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL321194,COc1ccc2c(c1)C(=O)C(c1c(O)[nH]c3ccc(OC)cc13)=N2,800.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL99779,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1Cc1ccccc1,269773.94,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL121543,O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cc(CC#CO)ccc2N1,1999.86,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL316485,CN1C(=O)Cc2c([nH]c3ccc(Br)cc23)-c2ccccc21,130016.96,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL318208,Cn1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2,399944.75,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL430574,O=C1Cc2c([nH]c3ccccc23)-c2ccccc2N1,10092.53,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL317964,Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3,6295.06,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL120030,CC(=O)OCN1C(=O)Cc2c([nH]c3ccc(Br)cc23)-c2ccccc21,5296.63,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL331722,O=C1Cc2c([nH]c3ccc(Cl)cc23)-c2cccnc2N1,41975.9,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL331120,CSC1=Nc2ccccc2-c2c(c3cc([N+](=O)[O-])ccc3n2C)C1,849180.48,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL95477,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cccc(O)c2N1,849180.48,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL545053,Cl.NCCCCOc1ccc2c(c1)NC(=O)Cc1c-2[nH]c2ccc(Br)cc12,419758.98,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL97844,CCN1C(=O)Cc2c([nH]c3ccc(Br)cc23)-c2ccccc21,799834.26,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL121958,COC(=O)/C=C/c1ccc2c(c1)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2,14996.85,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL325403,COc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,69.98,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL98360,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cc(Br)ccc2N1,10000.0,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL98554,O=C1Cc2c([nH]c3cc(Br)ccc23)-c2ccccc2N1,2697.74,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL332678,CC(=O)OCn1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2,349945.17,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL121957,O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cc(I)ccc2N1,6998.42,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL99037,O=C1Cc2c([nH]c3ccc(F)cc23)-c2ccccc2N1,1300.17,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL328194,COc1cc2c(cc1OC)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2,429.54,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL324064,C=C(C)n1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2,239883.29,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL98153,O=C1Cc2c([nH]c3ccc(Cl)cc23)-c2ccccc2N1,799.83,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL319373,COc1cc2c(cc1OC)-c1[nH]c3ccc(Br)cc3c1CC(=O)N2,500.03,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL116545,COc1ccc2c(c1)NC(=O)Cc1c-2[nH]c2ccc([N+](=O)[O-])cc12,629.51,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL331000,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccc(O)cc2N1,829.85,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL318471,O=C1Cc2c([nH]c3c(Cl)cccc23)-c2ccccc2N1,2897.34,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL331190,COc1cc2c(cc1OC)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,20.99,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL334084,COc1ccc2c(c1)NC(=O)Cc1c-2[nH]c2ccc(C(F)(F)F)cc12,2197.86,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL121492,N#CCCc1ccc2c(c1)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2,33.04,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL329063,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cc(O)c(O)cc2N1,7998.34,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL316940,O=C1Cc2c([nH]c3ccccc23)-c2cc(Br)ccc2N1,5000.35,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL431634,COc1cc2c(cc1OC)-c1[nH]c3ccccc3c1CC(=O)N2,5395.11,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL99803,O=C1Cc2c(n(CCO)c3ccc(Br)cc23)-c2ccccc2N1,139958.73,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL116832,O=C1Cc2c([nH]c3ccccc23)-c2cc(I)ccc2N1,7396.05,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL120355,Nc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3,29991.63,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL331783,O=C1Cc2c([nH]c3ncccc23)-c2ccccc2N1,3303.7,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL334031,O=C1Cc2c([nH]c3ccc(Cl)cc23)-c2sccc2N1,5000.35,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL100309,O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cc(Br)ccc2N1,2999.16,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL317150,CCc1cccc2c3c([nH]c12)-c1ccccc1NC(=O)C3,23014.42,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL120137,COc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ncccc1-3,419758.98,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL121953,Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ncccc1-3,429536.43,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL120941,NCC(=O)c1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3,5495.41,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL120078,O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cccnc2N1,13001.7,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL329505,O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2ccccc2N1,599.79,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL316512,O=C1Cc2c([nH]c3cc(Cl)cc(Cl)c23)-c2ccccc2N1,349945.17,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL331502,SC1=Nc2ccccc2-c2cc(-c3ccccn3)cc(-c3cccs3)c2C1,699842.0,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL333894,CC(=O)Cc1ccc2c(c1)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2,419.76,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL318911,O=C1Cc2c([nH]c3c(Br)cccc23)-c2ccccc2N1,1698.24,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL299756,N#Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3,43.95,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL98501,Cc1cccc2c3c([nH]c12)-c1ccccc1NC(=O)C3,8994.98,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL52551,SC1=Nc2ccccc2-c2[nH]c3ccc(Br)cc3c2C1,7998.34,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL328164,CSC1=Nc2ccccc2-c2[nH]c3ccc(Br)cc3c2C1,449779.85,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL323657,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2sccc2N1,3999.45,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL95827,COc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3,2098.94,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL99423,COc1cccc2c1NC(=O)Cc1c-2[nH]c2ccccc12,1000000.0,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL333006,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2cc(Br)ccc2N1,119.95,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL332359,COc1ccc2c(c1)NC(=O)Cc1c-2[nH]c2ccc(C#N)cc12,1000.0,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL120497,O=[N+]([O-])c1ccc2[nH]c3c(c2c1)CC(S)=Nc1ccccc1-3,1698.24,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL100312,CC(C)(C)OC(=O)n1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2,799834.26,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL419054,N#C/C=C/c1ccc2c(c1)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2,9506.05,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL333066,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cc(I)ccc2N1,29991.63,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL325654,COc1cc2c(cc1OC)-c1[nH]c3ccc(C#N)cc3c1CC(=O)N2,59.98,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL119989,CC(=O)/C=C/c1ccc2c(c1)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2,33962.53,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL331759,Brc1ccc2[nH]c3c(c2c1)CCCc1ccccc1-3,859013.52,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL119932,N#Cc1ccc2c(c1)-c1[nH]c3ccccc3c1CC(=O)N2,449779.85,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL119963,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2sccc2N1,100.0,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL328627,CCn1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2,260015.96,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL330398,COc1cccc2c1NC(=O)Cc1c-2[nH]c2ccc(Br)cc12,399944.75,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL118406,Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccsc1-3,39994.47,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL120664,O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cc(C#CC3(O)CCCCC3)ccc2N1,8298.51,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL118162,N#Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccsc1-3,319.89,nM,Inhibitory activity against cyclin-dependent kinase 5/p25
CHEMBL336961,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1,4200.0,nM,Inhibition of human Cyclin-dependent kinase 5-p35nck5a
CHEMBL134501,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cccnc2N1,12000.0,nM,Inhibition of human Cyclin-dependent kinase 5-p35nck5a
CHEMBL334091,O=C(Nc1csc(Cc2c(Cl)cccc2Cl)n1)NN1CCCC1,3000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL119143,CN(C)NC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1,4000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL332112,O=C(Nc1csc(Cc2ccccc2)n1)NN1CCOCC1,55000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL118659,O=C(NNc1ccccc1)Nc1csc(Cc2c(Cl)cccc2Cl)n1,100000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL116339,CN(NC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1)c1ccccc1,10000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL117779,Cc1cccc(-c2nc(NC(=O)NOc3ccccc3)cs2)c1,16000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL116017,O=C(Nc1csc(CSc2ccccc2)n1)NN1CCOCC1,30000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL118199,O=C(Nc1csc(-c2ccc(Cl)cc2)n1)NN1CCOCC1,100000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL116615,O=C(NOc1ccccc1)Nc1csc(-c2ccccc2)n1,8000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL324961,CNNC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1,100000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL333215,NNC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1,100000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL117906,O=C(Nc1csc(Cc2c(Cl)cccc2Cl)n1)NN1CCCCCC1,10000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL115625,O=C(Nc1csc(-c2ccccc2Cl)n1)NN1CCOCC1,30000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL119430,CCc1nc(NC(=O)NN2CCOCC2)cs1,100000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL118253,O=C(Nc1csc(Cc2c(Cl)cccc2Cl)n1)NN(Cc1ccccc1)Cc1ccccc1,100000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL115650,Cc1cccc(-c2nc(NC(=O)NN3CCOCC3)cs2)c1,30000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL117950,CC(C)(C)ONC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1,1000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL115472,O=C(Nc1csc(Cc2c(Cl)cccc2Cl)n1)NN1CCCCC1,6000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL116326,CNNCC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1,100000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL116949,O=C(Nc1csc(CS(=O)(=O)c2ccccn2)n1)NN1CCOCC1,10000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL119530,O=C(NOc1ccccc1)Nc1csc(Cc2c(Cl)cccc2Cl)n1,900.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL115429,COc1ccc(OCc2nc(NC(=O)NN3CCOCC3)cs2)cc1,30000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL327004,O=C(Nc1csc(Cc2c(Cl)cccc2Cl)n1)NN1CCOCC1,1000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL333136,O=C(Nc1csc(-c2ccccc2)n1)NN1CCOCC1,9000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL119796,CCONC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1,5000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL117778,CS(=O)(=O)Cc1nc(NC(=O)NOc2ccccc2)cs1,6000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL325452,O=C(NOc1ccccc1)Nc1csc(Cc2ccccc2)n1,20000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL117800,CONC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1,9000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL118043,O=C(Nc1csc(COc2ccccc2)n1)NN1CCOCC1,80000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL334062,O=C(NOCc1c(F)c(F)c(F)c(F)c1F)Nc1csc(Cc2c(Cl)cccc2Cl)n1,100000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL118685,C=CCONC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1,6000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL119041,O=C(NOC1CCCCO1)Nc1csc(Cc2c(Cl)cccc2Cl)n1,3000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL117768,COC[C@H]1CCCN1NC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1,100000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL115649,Cc1ccc(-c2nc(NC(=O)NN3CCOCC3)cs2)cc1,100000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL119812,O=C(Nc1csc(-c2cccs2)n1)NN1CCOCC1,30000.0,nM,Ability to inhibit Cyclin-dependent kinase 5-p35.
CHEMBL50226,Nc1nccc(-c2cc3ccccc3[nH]2)n1,130000.0,nM,Inhibition of human Cyclin-dependent kinase 5-p35nck5a
CHEMBL296682,Nc1nccc(-c2c[nH]c3c(Br)ccc(O)c23)n1,150.0,nM,Inhibition of human Cyclin-dependent kinase 5-p35nck5a
CHEMBL44545,Nc1nccc(-c2c[nH]c3cc(Br)cc(O)c23)n1,1000.0,nM,Inhibition of human Cyclin-dependent kinase 5-p35nck5a
CHEMBL46440,Nc1nccc(-c2c[nH]c3cc(Br)ccc23)n1,5500.0,nM,Inhibition of human Cyclin-dependent kinase 5-p35nck5a
CHEMBL48081,Nc1nccc(-c2cc3cc(Br)ccc3[nH]2)n1,300000.0,nM,Inhibition of human Cyclin-dependent kinase 5-p35nck5a
CHEMBL48082,Nc1nccc(-c2c[nH]c3ccccc23)n1,140000.0,nM,Inhibition of human Cyclin-dependent kinase 5-p35nck5a
CHEMBL296271,Nc1nccc(-c2c[nH]c3cc(Br)c(Br)cc23)n1,20000.0,nM,Inhibition of human Cyclin-dependent kinase 5-p35nck5a
CHEMBL44541,Nc1nccc(-c2c[nH]c3ccc(Br)cc23)n1,6000.0,nM,Inhibition of human Cyclin-dependent kinase 5-p35nck5a
CHEMBL14217,O=[N+]([O-])c1ccc(Cl)c(-c2[nH]ccc3c4ccccc4nc2-3)c1,1200000.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL273547,Cc1[nH]cnc1-c1[nH]ccc2c3ccccc3nc1-2,5000.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL14445,Cc1nccc2c1[nH]c1cc(F)ccc12,24000.0,nM,Inhibition of Cyclin-dependent kinase 5-p35nck5a
CHEMBL31574,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,570.0,nM,Inhibition of Cyclin-dependent kinase 5-p25nck5a
CHEMBL28,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,1600.0,nM,Inhibition of Cyclin-dependent kinase 5-p25nck5a
CHEMBL150,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,51000.0,nM,Inhibition of Cyclin-dependent kinase 5-p25nck5a
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,23000.0,nM,Inhibition of Cyclin-dependent kinase 5-p25nck5a
CHEMBL151,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,3800.0,nM,Inhibition of Cyclin-dependent kinase 5-p25nck5a
CHEMBL117,O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12,3100.0,nM,Inhibition of Cyclin-dependent kinase 5-p25nck5a
CHEMBL179219,Cc1cnc2oc3ccc(O)cc3c2c1-c1ccccc1,,nM,Inhibitory concentration tested against Cyclin-dependent kinase 5; NA: not active
CHEMBL183408,COc1cnc2oc3ccc(O)cc3c2c1-c1ccccc1,6300.0,nM,Inhibitory concentration tested against Cyclin-dependent kinase 5
CHEMBL361537,CCOc1cnc2oc3ccc(O)cc3c2c1-c1ccccc1,5900.0,nM,Inhibitory concentration tested against Cyclin-dependent kinase 5
CHEMBL361565,Oc1ccc2oc3ncc(Cl)c(-c4ccccc4)c3c2c1,,nM,Inhibitory concentration tested against Cyclin-dependent kinase 5; NA: not active
CHEMBL361573,Oc1ccc2oc3ncc(Br)c(-c4ccccc4)c3c2c1,,nM,Inhibitory concentration tested against Cyclin-dependent kinase 5; NA: not active
CHEMBL191336,OCCCNc1cc(-c2ncnc(Nc3cccc(Cl)c3)n2)ccn1,3.0,nM,Inhibition of CDK5/p35
CHEMBL191144,C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCCC2=O)cc1,65.0,nM,Inhibition of cyclin-dependent kinase 5 p25 alpha (n=5)
CHEMBL191834,C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCOC2=O)cc1,57.0,nM,Inhibition of cyclin-dependent kinase 5 p25 alpha (n=4)
CHEMBL201382,O=C1c2c(c3c4ccccc4[nH]c3c3ccccc23)C(=O)N1CCc1c[nH]cn1,10000.0,nM,Inhibitory activity against CDK5/p25
CHEMBL383097,O=C1c2c(c3c4cc(O)ccc4[nH]c3c3ccccc23)C(=O)N1CCc1c[nH]cn1,10000.0,nM,Inhibitory activity against CDK5/p25
CHEMBL378359,CN1C(=O)c2c(c3c4ccccc4[nH]c3c3ccccc23)C1=O,10000.0,nM,Inhibitory activity against CDK5/p25
CHEMBL201418,O=C1c2c(c3c4cc(O)ccc4[nH]c3c3ccccc23)C(=O)N1C(CO)CO,10000.0,nM,Inhibitory activity against CDK5/p25
CHEMBL201114,O=C1c2c(c3c4ccccc4[nH]c3c3ccccc23)C(=O)N1C(CO)CO,10000.0,nM,Inhibitory activity against CDK5/p25
CHEMBL202979,CN(C)CCN1C(=O)c2c(c3c4cc(O)ccc4[nH]c3c3ccccc23)C1=O,10000.0,nM,Inhibitory activity against CDK5/p25
CHEMBL382056,CN(C)CCN1C(=O)c2c(c3c4ccccc4[nH]c3c3ccccc23)C1=O,10000.0,nM,Inhibitory activity against CDK5/p25
CHEMBL202935,O=C1NC(=O)c2c1c1ccccc1c1[nH]c3ccc(O)cc3c21,250.0,nM,Inhibitory activity against CDK5/p25
CHEMBL421087,O=C1NC(=O)c2c1c1ccccc1c1[nH]c3ccccc3c21,8500.0,nM,Inhibitory activity against CDK5/p25
CHEMBL197700,O=C1OC(=O)c2c1c1ccccc1c1[nH]c3ccc(O)cc3c21,10000.0,nM,Inhibitory activity against CDK5/p25
CHEMBL382906,O=C1OC(=O)c2c1c1ccccc1c1[nH]c3ccccc3c21,10000.0,nM,Inhibitory activity against CDK5/p25
CHEMBL380656,CN1C(=O)c2c(c3c4cc(O)ccc4[nH]c3c3ccccc23)C1=O,10000.0,nM,Inhibitory activity against CDK5/p25
CHEMBL383104,CCCCNC(=O)N1Cc2n[nH]c(NC(=O)Cc3ccc(N4CCCC4)cc3)c2C1,280.0,nM,Inhibitory activity against CDK5/p25
CHEMBL380946,CCCCNC(=O)N1Cc2n[nH]c(NC(=O)[C@@H](C)c3ccc4ccccc4c3)c2C1,150.0,nM,Inhibitory activity against CDK5/p25
CHEMBL379029,COCCNc1nc(-c2ccc(C=O)cc2)nc2c1ncn2C(C)C,1400.0,nM,Inhibition of Cdk5/p25
CHEMBL377061,COc1ccc(CNc2nc(-c3ccc(C=O)cc3)nc3c2ncn3C(C)C)cc1,1300.0,nM,Inhibition of Cdk5/p25
CHEMBL209404,COCCNc1nc(-c2ccc(C#N)s2)nc2c1ncn2C(C)C,2200.0,nM,Inhibition of Cdk5/p25
CHEMBL379618,COCCNc1nc(-c2ccc(C(C)=O)s2)nc2c1ncn2C(C)C,4900.0,nM,Inhibition of Cdk5/p25
CHEMBL379811,COCCNc1nc(-c2ccc(NC(=O)OC)cc2)nc2c1ncn2C(C)C,4000.0,nM,Inhibition of Cdk5/p25
CHEMBL207426,COCCNc1nc(-c2ccc(C(=O)NCCC#N)cc2)nc2c1ncn2C(C)C,3400.0,nM,Inhibition of Cdk5/p25
CHEMBL437325,CNC(=O)c1ccc(-c2nc(NCCOC)c3ncn(C(C)C)c3n2)cc1,1800.0,nM,Inhibition of Cdk5/p25
CHEMBL210839,COCCNc1nc(-c2ccc(NS(C)(=O)=O)cc2)nc2c1ncn2C(C)C,3000.0,nM,Inhibition of Cdk5/p25
CHEMBL208017,COCCNc1nc(-c2ccc(C(C)=O)cc2)nc2c1ncn2C(C)C,2800.0,nM,Inhibition of Cdk5/p25
CHEMBL438791,Cn1c(O)c(C2=Nc3ccccc3/C2=N\OCCn2ccnc2)c2cccc(Br)c21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL211192,CCN(CC)CCO/N=C1/C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21.Cl,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL253770,O=C1Nc2ccc(Br)cc2/C1=C1/Nc2ccccc2/C1=N\O,28.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL377536,CCN(CC)C(=O)O/N=C1/C(c2c(O)n(C)c3c(Br)cccc23)=Nc2ccccc21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL378485,CCN(CC)C(=O)O/N=C1/C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL211457,CCN(CC)CCO/N=C1/C(c2c(O)n(C)c3c(Br)cccc23)=Nc2ccccc21.Cl,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL378059,CCN(CC)CCO/N=C1/C(c2c(O)n(C)c3c(Br)cccc23)=Nc2ccccc21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL379878,CCN(CC)CCO/N=C1/C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL213077,CN(C)CCO/N=C1/C(c2c(O)n(C)c3c(Br)cccc23)=Nc2ccccc21.Cl,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL208540,CN(C)CCO/N=C1/C(c2c(O)n(C)c3c(Br)cccc23)=Nc2ccccc21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL378198,CN(C)CCO/N=C1/C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21.Cl,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL212581,CN(C)CCO/N=C1/C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL379713,Cl.Cl.Oc1[nH]c2c(Br)cccc2c1C1=Nc2ccccc2/C1=N\OCCN1CCNCC1,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL379858,Oc1[nH]c2c(Br)cccc2c1C1=Nc2ccccc2/C1=N\OCCN1CCNCC1,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL211093,Cl.Oc1[nH]c2c(Br)cccc2c1C1=Nc2ccccc2/C1=N\OCCn1ccnc1,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL213401,Oc1[nH]c2c(Br)cccc2c1C1=Nc2ccccc2/C1=N\OCCn1ccnc1,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL379146,Cl.Cn1c(O)c(C2=Nc3ccccc3/C2=N\OCCN2CCOCC2)c2cccc(Br)c21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL426693,Cn1c(O)c(C2=Nc3ccccc3/C2=N\OCCN2CCOCC2)c2cccc(Br)c21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL213894,Cl.Oc1[nH]c2c(Br)cccc2c1C1=Nc2ccccc2/C1=N\OCCN1CCOCC1,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL211409,Oc1[nH]c2c(Br)cccc2c1C1=Nc2ccccc2/C1=N\OCCN1CCOCC1,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL377981,Cl.Cn1c(O)c(C2=Nc3ccccc3/C2=N\OCCN2CCCC2)c2cccc(Br)c21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL210104,Cn1c(O)c(C2=Nc3ccccc3/C2=N\OCCN2CCCC2)c2cccc(Br)c21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL211430,Cl.Oc1[nH]c2c(Br)cccc2c1C1=Nc2ccccc2/C1=N\OCCN1CCCC1,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL211429,Oc1[nH]c2c(Br)cccc2c1C1=Nc2ccccc2/C1=N\OCCN1CCCC1,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL384159,Cn1c(O)c(C2=Nc3ccccc3/C2=N\OCCBr)c2cccc(Br)c21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL377410,Oc1[nH]c2c(Br)cccc2c1C1=Nc2ccccc2/C1=N\OCCBr,25000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL208832,CC(=O)O/N=C1/C(c2c(O)n(C)c3c(I)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL378316,CO/N=C1/C(c2c(O)n(C)c3c(I)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL374006,Cn1c(O)c(-c2[nH]c3ccccc3c2N=O)c2cccc(I)c21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL210161,Cn1c(O)c(C2=Nc3ccccc3C2=O)c2cccc(I)c21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL378937,CC(=O)O/N=C1/C(c2c(O)[nH]c3c(I)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL213128,CO/N=C1/C(c2c(O)[nH]c3c(I)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL209648,O=Nc1c(-c2c(O)[nH]c3c(I)cccc23)[nH]c2ccccc12,77000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL379160,O=C1C(c2c(O)[nH]c3c(I)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL209968,CC(=O)O/N=C1/C(c2c(O)n(C)c3c(Br)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL213506,CO/N=C1/C(c2c(O)n(C)c3c(Br)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL213742,CC(=O)O/N=C1/C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL436748,CO/N=C1/C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL214173,O=C1C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL378849,CC(=O)O/N=C1/C(c2c(O)n(C)c3c(Cl)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL212465,CO/N=C1/C(c2c(O)n(C)c3c(Cl)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL378205,Cn1c(O)c(-c2[nH]c3ccccc3c2N=O)c2cccc(Cl)c21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL380241,Cn1c(O)c(C2=Nc3ccccc3C2=O)c2cccc(Cl)c21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL380053,CC(=O)O/N=C1/C(c2c(O)[nH]c3c(Cl)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL211205,CO/N=C1/C(c2c(O)[nH]c3c(Cl)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL213650,O=Nc1c(-c2c(O)[nH]c3c(Cl)cccc23)[nH]c2ccccc12,6000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL378191,O=C1C(c2c(O)[nH]c3c(Cl)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL379378,CC(=O)O/N=C1/C(c2c(O)n(C)c3c(F)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL212057,CO/N=C1/C(c2c(O)n(C)c3c(F)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL211445,Cn1c(O)c(-c2[nH]c3ccccc3c2N=O)c2cccc(F)c21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL378787,Cn1c(O)c(C2=Nc3ccccc3C2=O)c2cccc(F)c21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL210073,CC(=O)O/N=C1/C(c2c(O)[nH]c3c(F)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL211593,CO/N=C1/C(c2c(O)[nH]c3c(F)cccc23)=Nc2ccccc21,100000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL212174,O=Nc1c(-c2c(O)[nH]c3c(F)cccc23)[nH]c2ccccc12,510.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL210446,O=C1C(c2c(O)[nH]c3c(F)cccc23)=Nc2ccccc21,10000.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL209849,CC(=O)O/N=C1\C(c2c(O)[nH]c3ccccc23)=Nc2ccccc21,700.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL211243,CO/N=C1\C(c2c(O)[nH]c3ccccc23)=Nc2ccccc21,400.0,nM,Inhibition of mammalian CDK5/p25
CHEMBL210229,CC(C)n1cnc2ccc3nc(C(=N)NCCN(C)C)sc3c2c1=O,4000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL210474,CCn1cnc2ccc3nc(C(=N)NCCN(C)C)sc3c2c1=O,,,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL378190,CC(C)NC(=N)c1nc2ccc3ncn(C(C)C)c(=O)c3c2s1,,,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL208741,CCn1cnc2ccc3nc(C(=N)NC(C)C)sc3c2c1=O,,,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL211803,COc1ccc(Cn2cnc3ccc4nc(C5=NCCN5)sc4c3c2=O)cc1,,,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL211562,O=c1c2c(ccc3nc(C4=NCCN4)sc32)ncn1Cc1ccccc1,10000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL210236,CC(C)CCn1cnc2ccc3nc(C4=NCCN4)sc3c2c1=O,10000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL210919,CC(C)Cn1cnc2ccc3nc(C4=NCCN4)sc3c2c1=O,100000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL210918,CCCn1cnc2ccc3nc(C4=NCCN4)sc3c2c1=O,100000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL439502,CC(C)n1cnc2ccc3nc(C4=NCCN4)sc3c2c1=O,100000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL209336,CCn1cnc2ccc3nc(C4=NCCN4)sc3c2c1=O,100000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL378307,COc1ccc(CN2C=Nc3ccc4nc(C#N)sc4c3C2)cc1,,,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL379530,N#Cc1nc2ccc3c(c2s1)CN(Cc1ccccc1)C=N3,10000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL210385,CC(C)CCN1C=Nc2ccc3nc(C#N)sc3c2C1,100000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL210330,CC(C)CN1C=Nc2ccc3nc(C#N)sc3c2C1,10000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL210106,CCCN1C=Nc2ccc3nc(C#N)sc3c2C1,100000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL210105,CC(C)N1C=Nc2ccc3nc(C#N)sc3c2C1,10000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL210001,CCN1C=Nc2ccc3nc(C#N)sc3c2C1,27000.0,nM,Inhibition of CDK5/p25 in presence of 15 uM ATP
CHEMBL389447,CCCC(=O)Nc1nc(NCc2ccc(OC)cc2)c2ncn(C(C)C)c2n1,3900.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL224112,COCCNc1nc(C(=O)NC(C)C)nc2c1ncn2C(C)C,13000.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL387759,COCCNc1nc(C(=O)NCC(C)C)nc2c1ncn2C(C)C,16000.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL224695,CC(C)NC(=O)c1nc(NCc2ccc(Cl)cc2)c2ncn(C(C)C)c2n1,2000.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL225424,COc1ccc(CNc2nc(C(=O)NC(C)C)nc3c2ncn3C(C)C)cc1,2400.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL224840,COc1ccc(CNc2nc(C(=O)NCC(C)C)nc3c2ncn3C(C)C)cc1,2100.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL224261,COCCNc1nc(NC(=O)c2ccc(OC)cc2)nc2c1ncn2C(C)C,,,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL224387,COCCNc1nc(NC(=O)CC(C)=O)nc2c1ncn2C(C)C,,,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL224386,COCCNc1nc(NC(=O)C(C)C)nc2c1ncn2C(C)C,7000.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL224694,COCCNc1nc(NC(=O)CC(C)C)nc2c1ncn2C(C)C,6600.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL225056,CCCC(=O)Nc1nc(NCCOC)c2ncn(C(C)C)c2n1,10000.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL224927,COc1ccc(C(=O)Nc2nc(NCc3ccc(Cl)cc3)c3ncn(C(C)C)c3n2)cc1,19000.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL225096,CC(C)C(=O)Nc1nc(NCc2ccc(Cl)cc2)c2ncn(C(C)C)c2n1,900.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL425121,CC(C)CC(=O)Nc1nc(NCc2ccc(Cl)cc2)c2ncn(C(C)C)c2n1,1600.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL225645,CCCC(=O)Nc1nc(NCc2ccc(Cl)cc2)c2ncn(C(C)C)c2n1,2100.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL225055,COc1ccc(CNc2nc(NC(=O)c3ccc(OC)cc3)nc3c2ncn3C(C)C)cc1,3400.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL224257,COc1ccc(CNc2nc(NC(=O)CC(C)=O)nc3c2ncn3C(C)C)cc1,1600.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL225043,COc1ccc(CNc2nc(NC(=O)C(C)C)nc3c2ncn3C(C)C)cc1,1300.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL225002,COc1ccc(CNc2nc(NC(=O)CC(C)C)nc3c2ncn3C(C)C)cc1,1800.0,nM,Inhibition of recombinant mammalian CDK5/p25 expressed in Escherichia coli
CHEMBL231568,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OC[C@@H]5CCCN5C)c4)nc3c2)ccn1,40000.0,nM,Inhibition of CDK5p25
CHEMBL243209,Nn1c(S)nnc1Cc1csc(NC(=O)CCl)n1,390.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234743,CC(=O)Nn1c(Cc2csc(NCCC(=O)O)n2)nnc1SCC#N,641.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL389762,CC(=O)Nn1c(Cc2csc(NC(=O)c3ccccc3)n2)nnc1SCC#N,574.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234742,CC(=O)Nc1nc(Cc2nnc(SCC#N)n2NC(C)=O)cs1,463.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233539,CC(=O)Nn1c(Cc2csc(NC(=O)CCl)n2)nnc1SCC#N,415.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244080,N#CCSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(=O)c1ccccc1,487.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL388905,N#CCSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccccc1,496.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL242151,CC(=O)Nc1nc(Cc2nnc(SCC#N)n2NC(=O)c2ccccc2)cs1,395.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL241941,N#CCSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccccc1,657.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233953,N#CCSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(=O)c1ccc(Cl)cc1,426.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL437560,N#CCSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccc(Cl)cc1,64.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL399828,CC(=O)Nc1nc(Cc2nnc(SCC#N)n2NC(=O)c2ccc(Cl)cc2)cs1,62.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234150,N#CCSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccc(Cl)cc1,562.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233935,CC(=O)Nn1c(Cc2csc(NCCC(=O)O)n2)nnc1SCSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(C)=O,743.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233934,CC(=O)Nn1c(Cc2csc(NC(=O)c3ccccc3)n2)nnc1SCSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(C)=O,764.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233331,CC(=O)Nc1nc(Cc2nnc(SCSc3nnc(Cc4csc(NC(C)=O)n4)n3NC(C)=O)n2NC(C)=O)cs1,847.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234765,CC(=O)Nn1c(Cc2csc(NC(=O)CCl)n2)nnc1SCSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(C)=O,847.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233933,O=C(O)CCNc1nc(Cc2nnc(SCSc3nnc(Cc4csc(NC(=O)CCC(=O)O)n4)n3NC(=O)c3ccccc3)n2NC(=O)c2ccccc2)cs1,587.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244070,O=C(Nc1nc(Cc2nnc(SCSc3nnc(Cc4csc(NC(=O)c5ccccc5)n4)n3NC(=O)c3ccccc3)n2NC(=O)c2ccccc2)cs1)c1ccccc1,698.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL395553,CC(=O)Nc1nc(Cc2nnc(SCSc3nnc(Cc4csc(NC(C)=O)n4)n3NC(=O)c3ccccc3)n2NC(=O)c2ccccc2)cs1,647.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL395083,O=C(CCl)Nc1nc(Cc2nnc(SCSc3nnc(Cc4csc(NC(=O)CCl)n4)n3NC(=O)c3ccccc3)n2NC(=O)c2ccccc2)cs1,674.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL265602,O=C(O)CCNc1nc(Cc2nnc(SCSc3nnc(Cc4csc(NCCC(=O)O)n4)n3NC(=O)c3ccc(Cl)cc3)n2NC(=O)c2ccc(Cl)cc2)cs1,168.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL439029,O=C(Nc1nc(Cc2nnc(SCSc3nnc(Cc4csc(NC(=O)c5ccccc5)n4)n3NC(=O)c3ccc(Cl)cc3)n2NC(=O)c2ccc(Cl)cc2)cs1)c1ccccc1,640.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL398141,CC(=O)Nc1nc(Cc2nnc(SCSc3nnc(Cc4csc(NC(C)=O)n4)n3NC(=O)c3ccc(Cl)cc3)n2NC(=O)c2ccc(Cl)cc2)cs1,382.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233334,O=C(CCl)Nc1nc(Cc2nnc(SCSc3nnc(Cc4csc(NC(=O)CCl)n4)n3NC(=O)c3ccc(Cl)cc3)n2NC(=O)c2ccc(Cl)cc2)cs1,340.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL396826,CC(=O)Nn1c(S)nnc1Cc1csc(NCCC(=O)O)n1,436.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL396357,CC(=O)Nn1c(S)nnc1Cc1csc(NC(=O)c2ccccc2)n1,614.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234349,CC(=O)Nc1nc(Cc2nnc(S)n2NC(C)=O)cs1,598.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232087,CC(=O)Nn1c(S)nnc1Cc1csc(NC(=O)CCl)n1,684.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL396526,O=C(O)CCNc1nc(Cc2nnc(S)n2NC(=O)c2ccccc2)cs1,674.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL242997,O=C(Nc1nc(Cc2nnc(S)n2NC(=O)c2ccccc2)cs1)c1ccccc1,894.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL242996,CC(=O)Nc1nc(Cc2nnc(S)n2NC(=O)c2ccccc2)cs1,574.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL242782,O=C(CCl)Nc1nc(Cc2nnc(S)n2NC(=O)c2ccccc2)cs1,761.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL398390,O=C(O)CCNc1nc(Cc2nnc(S)n2NC(=O)c2ccc(Cl)cc2)cs1,462.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233519,O=C(Nc1nc(Cc2nnc(S)n2NC(=O)c2ccc(Cl)cc2)cs1)c1ccccc1,186.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL398389,CC(=O)Nc1nc(Cc2nnc(S)n2NC(=O)c2ccc(Cl)cc2)cs1,462.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233518,O=C(CCl)Nc1nc(Cc2nnc(S)n2NC(=O)c2ccc(Cl)cc2)cs1,642.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL243211,Nn1c(S)nnc1Cc1csc(NCCC(=O)O)n1,264.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL243210,Nn1c(S)nnc1Cc1csc(NC(=O)c2ccccc2)n1,630.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL390918,CC(=O)Nc1nc(Cc2nnc(S)n2N)cs1,48.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL397760,COC(=O)CSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(C)=O,746.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL391674,COC(=O)CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(C)=O,598.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232270,COC(=O)CSc1nnc(Cc2csc(NC(C)=O)n2)n1NC(C)=O,467.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232064,COC(=O)CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(C)=O,695.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL428572,COC(=O)CSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(=O)c1ccccc1,648.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL388906,COC(=O)CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccccc1,364.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL243704,COC(=O)CSc1nnc(Cc2csc(NC(C)=O)n2)n1NC(=O)c1ccccc1,587.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244081,COC(=O)CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccccc1,674.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232524,COC(=O)CSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(=O)c1ccc(Cl)cc1,560.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL399387,COC(=O)CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccc(Cl)cc1,290.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232522,COC(=O)CSc1nnc(Cc2csc(NC(C)=O)n2)n1NC(=O)c1ccc(Cl)cc1,380.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232320,COC(=O)CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccc(Cl)cc1,440.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL392947,CC(=O)Nn1c(Cc2csc(NCCC(=O)O)n2)nnc1SCC(=O)NN,943.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232088,CC(=O)Nn1c(Cc2csc(NC(=O)c3ccccc3)n2)nnc1SCC(=O)NN,186.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234564,CC(=O)Nc1nc(Cc2nnc(SCC(=O)NN)n2NC(C)=O)cs1,241.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234563,CC(=O)Nn1c(Cc2csc(NC(=O)CCl)n2)nnc1SCC(=O)NN,201.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL414802,NNC(=O)CSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(=O)c1ccccc1,465.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL390697,NNC(=O)CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccccc1,268.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244490,CC(=O)Nc1nc(Cc2nnc(SCC(=O)NN)n2NC(=O)c2ccccc2)cs1,197.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244489,NNC(=O)CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccccc1,246.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL399808,NNC(=O)CSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(=O)c1ccc(Cl)cc1,64.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL398774,NNC(=O)CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccc(Cl)cc1,34.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233491,CC(=O)Nc1nc(Cc2nnc(SCC(=O)NN)n2NC(=O)c2ccc(Cl)cc2)cs1,72.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233489,NNC(=O)CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccc(Cl)cc1,44.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL411969,CC(=O)Nn1c(Cc2csc(NCCC(=O)O)n2)nnc1SCC(=O)NNC(=O)CCl,264.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL231671,CC(=O)Nn1c(Cc2csc(NC(=O)c3ccccc3)n2)nnc1SCC(=O)NNC(=O)CCl,356.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL391207,CC(=O)Nc1nc(Cc2nnc(SCC(=O)NNC(=O)CCl)n2NC(C)=O)cs1,476.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL394336,CC(=O)Nn1c(Cc2csc(NC(=O)CCl)n2)nnc1SCC(=O)NNC(=O)CCl,462.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234780,CC(=O)Nn1c(Cc2csc(NCCC(=O)O)n2)nnc1SCC(=O)NNC(=O)c1ccccc1,476.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL394335,CC(=O)Nn1c(Cc2csc(NC(=O)c3ccccc3)n2)nnc1SCC(=O)NNC(=O)c1ccccc1,413.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234572,CC(=O)Nc1nc(Cc2nnc(SCC(=O)NNC(=O)c3ccccc3)n2NC(C)=O)cs1,436.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL231668,CC(=O)Nn1c(Cc2csc(NC(=O)CCl)n2)nnc1SCC(=O)NNC(=O)c1ccccc1,365.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL392980,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(C)=O,463.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234778,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(C)=O,643.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234777,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NC(C)=O)n2)n1NC(C)=O,384.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL392948,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(C)=O,354.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244336,O=C(O)CCNc1nc(Cc2nnc(SCC(=O)NNC(=O)CCl)n2NC(=O)c2ccccc2)cs1,462.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL243439,O=C(CCl)NNC(=O)CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccccc1,542.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL437569,CC(=O)Nc1nc(Cc2nnc(SCC(=O)NNC(=O)CCl)n2NC(=O)c2ccccc2)cs1,643.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL243438,O=C(CCl)NNC(=O)CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccccc1,530.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL390029,O=C(O)CCNc1nc(Cc2nnc(SCC(=O)NNC(=O)c3ccccc3)n2NC(=O)c2ccccc2)cs1,432.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244852,O=C(CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccccc1)NNC(=O)c1ccccc1,463.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244318,CC(=O)Nc1nc(Cc2nnc(SCC(=O)NNC(=O)c3ccccc3)n2NC(=O)c2ccccc2)cs1,421.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244692,O=C(CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccccc1)NNC(=O)c1ccccc1,467.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244691,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(=O)c1ccccc1,472.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244504,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccccc1,564.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL396547,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NC(C)=O)n2)n1NC(=O)c1ccccc1,542.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL437951,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccccc1,356.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232492,O=C(O)CCNc1nc(Cc2nnc(SCC(=O)NNC(=O)CCl)n2NC(=O)c2ccc(Cl)cc2)cs1,180.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL393528,O=C(CCl)NNC(=O)CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccc(Cl)cc1,340.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232077,CC(=O)Nc1nc(Cc2nnc(SCC(=O)NNC(=O)CCl)n2NC(=O)c2ccc(Cl)cc2)cs1,260.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL428540,O=C(CCl)NNC(=O)CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccc(Cl)cc1,224.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL231867,O=C(O)CCNc1nc(Cc2nnc(SCC(=O)NNC(=O)c3ccccc3)n2NC(=O)c2ccc(Cl)cc2)cs1,268.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL393676,O=C(CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccc(Cl)cc1)NNC(=O)c1ccccc1,484.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234763,CC(=O)Nc1nc(Cc2nnc(SCC(=O)NNC(=O)c3ccccc3)n2NC(=O)c2ccc(Cl)cc2)cs1,534.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL439021,O=C(CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccc(Cl)cc1)NNC(=O)c1ccccc1,640.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234557,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(=O)c1ccc(Cl)cc1,352.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234556,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccc(Cl)cc1,340.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234343,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NC(C)=O)n2)n1NC(=O)c1ccc(Cl)cc1,641.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL234342,CC(=O)NNC(=O)CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccc(Cl)cc1,464.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233122,CC(=O)Nn1c(Cc2csc(NCCC(=O)O)n2)nnc1SCc1nnc(S)n1N,6412.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233121,CC(=O)Nn1c(Cc2csc(NC(=O)c3ccccc3)n2)nnc1SCc1nnc(S)n1N,6342.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL393355,CC(=O)Nc1nc(Cc2nnc(SCc3nnc(S)n3N)n2NC(C)=O)cs1,5246.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233120,CC(=O)Nn1c(Cc2csc(NC(=O)CCl)n2)nnc1SCc1nnc(S)n1N,4635.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL388028,Nn1c(S)nnc1CSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(=O)c1ccccc1,4785.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244703,Nn1c(S)nnc1CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccccc1,4653.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244528,CC(=O)Nc1nc(Cc2nnc(SCc3nnc(S)n3N)n2NC(=O)c2ccccc2)cs1,6537.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL244527,Nn1c(S)nnc1CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccccc1,6985.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL231860,Nn1c(S)nnc1CSc1nnc(Cc2csc(NCCC(=O)O)n2)n1NC(=O)c1ccc(Cl)cc1,6650.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL231859,Nn1c(S)nnc1CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccc(Cl)cc1,3180.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL401232,CC(=O)Nc1nc(Cc2nnc(SCc3nnc(S)n3N)n2NC(=O)c2ccc(Cl)cc2)cs1,7480.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232677,Nn1c(S)nnc1CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccc(Cl)cc1,3260.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232913,CC(=O)Nn1c(Cc2csc(NCCC(=O)O)n2)nnc1SCC(=O)N/N=C/c1ccccc1,635.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232912,CC(=O)Nn1c(Cc2csc(NC(=O)c3ccccc3)n2)nnc1SCC(=O)N/N=C/c1ccccc1,467.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL392055,CC(=O)Nc1nc(Cc2nnc(SCC(=O)N/N=C/c3ccccc3)n2NC(C)=O)cs1,463.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL231673,CC(=O)Nn1c(Cc2csc(NC(=O)CCl)n2)nnc1SCC(=O)N/N=C/c1ccccc1,536.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL231672,O=C(O)CCNc1nc(Cc2nnc(SCC(=O)N/N=C/c3ccccc3)n2NC(=O)c2ccccc2)cs1,526.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL241938,O=C(CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccccc1)N/N=C/c1ccccc1,496.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL243459,CC(=O)Nc1nc(Cc2nnc(SCC(=O)N/N=C/c3ccccc3)n2NC(=O)c2ccccc2)cs1,485.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL243458,O=C(CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccccc1)N/N=C/c1ccccc1,467.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL233073,O=C(O)CCNc1nc(Cc2nnc(SCC(=O)N/N=C/c3ccccc3)n2NC(=O)c2ccc(Cl)cc2)cs1,238.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL413137,O=C(CSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)n1NC(=O)c1ccc(Cl)cc1)N/N=C/c1ccccc1,246.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL232864,CC(=O)Nc1nc(Cc2nnc(SCC(=O)N/N=C/c3ccccc3)n2NC(=O)c2ccc(Cl)cc2)cs1,30.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL395512,O=C(CSc1nnc(Cc2csc(NC(=O)CCl)n2)n1NC(=O)c1ccc(Cl)cc1)N/N=C/c1ccccc1,42.0,nM,Inhibition of human cdk5/p25 by SPA
CHEMBL239203,CC(=O)Nc1cc(C)c(-c2nnc(S)n2N)s1,58.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL394959,O=C(CCl)Nc1cc(-c2ccccc2)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2cccc([N+](=O)[O-])c2)S3)s1,2684.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL394958,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2cccc([N+](=O)[O-])c2)S3)s1,2436.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL235660,O=C(CCl)Nc1cc(-c2ccccc2)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2ccc(Cl)cc2)S3)s1,2448.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL414698,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2ccc(Cl)cc2)S3)s1,2482.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL394452,O=C(CCl)Nc1cc(-c2ccccc2)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2ccccc2Cl)S3)s1,2458.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL435355,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2ccccc2Cl)S3)s1,2464.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL394451,O=C(CCl)Nc1cc(-c2ccccc2)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2ccccc2)S3)s1,2486.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL236102,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2ccccc2)S3)s1,1452.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL237857,O=C(CCl)Nc1cc(-c2ccccc2)c(-c2nnc3sc(-c4cccc([N+](=O)[O-])c4)nn23)s1,48.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL237856,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3sc(-c4cccc([N+](=O)[O-])c4)nn23)s1,60.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL237855,O=C(CCl)Nc1cc(-c2ccccc2)c(-c2nnc3sc(-c4ccccc4)nn23)s1,28.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL237674,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3sc(-c4ccccc4)nn23)s1,38.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL396649,O=C(CCl)Nc1cc(-c2ccccc2)c(-c2nnc3sc(=S)[nH]n23)s1,5896.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL237659,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3sc(=S)[nH]n23)s1,2058.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL399188,O=C(CCl)Nc1cc(-c2ccccc2)c(-c2nnc3n2Nc2nc4ccccc4nc2S3)s1,30.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL239215,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3n2Nc2nc4ccccc4nc2S3)s1,54.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL239856,O=C(CCl)Nc1cc(-c2ccccc2)c(-c2nnc3n2NC(c2ccccc2)=C(c2ccccc2)S3)s1,62.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL391315,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3n2NC(c2ccccc2)=C(c2ccccc2)S3)s1,40.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL391314,CC1=Nn2c(nnc2-c2sc(NC(=O)CCl)cc2-c2ccccc2)SC1,368.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL238267,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3n2N=C(C)CS3)s1,448.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL238116,O=C(CCl)Nc1cc(-c2ccccc2)c(-c2nnc3n2NC(=O)CS3)s1,634.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL391723,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc3n2NC(=O)CS3)s1,418.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL442239,Nn1c(S)nnc1-c1sc(NC(=O)CCl)cc1-c1ccccc1,42.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL235972,CC(=O)Nc1cc(-c2ccccc2)c(-c2nnc(S)n2N)s1,54.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL392317,Cc1cc(NC(=O)CCl)sc1-c1nnc2n1N=C(c1cc(F)c(Cl)cc1Cl)/C(=C/c1cccc([N+](=O)[O-])c1)S2,3074.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL235887,CC(=O)Nc1cc(C)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2cccc([N+](=O)[O-])c2)S3)s1,3046.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL235886,Cc1cc(NC(=O)CCl)sc1-c1nnc2n1N=C(c1cc(F)c(Cl)cc1Cl)/C(=C/c1ccc(Cl)cc1)S2,2968.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL235671,CC(=O)Nc1cc(C)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2ccc(Cl)cc2)S3)s1,3386.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL391666,Cc1cc(NC(=O)CCl)sc1-c1nnc2n1N=C(c1cc(F)c(Cl)cc1Cl)/C(=C/c1ccccc1Cl)S2,3340.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL235670,CC(=O)Nc1cc(C)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2ccccc2Cl)S3)s1,3284.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL1162017,Cc1cc(NC(=O)CCl)sc1-c1nnc2n1N=C(c1cc(F)c(Cl)cc1Cl)/C(=C/c1ccccc1)S2,3420.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL1162016,CC(=O)Nc1cc(C)c(-c2nnc3n2N=C(c2cc(F)c(Cl)cc2Cl)/C(=C/c2ccccc2)S3)s1,2370.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL235967,Cc1cc(NC(=O)CCl)sc1-c1nnc2sc(-c3cccc([N+](=O)[O-])c3)nn12,53.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL235965,CC(=O)Nc1cc(C)c(-c2nnc3sc(-c4cccc([N+](=O)[O-])c4)nn23)s1,64.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL397170,Cc1cc(NC(=O)CCl)sc1-c1nnc2sc(-c3ccccc3)nn12,30.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL238105,CC(=O)Nc1cc(C)c(-c2nnc3sc(-c4ccccc4)nn23)s1,42.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL239213,Cc1cc(NC(=O)CCl)sc1-c1nnc2sc(=S)[nH]n12,7480.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL238999,CC(=O)Nc1cc(C)c(-c2nnc3sc(=S)[nH]n23)s1,3260.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL238997,Cc1cc(NC(=O)CCl)sc1-c1nnc2n1Nc1nc3ccccc3nc1S2,64.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL238789,CC(=O)Nc1cc(C)c(-c2nnc3n2Nc2nc4ccccc4nc2S3)s1,34.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL238576,Cc1cc(NC(=O)CCl)sc1-c1nnc2n1NC(c1ccccc1)=C(c1ccccc1)S2,72.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL394010,CC(=O)Nc1cc(C)c(-c2nnc3n2NC(c2ccccc2)=C(c2ccccc2)S3)s1,44.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL238575,CC1=Nn2c(nnc2-c2sc(NC(=O)CCl)cc2C)SC1,462.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL241764,CC(=O)Nc1cc(C)c(-c2nnc3n2N=C(C)CS3)s1,642.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL239637,Cc1cc(NC(=O)CCl)sc1-c1nnc2n1NC(=O)CS2,820.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL239853,CC(=O)Nc1cc(C)c(-c2nnc3n2NC(=O)CS3)s1,630.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL239205,Cc1cc(NC(=O)CCl)sc1-c1nnc(S)n1N,46.0,nM,Inhibitory activity against Cdk5/p25
CHEMBL238089,CN1CCN(c2cccc(NC(=O)Nc3csc(-c4ccncc4)n3)n2)CC1,15.0,nM,Inhibition of human His-tagged p25/CDK5
CHEMBL392228,O=C(Nc1ccccc1)Nc1csc(-c2ccncc2)n1,2990.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL239709,O=C(Nc1ccccn1)Nc1csc(-c2ccncc2)n1,192.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL400630,O=C1Nc2cc(CN3CCOCC3)ccc2CN1c1csc(-c2ccncc2)n1,62.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL400433,O=C1Nc2cccc(CN3CCOCC3)c2CN1c1csc(-c2ccncc2)n1,284.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL238709,CN1CCN(c2ccc3c(c2)CN(c2csc(-c4ccncc4)n2)C(=O)N3)CC1,1165.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL392784,CN1CCN(c2cccc3c2CN(c2csc(-c4ccncc4)n2)C(=O)N3)CC1,829.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL238494,O=C1Nc2cc(-c3ccccc3)ccc2CN1c1csc(-c2ccncc2)n1,113.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL392738,O=C1Nc2cc(Br)ccc2CN1c1csc(-c2ccncc2)n1,38.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL393041,O=C1Nc2cc(F)ccc2CN1c1csc(-c2ccncc2)n1,16.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL239106,Cc1ccc2c(c1)CN(c1csc(-c3ccncc3)n1)C(=O)N2,165.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL238684,O=C1Nc2ccc(F)cc2CN1c1csc(-c2ccncc2)n1,72.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL238683,COc1cccc2c1CN(c1csc(-c3ccncc3)n1)C(=O)N2,362.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL238682,Cc1cccc2c1CN(c1csc(-c3ccncc3)n1)C(=O)N2,1260.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL238463,O=C1Nc2cccc(Br)c2CN1c1csc(-c2ccncc2)n1,228.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL241451,O=C1Nc2cccc(Cl)c2CN1c1csc(-c2ccncc2)n1,332.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL400813,O=C1Nc2cccc(F)c2CN1c1csc(-c2ccncc2)n1,240.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL240800,O=C1Nc2ccccc2CN1c1cccc(-c2ccncc2)c1,10000.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL392982,O=C1Nc2ccccc2CN1c1ccc(-c2ccncc2)s1,10000.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL241439,O=C1Nc2ccccc2CN1c1nc(-c2ccncc2)ns1,616.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL238462,O=C1Nc2ccccc2CN1c1nc(-c2ccncc2)no1,10000.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL391058,O=C1Nc2ccccc2CN1c1nc(-c2ccncc2)cs1,77.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL392792,O=c1[nH]c2ccccc2n1-c1csc(-c2ccncc2)n1,1160.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL239924,O=c1[nH]c2ccccc2c(=O)n1-c1csc(-c2ccncc2)n1,10000.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL240353,CCc1cc(-c2nc(N3Cc4ccccc4NC3=O)cs2)ccn1,746.0,nM,Inhibition of human His-tagged p25/CDK5
CHEMBL393491,O=C1Nc2ccccc2CN1c1nc(-c2ccccn2)cs1,7360.0,nM,Inhibition of human His-tagged p25/CDK5
CHEMBL238716,O=C1Nc2ccccc2CN1c1nc(-c2cccnc2)cs1,399.0,nM,Inhibition of human His-tagged p25/CDK5
CHEMBL238790,O=c1[nH]c2ccccc2cc1-c1csc(C[S+]([O-])c2ccccc2)n1,120.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL394009,CC(C)(C)S(=O)(=O)Cc1nc(-c2cc3ccccc3[nH]c2=O)cs1,6900.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL241765,CS(=O)(=O)Cc1nc(-c2cc3ccccc3[nH]c2=O)cs1,300.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL239855,O=c1[nH]c2ccccc2cc1-c1csc(CS(=O)(=O)c2ccc(Cl)cc2)n1,240.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL391906,O=c1[nH]c2ccccc2cc1-c1csc(CS(=O)(=O)c2cccs2)n1,2.1,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL239636,O=c1[nH]c2ccccc2cc1-c1csc(CS(=O)(=O)c2ccccn2)n1,10.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL391905,O=c1[nH]c2ccccc2cc1-c1csc(CS(=O)(=O)c2ccccc2)n1,29.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL391726,COc1ccc(-c2nc(-c3cc4ccccc4[nH]c3=O)cs2)cc1,10000.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL241545,O=c1[nH]c2ccccc2cc1-c1csc(-c2ccc(O)cc2)n1,24.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL241335,Nc1ccc(-c2nc(-c3cc4ccccc4[nH]c3=O)cs2)cc1,170.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL429814,O=c1[nH]c2ccccc2cc1-c1csc(-c2ccc(Cl)cc2)n1,10000.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL395147,O=c1[nH]c2ccccc2cc1-c1csc(-c2cccc(Cl)c2)n1,10000.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL393910,O=c1[nH]c2ccccc2cc1-c1csc(-c2ccccc2Cl)n1,10000.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL240478,O=c1[nH]c2ccccc2cc1-c1csc(-c2cccnc2)n1,50.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL393909,O=c1[nH]c2ccccc2cc1-c1csc(-c2ccsc2)n1,410.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL240264,O=c1[nH]c2ccccc2cc1-c1csc(-c2ccccc2)n1,1400.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL392145,CN1CCN(c2ccc3[nH]c(=O)c(-c4csc(-c5ccncc5)n4)c(N)c3c2)CC1,120.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL240048,Nc1c(-c2csc(-c3ccncc3)n2)c(=O)[nH]c2ccc(N3CCCCC3)cc12,250.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL394007,Nc1c(-c2csc(-c3ccncc3)n2)c(=O)[nH]c2ccc(Cl)cc12,3.8,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL241326,Nc1c(-c2csc(-c3ccncc3)n2)c(=O)[nH]c2ccccc12,11.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL391116,Cc1c(-c2csc(-c3ccncc3)n2)c(=O)[nH]c2ccccc12,2800.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL241325,O=c1[nH]c2ccccc2c(-c2ccccc2)c1-c1csc(-c2ccncc2)n1,470.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL392343,O=c1[nH]c2ccccc2c(O)c1-c1csc(-c2ccncc2)n1,160.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL241116,O=C(c1ccc2cc(-c3csc(-c4ccncc4)n3)c(=O)[nH]c2c1)N1CCCCC1,2.7,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL399626,CN1CCN(C(=O)c2ccc3cc(-c4csc(-c5ccncc5)n4)c(=O)[nH]c3c2)CC1,4.4,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL236996,CCN(CCN(C)C)C(=O)c1ccc2cc(-c3csc(-c4ccncc4)n3)c(=O)[nH]c2c1,8.3,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL235963,O=c1[nH]c2cc(C(F)(F)F)ccc2cc1-c1csc(-c2ccncc2)n1,6.3,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL235962,O=c1[nH]c2ccc(Cl)cc2cc1-c1csc(-c2ccncc2)n1,11.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL238104,O=c1[nH]c2ccc(F)cc2cc1-c1csc(-c2ccncc2)n1,110.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL392341,CCN(CC)C(=O)c1cccc2[nH]c(=O)c(-c3csc(-c4ccncc4)n3)cc12,480.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL392125,O=C(O)c1cccc2[nH]c(=O)c(-c3csc(-c4ccncc4)n3)cc12,10000.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL393921,COC(=O)c1cccc2[nH]c(=O)c(-c3csc(-c4ccncc4)n3)cc12,33.0,nM,Inhibition of human CDK5/p25 by HTRF assay
CHEMBL403233,O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@H]12,1500.0,nM,Inhibition of human recombinant CDK5/p35
CHEMBL411704,COc1ccnc2c1c(-c1ccnc(N)n1)c1ccnc(N)n12,90.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL402443,COc1ccnc2[nH]cc(-c3ccncn3)c12,1300.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL405200,Oc1ccnc2[nH]cc(-c3ccncn3)c12,700.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL270926,COc1ccnc2[nH]cc(-c3ccnc(SC)n3)c12,2300.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL271195,Nc1nccc(-c2c[nH]c3nc(Br)ccc23)n1,680.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL271597,Nc1nccc(-c2c[nH]c3nccc(Cl)c23)n1,230.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL270346,COc1ccnc2c1c(-c1ccnc(N)n1)cn2C,73000.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL406102,Cn1cc(-c2ccnc(N)n2)c2c(O)ccnc21,5500.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL405074,COCCOc1ccnc2[nH]cc(-c3ccnc(N)n3)c12,14000.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL406463,CC(C)Oc1ccnc2[nH]cc(-c3ccnc(N)n3)c12,3.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL270687,CCCOc1ccnc2[nH]cc(-c3ccnc(N)n3)c12,3.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL406464,CCOc1ccnc2[nH]cc(-c3ccnc(N)n3)c12,5.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL270686,COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12,170.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL270897,Nc1nccc(-c2c[nH]c3nccc(O)c23)n1,50.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL405665,Nc1nccc(-c2c[nH]c3ncccc23)n1,510.0,nM,Inhibition of recombinant GST-CDK5/p25 expressed in Escherichia coli
CHEMBL264177,N#Cc1ccc2c(c1)-c1[nH]c3ccc(C#N)cc3c1CC(=O)N2,730.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL260656,Cn1c2c(c3ccccc31)CC(=O)Nc1cccnc1-2,3000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL407408,COc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccncc1-3,400.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL260045,O=C1Cc2c([nH]c3ccc(Cl)cc23)-c2cnccc2N1,210.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL260657,O=C1Cc2c([nH]c3ccc(F)cc23)-c2cnccc2N1,260.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL260119,O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cnccc2N1,120.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL260136,N#Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccncc1-3,32.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL406619,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cnccc2N1,180.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL413294,N#Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccc(Br)nc1-3,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL258482,N#Cc1cc(I)c2[nH]c3c(c2c1)CC(=O)Nc1cccnc1-3,2000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL261252,O=C1Cc2c([nH]c3ccc(O)cc23)-c2ncccc2N1,5000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL409492,Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1cccnc1-3,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL258700,COc1ccc2[nH]c3c(c2c1)CC(=O)Nc1cccnc1-3,4000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL407413,O=C1Cc2c([nH]c3c(F)cc(F)cc23)-c2ncccc2N1,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL260487,O=C1Cc2c([nH]c3ccc(I)cc23)-c2ncccc2N1,6000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL260678,O=C1Cc2c([nH]c3ccccc23)-c2ncccc2N1,9000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL260679,O=C1Cc2c([nH]c3cc(Cl)cc(Cl)c23)-c2ncccc2N1,100000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL261025,O=C1Cc2c([nH]c3ccc(C(=O)O)cc23)-c2ncccc2N1,30000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL406748,O=C1Cc2c([nH]c3ccc(Cl)cc23)-c2ncccc2N1,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL261470,O=C1Cc2c([nH]c3ccc(F)cc23)-c2ncccc2N1,3000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL411728,O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2ncccc2N1,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL259638,N#Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1cccnc1-3,300.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL264179,O=C1Cc2c(oc3ccc(Cl)cc23)-c2ccccc2N1,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL441733,O=C1Cc2c(oc3ccc(Br)cc23)-c2ccccc2N1,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL410936,O=C1Cc2c(oc3ccccc23)-c2ccccc2N1,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL260428,O=C1Cc2c(n(Cc3ccccc3)c3ccccc23)-c2cnccc2N1,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL411133,CCn1c2c(c3ccccc31)CC(=O)Nc1ccncc1-2,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL411641,Cn1c2c(c3ccccc31)CC(=O)Nc1ccncc1-2,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL259697,O=C1Cc2c(n3c4c(cccc24)CC3)-c2ncccc2N1,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL411642,O=C1Cc2c(n(-c3ccccc3)c3ccccc23)-c2ncccc2N1,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL429329,O=C1Cc2c(n(Cc3ccccc3)c3ccccc23)-c2ncccc2N1,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL412255,CCn1c2c(c3ccccc31)CC(=O)Nc1cccnc1-2,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL524266,Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1,1620.0,nM,Inhibition of CDK5/p25
CHEMBL522590,Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(F)c(Cl)cc21,18900.0,nM,Inhibition of CDK5/P25
CHEMBL522760,COc1cccc2c(C3=C(c4cn(C)c5cc(Cl)c(F)cc45)C(=O)NC3=O)coc12,108000.0,nM,Inhibition of CDK5/P25
CHEMBL489833,Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(Br)ccc21,1160.0,nM,Inhibition of CDK5/P25
CHEMBL491647,COCc1cccc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(C)c12,12900.0,nM,Inhibition of CDK5/P25
CHEMBL388978,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,4.0,nM,Inhibition of CDK5/P25
CHEMBL23327,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,75.0,nM,Inhibition of human cdk5/p35
CHEMBL23254,CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1,6.0,nM,Inhibition of human cdk5/p35
CHEMBL480442,CC(C)c1cnn2c(NCc3ccc(Cl)cc3)nc(N[C@@H](CO)C(C)C)nc12,60.0,nM,Inhibition of human recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL482193,CC[C@H](CO)Nc1nc(NCc2ccccc2)n2ncc(C(C)C)c2n1,70.0,nM,Inhibition of human recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL521274,CC[C@@H](CO)Nc1nc(NCc2ccccc2)n2ncc(C(C)C)c2n1,130.0,nM,Inhibition of human recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL482211,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncc(C(C)C)n2n1,320.0,nM,Inhibition of human recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL506669,CCOC(=N)c1nc2ccc3ncn(CC)c(=O)c3c2s1,,,Inhibition of CDK5/p25
CHEMBL453130,CCn1cnc2ccc3nc(C(=N)OC(C)C)sc3c2c1=O,,,Inhibition of CDK5/p25
CHEMBL453131,CCCCOC(=N)c1nc2ccc3ncn(CC)c(=O)c3c2s1,,,Inhibition of CDK5/p25
CHEMBL453132,CCn1cnc2ccc3nc(C(=N)OCc4ccccc4)sc3c2c1=O,100000.0,nM,Inhibition of CDK5/p25
CHEMBL453133,CCn1cnc2ccc3nc(C(=N)OCCc4ccccc4)sc3c2c1=O,4000.0,nM,Inhibition of CDK5/p25
CHEMBL510863,CCOC(=N)c1nc2ccc3ncn(C(C)C)c(=O)c3c2s1,43000.0,nM,Inhibition of CDK5/p25
CHEMBL454126,CC(C)OC(=N)c1nc2ccc3ncn(C(C)C)c(=O)c3c2s1,,,Inhibition of CDK5/p25
CHEMBL453128,CCCCOC(=N)c1nc2ccc3ncn(C(C)C)c(=O)c3c2s1,,,Inhibition of CDK5/p25
CHEMBL453129,CC(C)n1cnc2ccc3nc(C(=N)OCc4ccccc4)sc3c2c1=O,100000.0,nM,Inhibition of CDK5/p25
CHEMBL454130,CCn1cnc2ccc3nc(C(=N)NCc4ccccc4)sc3c2c1=O,100000.0,nM,Inhibition of CDK5/p25
CHEMBL461739,CC(C)n1cnc2ccc3nc(C(=N)NCc4ccccc4)sc3c2c1=O,100000.0,nM,Inhibition of CDK5/p25
CHEMBL500783,CC1(C)CNC(=O)c2cc3n(c2C1)CCc1cc(F)ccc1-3,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL514247,CC1(C)CNC(=O)c2cc3n(c2C1)CCc1cc([N+](=O)[O-])ccc1-3,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL456208,CC1(C)CNC(=O)c2cc3n(c2C1)CCc1cc(Br)ccc1-3,10000.0,nM,Inhibition of recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL564829,CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,265.0,nM,Inhibition of CDK5/p35
CHEMBL560452,CCCCc1c(-c2ccc(O)cc2)n(C)c2nccnc12,160000.0,nM,Inhibition of GST-fused recombinant CDK5/p25 expressed in Escherichia coli after 30 mins by scintillation counting
CHEMBL560453,CCCCc1c(-c2ccc(OCCOCCOCCN)cc2)[nH]c2nccnc12,660.0,nM,Inhibition of GST-fused recombinant CDK5/p25 expressed in Escherichia coli after 30 mins by scintillation counting
CHEMBL551510,CCCCc1c(-c2ccc(OCCOCCOCCN)cc2)n(C)c2nccnc12,50000.0,nM,Inhibition of GST-fused recombinant CDK5/p25 expressed in Escherichia coli after 30 mins by scintillation counting
CHEMBL557499,CCCCc1c(-c2ccc(O)c(-c3cn(CCOCCOCCN)nn3)c2)[nH]c2nccnc12,10000.0,nM,Inhibition of GST-fused recombinant CDK5/p25 expressed in Escherichia coli after 30 mins by scintillation counting
CHEMBL564656,CCCCc1c(-c2ccc(O)c(-c3cn(CCOCCOCCN)nn3)c2)n(C)c2nccnc12,10000.0,nM,Inhibition of GST-fused recombinant CDK5/p25 expressed in Escherichia coli after 30 mins by scintillation counting
CHEMBL552324,Cn1cc(-c2nc(N)ncc2I)c2ccccc21,2600.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL563962,Cn1cc(-c2nc(N)ncc2-c2ccncc2)c2ccccc21,5300.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL550658,Nc1ncc(-c2ccc(C(F)(F)F)cc2)c(-c2c[nH]c3ccccc23)n1,11000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL562648,Nc1ncc(-c2ccc(OC(F)(F)F)cc2)c(-c2c[nH]c3ccccc23)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL560787,CC(=O)c1ccc(-c2cnc(N)nc2-c2cn(C)c3ccccc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL559538,Cn1cc(-c2nc(N)ncc2-c2ccc(-c3ccccc3)cc2)c2ccccc21,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL552407,COc1cccc(-c2cnc(N)nc2-c2c[nH]c3ccccc23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL538190,COc1cccc(-c2cnc(N)nc2-c2cn(C)c3ccccc23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL559734,Nc1cccc(-c2cnc(N)nc2-c2c[nH]c3ccccc23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL559735,Cn1cc(-c2nc(N)ncc2-c2cccc(N)c2)c2ccccc21,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL559591,NC(=O)c1ccc(-c2cnc(N)nc2-c2c[nH]c3ccccc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL560521,Cn1cc(-c2nc(N)ncc2-c2ccc(C(N)=O)cc2)c2ccccc21,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL563961,Cn1cc(-c2nc(N)ncc2-c2ccc(C(=O)O)cc2)c2ccccc21,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL559592,Cn1cc(-c2nc(N)ncc2-c2cncnc2)c2ccccc21,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL553398,N#Cc1cc2c(N)n[nH]c2nc1N,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL552418,COc1nc(NNC(C)=O)c(C#N)c(-c2ccccc2)c1C#N,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL571001,COc1nc(NN)c(C#N)c(-c2ccccc2)c1C#N,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL552925,N#Cc1c(N2CCOCC2)nc2[nH]nc(N)c2c1-c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL552957,N#Cc1c(Cl)nc2[nH]nc(N)c2c1-c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL559608,CC(=O)Nc1nc2nn(-c3ccccc3)c(NC(C)=O)c2cc1C#N,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL549301,CC(=O)Nc1nn(C)c2nc(N)c(C#N)c(-c3ccccc3)c12,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL562397,CC(=O)Nc1nn(C)c2nc(N)c(C#N)cc12,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL562734,CC(=O)n1nc(N)c2c(-c3ccccc3)c(C#N)c(N)nc21,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL539451,CC(=O)Nc1nc2[nH]nc(NC(C)=O)c2cc1C#N,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL557120,N#Cc1cc2c(N)n(-c3ccccc3)nc2nc1N,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL552134,Cn1nc(N)c2c(-c3ccccc3)c(C#N)c(N)nc21,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL562396,Cn1nc(N)c2cc(C#N)c(N)nc21,10000.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL564921,N#Cc1c(N)nc2[nH]nc(N)c2c1-c1ccccc1,410.0,nM,Inhibition of human recombinant CDK5/P25 by scintillation counting
CHEMBL567005,CCCc1[nH]c(=O)c(-c2csc(CS(=O)(=O)c3ccccc3)n2)cc1C(=O)OCC,1.4,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL567004,CCOC(=O)c1cc(-c2csc(CS(=O)(=O)c3ccccc3)n2)c(=O)[nH]c1C,3.3,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL567832,CCOC(=O)c1cc(-c2csc(CS(=O)(=O)c3ccccc3)n2)c(=O)[nH]c1COCc1ccccc1,5.3,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL566767,CCN(CC)CCCOC(=O)c1cc(-c2csc(-c3ccncc3)n2)c(=O)[nH]c1C(C)C,47.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL584268,CCOC(=O)c1cc(-c2csc(-c3ccnc(NCC(C)C)c3)n2)c(=O)[nH]c1C,14.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL566114,CCCc1[nH]c(=O)c(-c2csc(-c3ccncc3)n2)cc1C(=O)OCC,55.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL583636,CCOC(=O)c1cc(-c2csc(-c3ccnc(NC)c3)n2)c(=O)[nH]c1C(C)C,28.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL567006,CCN(CC)CC(C)OC(=O)c1cc(-c2csc(-c3ccncc3)n2)c(=O)[nH]c1C(C)C,36.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL568084,CC(C)c1[nH]c(=O)c(-c2csc(-c3ccncc3)n2)cc1C(=O)OCCN1CCCC1,112.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL583632,CC(C)c1[nH]c(=O)c(-c2csc(-c3ccncc3)n2)cc1C(=O)OC1CCCN(C)C1,73.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL565471,CCN(CC)CCOC(=O)c1cc(-c2csc(-c3ccncc3)n2)c(=O)[nH]c1C(C)C,53.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL565918,CCOC(=O)c1cc(-c2csc(-c3ccnc(NCCN(CC)CC)c3)n2)c(=O)[nH]c1C,139.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL567223,CCOC(=O)c1cc(-c2csc(-c3ccnc(OC)c3)n2)c(=O)[nH]c1C(C)C,672.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL584506,CCOC(=O)c1cc(-c2csc(-c3ccncc3)n2)c(=O)[nH]c1C1CC1,198.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL566994,CCOC(=O)c1cc(-c2csc(-c3ccncc3)n2)c(=O)[nH]c1C(C)C,157.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL568083,CCOC(=O)c1cc(-c2csc(-c3ccncc3)n2)c(=O)[nH]c1COCc1ccccc1,779.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL567437,CC(C)c1[nH]c(=O)c(-c2csc(-c3ccncc3)n2)cc1C(=O)OC1CCN(C)CC1,647.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL565675,CCOC(=O)c1cc(-c2csc(-c3ccncc3)n2)c(=O)[nH]c1C(F)(F)F,11489.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL566532,CCOC(=O)c1cc(-c2csc(-c3ccncc3)n2)c(=O)[nH]c1CC,4.1,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL578375,CCOC(=O)c1cc(-c2csc(-c3ccnc(Cl)c3)n2)c(=O)[nH]c1C,160.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL577495,CCOC(=O)c1cc(-c2csc(-c3ccnc(N)c3)n2)c(=O)[nH]c1C,20.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL566115,CC(C)c1[nH]c(=O)c(-c2csc(-c3ccncc3)n2)cc1C(=O)OCCc1ccccc1,119.0,nM,Inhibition of human CDK5/p25 assessed as histone h1 phosphorylation in presence of ATP
CHEMBL569341,O=C(Cc1ccccc1)Nc1cn(C2CCC2)cn1,500.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL578621,COc1ccc(CC(=O)Nc2cn(C3CCC3)cn2)cc1,145.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL571565,O=C(Cc1cccc2ccccc12)Nc1cn(C2CCC2)cn1,46.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL570472,COc1ccc(CC(=O)Nc2cn(C)cn2)cc1,10000.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL570935,COc1ccc(CC(=O)Nc2cn(C(C)C)cn2)cc1,425.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL571150,COc1ccc(CC(=O)Nc2cn(C3CC3)cn2)cc1,814.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL570262,COc1ccc(CC(=O)Nc2cn(C3CCCC3)cn2)cc1,154.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL569584,COc1ccc(CC(=O)Nc2cn(C3CCCCC3)cn2)cc1,748.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL569816,COc1ccc(CC(=O)Nc2cn(Cc3ccccc3)cn2)cc1,8640.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL571781,COc1ccc(CC(=O)Nc2cn([C@H]3C[C@@H](O)C3)cn2)cc1,95.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL571523,COc1ccc(CC(=O)Nc2cn([C@H]3C[C@H](O)C3)cn2)cc1,1090.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL576126,COc1ccc(CC(=O)Nc2cn([C@H]3C[C@@H](C(=O)OC)C3)cn2)cc1,145.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL577998,COc1ccc(CC(=O)Nc2cn([C@H]3C[C@H](C(=O)OC)C3)cn2)cc1,4380.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL576502,COc1ccc(CC(=O)Nc2cn([C@H]3C[C@@H](NC(C)=O)C3)cn2)cc1,9.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL570261,COc1ccc(CC(=O)Nc2cn([C@H]3C[C@@H](NS(C)(=O)=O)C3)cn2)cc1,178.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL571780,CC(=O)N[C@H]1C[C@@H](n2cnc(NC(=O)Cc3cccc4ccccc34)c2)C1,8.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL570473,NC(=O)[C@H]1C[C@@H](n2cnc(NC(=O)Cc3cccc4ccccc34)c2)C1,391.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL572188,CC(=O)N(C)[C@H]1C[C@@H](n2cnc(NC(=O)Cc3cccc4ccccc34)c2)C1,107.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL582813,O=C(Cc1cccc2ccccc12)Nc1cn([C@H]2C[C@@H](NC(=O)c3ccncc3)C2)cn1,28.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL569586,O=C(Cc1cccc2ccccc12)Nc1cn([C@H]2C[C@@H](NC(=O)c3cccnc3)C2)cn1,46.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL569587,O=C(Cc1cccc2ccccc12)Nc1cn([C@H]2C[C@@H](NC(=O)c3ccccn3)C2)cn1,14.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL571782,O=C(Cc1cccc2ccccc12)Nc1cn([C@H]2C[C@@H](NC(=O)c3cccc(Cl)n3)C2)cn1,6.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL583658,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc(NC(=O)Cc4cccc5ccccc45)c3)C2)n1,6.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL369303,O=Nc1c(-c2c(O)[nH]c3ccc([N+](=O)[O-])cc23)[nH]c2ccccc12,6.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL593698,CC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3C1=O)C(=O)N2,18.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL1086983,O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C1/Nc2ccc(Br)cc2/C1=N/O,50.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL604270,CC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccc(Br)cc3C1=O)C(=O)N2,110.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL594403,O=C1Nc2cc([N+](=O)[O-])ccc2/C1=C1/Nc2ccccc2/C1=N\O,120.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL604263,Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2,150.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL445348,CC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2,160.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL593968,Nc1ccc2c(c1)NC(=O)/C2=C1\Nc2ccccc2\C1=N/O,200.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL606982,O=C1Nc2cc([N+](=O)[O-])ccc2/C1=C1/Nc2ccc(Br)cc2/C1=N\O,300.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL610451,Nc1ccc2c(c1)/C(=C1/Nc3ccc(Br)cc3C1=O)C(=O)N2,550.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL594192,Nc1ccc2c(c1)/C(=C1/Nc3ccccc3C1=O)C(=O)N2,590.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL606920,Nc1ccc2c(c1)/C(=C1/Nc3ccc(Br)cc3/C1=N\O)C(=O)N2,1000.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL594857,CC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccc(Br)cc3/C1=N\O)C(=O)N2,3300.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL609580,Nc1ccc2c(c1)NC(=O)/C2=C1\Nc2ccccc2C1=O,4000.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL174025,O=C1C(c2c(O)[nH]c3ccc([N+](=O)[O-])cc23)=Nc2ccccc21,25000.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL605926,O=C1Nc2c(Br)cc([N+](=O)[O-])cc2/C1=C1/Nc2ccccc2C1=O,10000.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL606814,O=C1Nc2c(Br)cc([N+](=O)[O-])cc2/C1=C1/Nc2ccc(Br)cc2C1=O,10000.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL603641,O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C1/Nc2ccc(Br)cc2C1=O,10000.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL596037,O=C1Nc2c(Br)cc([N+](=O)[O-])cc2/C1=C1/Nc2ccccc2/C1=N\O,10000.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL604470,O=C1Nc2c(Br)cc([N+](=O)[O-])cc2/C1=C1/Nc2ccc(Br)cc2/C1=N\O,10000.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL593700,O=C1Nc2cc([N+](=O)[O-])ccc2/C1=C1/Nc2ccccc2C1=O,10000.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL606865,O=C1Nc2cc([N+](=O)[O-])ccc2/C1=C1/Nc2ccc(Br)cc2C1=O,10000.0,nM,Inhibition of GST-fused CDK5/p25 expressed in Escherichia coli assessed as [gamma-33P]ATP incorporation after 10 mins by scintillation counting
CHEMBL590109,NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21,230.0,nM,Inhibition of CDK5/P25
CHEMBL599224,CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1,9.0,nM,Inhibition of CDK5/P25
CHEMBL599428,Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2,10.0,nM,Inhibition of CDK5/P25
CHEMBL597754,CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2,6.0,nM,Inhibition of CDK5/P25
CHEMBL604712,CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C,140.0,nM,Inhibition of CDK5/p25 by scintillation proximity assay
CHEMBL1082135,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCNCc1ccccc1,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1082136,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCNCc1ccc2c(c1)OCO2,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081218,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCNCc1ccc2c(c1)OCC2,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081219,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCNCc1ccc2c(c1)OCCO2,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081220,COc1ccc(CNCCNC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2C)cc1,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081221,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCNCc1ccc([N+](=O)[O-])cc1,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1076139,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCNCc1ccc(Cl)cc1,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081242,COc1cc(CNCCNC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2C)cc(OC)c1OC,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081243,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCN.Cl,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081244,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCC/N=C/c1ccccc1,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081757,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCC/N=C/c1ccc2c(c1)OCO2,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1076156,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCC/N=C/c1ccc2c(c1)OCC2,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081557,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCC/N=C/c1ccc2c(c1)OCCO2,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081558,COc1ccc(/C=N/CCNC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2C)cc1,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081737,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCC/N=C/c1ccc([N+](=O)[O-])cc1,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1076164,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCC/N=C/c1ccc(Cl)cc1,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1081014,COc1cc(/C=N/CCNC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2C)cc(OC)c1OC,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL485053,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1N,100000.0,nM,Inhibition of human CDK5/p25
CHEMBL1094408,COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2,219.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
CHEMBL37139,COc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1O,10000.0,nM,Inhibition of CDK5/P25
CHEMBL81714,O=C(NCc1ccc(O)cc1O)c1ccc2ccc(C(=O)O)c(O)c2n1,10000.0,nM,Inhibition of CDK5/P25
CHEMBL1270230,NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1,10000.0,nM,Inhibition of Cdk5/P25
CHEMBL1288582,COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1,7410.0,nM,Inhibition of CDK5/p25
CHEMBL1099005,CCC(CO)Oc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1,13000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1643061,CC(C)n1cnc2c(NCc3ccccc3)cc(OCCO)cc21,100000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1643062,CCC(O)COc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1,100000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1589837,CCC(COC)Oc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1,10000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1277151,COCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1,100000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1358008,CCC(CN(C)C)Oc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1,100000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1643063,CC(C)n1cnc2c(NCc3ccccc3)cc(OCC3CCNCC3)cc21,100000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1394969,CC(C)n1cnc2c(NCc3ccccc3)cc(OCC3CCN(C)CC3)cc21,100000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1277150,CCCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1,100000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1277149,CCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1,100000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1277060,CCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1,100000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL1096834,COc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1,10000.0,nM,Inhibition of CDK5/P25 GST-fusion protein assessed as substrate histone H1 phosphorylation by scintillation counting
CHEMBL184574,O=c1c2c(O)cc(O)cc2oc2c(O)ccc(O)c12,200.0,nM,Inhibition of CDK5/P25 using full length tau as substrate by colorimetric ELISA
CHEMBL1614763,Nc1nc(Nc2ccc(Cl)cc2)sc1C(=O)c1cccc([N+](=O)[O-])c1,2000.0,nM,Inhibition of CDK5/P25 using full length tau as substrate by colorimetric ELISA
CHEMBL1761778,Nc1nc(Nc2ccc(Cl)cc2)sc1C(=O)c1cccc(F)c1,700.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761779,COc1cccc(C(=O)c2sc(Nc3ccc(Cl)cc3)nc2N)c1,4000.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761780,Nc1nc(NC2CCCNC2)sc1C(=O)c1cccc(F)c1,500.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761781,Nc1nc(NC2CCNCC2)sc1C(=O)c1cccc(F)c1,6200.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761782,Nc1cccc(Nc2nc(N)c(C(=O)c3cccc(F)c3)s2)c1,31.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761783,CNc1cccc(Nc2nc(N)c(C(=O)c3cccc(F)c3)s2)c1,44.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761784,CN(C)c1ccc(Nc2nc(N)c(C(=O)c3cccc(F)c3)s2)cc1,68.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761785,Nc1nc(Nc2ccccn2)sc1C(=O)c1cccc(F)c1,33.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761786,Nc1nc(Nc2ccccn2)sc1C(=O)c1ccccc1F,38.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761787,Nc1nc(Nc2ccccn2)sc1C(=O)c1ccc(F)cc1,1200.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761788,COc1ccccc1C(=O)c1sc(Nc2ccccn2)nc1N,80.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761789,COc1cccc(C(=O)c2sc(Nc3ccccn3)nc2N)c1,400.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761790,COc1ccc(C(=O)c2sc(Nc3ccccn3)nc2N)cc1,1100.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761791,Nc1nc(Nc2cccnc2)sc1C(=O)c1ccccc1F,30.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761792,Nc1nc(Nc2cccnc2)sc1C(=O)c1cccc(F)c1,62.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761793,Nc1nc(Nc2cccnc2)sc1C(=O)c1ccc(F)cc1,4100.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761794,Nc1nc(Nc2cccnc2)sc1C(=O)c1ccccc1,341.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761795,Nc1nc(Nc2cccnc2)sc1C(=O)c1cccc([N+](=O)[O-])c1,130.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761796,COc1ccccc1C(=O)c1sc(Nc2cccnc2)nc1N,418.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761797,COc1cccc(C(=O)c2sc(Nc3cccnc3)nc2N)c1,11.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761798,COc1ccc(C(=O)c2sc(Nc3cccnc3)nc2N)cc1,3500.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761799,Nc1nc(Nc2ccncc2)sc1C(=O)c1ccccc1F,360.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761800,Nc1nc(Nc2ccncc2)sc1C(=O)c1cccc(F)c1,18.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761801,Nc1nc(Nc2ccncc2)sc1C(=O)c1ccc(F)cc1,400.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761802,COc1ccccc1C(=O)c1sc(Nc2ccncc2)nc1N,60.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761803,COc1cccc(C(=O)c2sc(Nc3ccncc3)nc2N)c1,200.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761804,COc1ccc(C(=O)c2sc(Nc3ccncc3)nc2N)cc1,600.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761805,Nc1nc(Nc2cccnc2)sc1C(=O)c1ccccn1,800.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761806,Nc1nc(Nc2cccnc2)sc1C(=O)c1cccnc1,100.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761807,Nc1nc(Nc2cccnc2)sc1C(=O)c1ccncc1,1710.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761808,CNc1nc(Nc2cccnc2)sc1C(=O)c1ccccc1F,10000.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1761809,Nc1nc(Nc2ccc(C(F)(F)F)nc2)sc1C(=O)c1ccccc1F,160.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counter
CHEMBL1738742,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2[nH]nc(C(C)C)c2n1,200.0,nM,Inhibition of human recombinant CDK5/p35
CHEMBL1738758,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1,10000.0,nM,Inhibition of CDK5/P25 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
CHEMBL1782168,O=C1Cc2c([nH]c3ccncc23)-c2ccccc2N1,3000.0,nM,Inhibition of human recombinant CDK5/p25 assessed as incorporation of [gamma-33P]-ATP into histone H1 substrate after 30 mins by scintillation counting
CHEMBL1782169,O=C1Cc2c([nH]c3cc[n+](Cc4ccccc4)cc23)-c2ccccc2N1.[Br-],10000.0,nM,Inhibition of human recombinant CDK5/p25 assessed as incorporation of [gamma-33P]-ATP into histone H1 substrate after 30 mins by scintillation counting
CHEMBL1782170,O=C1Cc2c([nH]c3cc[n+]([O-])cc23)-c2ccccc2N1,7300.0,nM,Inhibition of human recombinant CDK5/p25 assessed as incorporation of [gamma-33P]-ATP into histone H1 substrate after 30 mins by scintillation counting
CHEMBL1796144,O=C(Cc1c(NC(=O)CCl)sc2c1CCCC2)NNC(=S)[S-].[K+],247.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796145,CC(=O)Nc1sc2c(c1CC(=O)NNC(=S)[S-])CCCC2.[K+],346.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796146,O=C(Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2)NNC(=S)[S-].[K+],373.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796147,O=C(O)CCNc1sc2c(c1CC(=O)NNC(=S)[S-])CCCC2.[K+],397.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796148,Nn1c(S)nnc1Cc1c(NC(=O)CCl)sc2c1CCCC2,43.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796149,CC(=O)Nc1sc2c(c1Cc1nnc(S)n1N)CCCC2,386.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796150,Nn1c(S)nnc1Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2,621.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796151,Nn1c(S)nnc1Cc1c(NCCC(=O)O)sc2c1CCCC2,268.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796152,O=C(CCl)Nc1sc2c(c1Cc1nnc(S)n1NC(=O)c1ccc(Cl)cc1)CCCC2,343.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796153,CC(=O)Nc1sc2c(c1Cc1nnc(S)n1NC(=O)c1ccc(Cl)cc1)CCCC2,460.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1795354,O=C(Nc1sc2c(c1Cc1nnc(S)n1NC(=O)c1ccc(Cl)cc1)CCCC2)c1ccccc1,183.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796154,O=C(O)CCNc1sc2c(c1Cc1nnc(S)n1NC(=O)c1ccc(Cl)cc1)CCCC2,457.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796155,O=C(CCl)Nc1sc2c(c1Cc1nnc(S)n1NC(=O)c1ccccc1)CCCC2,751.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796156,CC(=O)Nc1sc2c(c1Cc1nnc(S)n1NC(=O)c1ccccc1)CCCC2,572.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796157,O=C(Nc1sc2c(c1Cc1nnc(S)n1NC(=O)c1ccccc1)CCCC2)c1ccccc1,891.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796158,O=C(O)CCNc1sc2c(c1Cc1nnc(S)n1NC(=O)c1ccccc1)CCCC2,674.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796159,CC(=O)Nn1c(S)nnc1Cc1c(NC(=O)CCl)sc2c1CCCC2,689.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796160,CC(=O)Nc1sc2c(c1Cc1nnc(S)n1NC(C)=O)CCCC2,584.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796161,CC(=O)Nn1c(S)nnc1Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2,618.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796162,CC(=O)Nn1c(S)nnc1Cc1c(NCCC(=O)O)sc2c1CCCC2,433.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796163,O=C(CCl)Nc1sc2c(c1Cc1nnc(SCSc3nnc(Cc4c(NC(=O)CCl)sc5c4CCCC5)n3NC(=O)c3ccc(Cl)cc3)n1NC(=O)c1ccc(Cl)cc1)CCCC2,340.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796164,CC(=O)Nc1sc2c(c1Cc1nnc(SCSc3nnc(Cc4c(NC(C)=O)sc5c4CCCC5)n3NC(=O)c3ccc(Cl)cc3)n1NC(=O)c1ccc(Cl)cc1)CCCC2,367.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796165,O=C(Nc1sc2c(c1Cc1nnc(SCSc3nnc(Cc4c(NC(=O)c5ccccc5)sc5c4CCCC5)n3NC(=O)c3ccc(Cl)cc3)n1NC(=O)c1ccc(Cl)cc1)CCCC2)c1ccccc1,627.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796166,O=C(O)CCNc1sc2c(c1Cc1nnc(SCSc3nnc(Cc4c(NCCC(=O)O)sc5c4CCCC5)n3NC(=O)c3ccc(Cl)cc3)n1NC(=O)c1ccc(Cl)cc1)CCCC2,164.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796167,O=C(CCl)Nc1sc2c(c1Cc1nnc(SCSc3nnc(Cc4c(NC(=O)CCl)sc5c4CCCC5)n3NC(=O)c3ccccc3)n1NC(=O)c1ccccc1)CCCC2,669.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796168,CC(=O)Nc1sc2c(c1Cc1nnc(SCSc3nnc(Cc4c(NC(C)=O)sc5c4CCCC5)n3NC(=O)c3ccccc3)n1NC(=O)c1ccccc1)CCCC2,646.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796169,O=C(Nc1sc2c(c1Cc1nnc(SCSc3nnc(Cc4c(NC(=O)c5ccccc5)sc5c4CCCC5)n3NC(=O)c3ccccc3)n1NC(=O)c1ccccc1)CCCC2)c1ccccc1,695.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796170,O=C(O)CCNc1sc2c(c1Cc1nnc(SCSc3nnc(Cc4c(NCCC(=O)O)sc5c4CCCC5)n3NC(=O)c3ccccc3)n1NC(=O)c1ccccc1)CCCC2,577.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796330,CC(=O)Nn1c(Cc2c(NC(=O)CCl)sc3c2CCCC3)nnc1SCSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(C)=O,849.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796331,CC(=O)Nc1sc2c(c1Cc1nnc(SCSc3nnc(Cc4c(NC(C)=O)sc5c4CCCC5)n3NC(C)=O)n1NC(C)=O)CCCC2,839.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796332,CC(=O)Nn1c(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)nnc1SCSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(C)=O,766.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796333,CC(=O)Nn1c(Cc2c(NCCC(=O)O)sc3c2CCCC3)nnc1SCSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(C)=O,734.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796334,N#CCSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,58.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796335,CC(=O)Nc1sc2c(c1Cc1nnc(SCC#N)n1NC(=O)c1ccc(Cl)cc1)CCCC2,415.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796336,N#CCSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,551.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796337,N#CCSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,422.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796338,N#CCSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccccc1,657.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796339,CC(=O)Nc1sc2c(c1Cc1nnc(SCC#N)n1NC(=O)c1ccccc1)CCCC2,393.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796340,N#CCSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccccc1,486.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796341,N#CCSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(=O)c1ccccc1,4874.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796342,CC(=O)Nn1c(Cc2c(NC(=O)CCl)sc3c2CCCC3)nnc1SCC#N,61.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796343,CC(=O)Nc1sc2c(c1Cc1nnc(SCC#N)n1NC(C)=O)CCCC2,458.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796344,CC(=O)Nn1c(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)nnc1SCC#N,564.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796345,CC(=O)Nn1c(Cc2c(NCCC(=O)O)sc3c2CCCC3)nnc1SCC#N,641.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796346,COC(=O)CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,443.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796347,COC(=O)CSc1nnc(Cc2c(NC(C)=O)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,389.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796348,COC(=O)CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,293.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796349,COC(=O)CSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,541.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796350,COC(=O)CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccccc1,681.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796351,COC(=O)CSc1nnc(Cc2c(NC(C)=O)sc3c2CCCC3)n1NC(=O)c1ccccc1,578.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1795356,COC(=O)CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccccc1,353.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796352,COC(=O)CSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(=O)c1ccccc1,641.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796353,COC(=O)CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(C)=O,695.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796354,COC(=O)CSc1nnc(Cc2c(NC(C)=O)sc3c2CCCC3)n1NC(C)=O,389.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796355,COC(=O)CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(C)=O,567.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796356,COC(=O)CSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(C)=O,733.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796357,NNC(=O)CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,39.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796358,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)NN)n1NC(=O)c1ccc(Cl)cc1)CCCC2,64.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796359,NNC(=O)CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,236.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796360,NNC(=O)CSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,201.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796361,NNC(=O)CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccccc1,37.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796362,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)NN)n1NC(=O)c1ccccc1)CCCC2,192.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796363,NNC(=O)CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccccc1,264.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796364,NNC(=O)CSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(=O)c1ccccc1,455.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796365,CC(=O)Nn1c(Cc2c(NC(=O)CCl)sc3c2CCCC3)nnc1SCC(=O)NN,61.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796366,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)NN)n1NC(C)=O)CCCC2,249.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796367,CC(=O)Nn1c(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)nnc1SCC(=O)NN,180.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796368,CC(=O)Nn1c(Cc2c(NCCC(=O)O)sc3c2CCCC3)nnc1SCC(=O)NN,931.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796369,CC(=O)NNC(=O)CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,468.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796370,CC(=O)NNC(=O)CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(C)=O,639.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796371,CC(=O)NNC(=O)CSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(C)=O,366.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796372,CC(=O)Nn1c(Cc2c(NC(=O)CCl)sc3c2CCCC3)nnc1SCC(=O)NNC(=O)c1ccccc1,363.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796373,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)NNC(=O)c3ccccc3)n1NC(C)=O)CCCC2,436.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796374,CC(=O)Nn1c(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)nnc1SCC(=O)NNC(=O)c1ccccc1,411.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796375,CC(=O)Nn1c(Cc2c(NCCC(=O)O)sc3c2CCCC3)nnc1SCC(=O)NNC(=O)c1ccccc1,476.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796376,CC(=O)Nn1c(Cc2c(NC(=O)CCl)sc3c2CCCC3)nnc1SCC(=O)NNC(=O)CCl,452.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796377,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)NNC(=O)CCl)n1NC(C)=O)CCCC2,474.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796378,CC(=O)Nn1c(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)nnc1SCC(=O)NNC(=O)CCl,358.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796495,CC(=O)Nn1c(Cc2c(NCCC(=O)O)sc3c2CCCC3)nnc1SCC(=O)NNC(=O)CCl,265.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796496,CC(=O)NNC(=O)CSc1nnc(Cc2c(NC(C)=O)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,641.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796497,CC(=O)NNC(=O)CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,318.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796498,CC(=O)NNC(=O)CSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,352.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796499,O=C(CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1)NNC(=O)c1ccccc1,617.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796500,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)NNC(=O)c3ccccc3)n1NC(=O)c1ccc(Cl)cc1)CCCC2,525.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796501,O=C(CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1)NNC(=O)c1ccccc1,483.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796502,O=C(O)CCNc1sc2c(c1Cc1nnc(SCC(=O)NNC(=O)c3ccccc3)n1NC(=O)c1ccc(Cl)cc1)CCCC2,271.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796503,O=C(CCl)NNC(=O)CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,229.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796504,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)NNC(=O)CCl)n1NC(=O)c1ccc(Cl)cc1)CCCC2,260.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796505,O=C(CCl)NNC(=O)CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,340.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796506,O=C(O)CCNc1sc2c(c1Cc1nnc(SCC(=O)NNC(=O)CCl)n1NC(=O)c1ccc(Cl)cc1)CCCC2,185.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796507,CC(=O)NNC(=O)CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccccc1,350.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796508,CC(=O)NNC(=O)CSc1nnc(Cc2c(NC(C)=O)sc3c2CCCC3)n1NC(=O)c1ccccc1,548.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796509,CC(=O)NNC(=O)CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccccc1,564.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796510,CC(=O)NNC(=O)CSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(=O)c1ccccc1,467.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796511,O=C(CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccccc1)NNC(=O)c1ccccc1,468.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796512,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)NNC(=O)c3ccccc3)n1NC(=O)c1ccccc1)CCCC2,413.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796513,O=C(CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccccc1)NNC(=O)c1ccccc1,466.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796514,O=C(O)CCNc1sc2c(c1Cc1nnc(SCC(=O)NNC(=O)c3ccccc3)n1NC(=O)c1ccccc1)CCCC2,434.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796515,O=C(CCl)NNC(=O)CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccccc1,532.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796516,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)NNC(=O)CCl)n1NC(=O)c1ccccc1)CCCC2,643.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796517,O=C(CCl)NNC(=O)CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccccc1,547.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796518,O=C(O)CCNc1sc2c(c1Cc1nnc(SCC(=O)NNC(=O)CCl)n1NC(=O)c1ccccc1)CCCC2,362.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796519,CC(=O)NNC(=O)CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(C)=O,454.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796520,CC(=O)NNC(=O)CSc1nnc(Cc2c(NC(C)=O)sc3c2CCCC3)n1NC(C)=O,327.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796521,O=C(CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1)N/N=C/c1ccccc1,35.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796522,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)N/N=C/c3ccccc3)n1NC(=O)c1ccc(Cl)cc1)CCCC2,213.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796523,O=C(CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1)N/N=C/c1ccccc1,217.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796524,O=C(O)CCNc1sc2c(c1Cc1nnc(SCC(=O)N/N=C/c3ccccc3)n1NC(=O)c1ccc(Cl)cc1)CCCC2,258.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796525,O=C(CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccccc1)N/N=C/c1ccccc1,32.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796526,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)N/N=C/c3ccccc3)n1NC(=O)c1ccccc1)CCCC2,385.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796527,O=C(CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccccc1)N/N=C/c1ccccc1,435.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796528,O=C(O)CCNc1sc2c(c1Cc1nnc(SCC(=O)N/N=C/c3ccccc3)n1NC(=O)c1ccccc1)CCCC2,267.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796529,CC(=O)Nn1c(Cc2c(NC(=O)CCl)sc3c2CCCC3)nnc1SCC(=O)N/N=C/c1ccccc1,336.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796530,CC(=O)Nc1sc2c(c1Cc1nnc(SCC(=O)N/N=C/c3ccccc3)n1NC(C)=O)CCCC2,453.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796531,CC(=O)Nn1c(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)nnc1SCC(=O)N/N=C/c1ccccc1,467.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796532,CC(=O)Nn1c(Cc2c(NCCC(=O)O)sc3c2CCCC3)nnc1SCC(=O)N/N=C/c1ccccc1,535.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796533,Nn1c(S)nnc1CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,2860.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796677,CC(=O)Nc1sc2c(c1Cc1nnc(SCc3nnc(S)n3N)n1NC(=O)c1ccc(Cl)cc1)CCCC2,6380.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796678,Nn1c(S)nnc1CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,3280.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796679,Nn1c(S)nnc1CSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(=O)c1ccc(Cl)cc1,5850.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796680,Nn1c(S)nnc1CSc1nnc(Cc2c(NC(=O)CCl)sc3c2CCCC3)n1NC(=O)c1ccccc1,6185.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796681,CC(=O)Nc1sc2c(c1Cc1nnc(SCc3nnc(S)n3N)n1NC(=O)c1ccccc1)CCCC2,6437.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796682,Nn1c(S)nnc1CSc1nnc(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)n1NC(=O)c1ccccc1,4587.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796683,Nn1c(S)nnc1CSc1nnc(Cc2c(NCCC(=O)O)sc3c2CCCC3)n1NC(=O)c1ccccc1,4985.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796684,CC(=O)Nn1c(Cc2c(NC(=O)CCl)sc3c2CCCC3)nnc1SCc1nnc(S)n1N,4035.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796685,CC(=O)Nc1sc2c(c1Cc1nnc(SCc3nnc(S)n3N)n1NC(C)=O)CCCC2,5146.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796686,CC(=O)Nn1c(Cc2c(NC(=O)c3ccccc3)sc3c2CCCC3)nnc1SCc1nnc(S)n1N,6142.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1796687,CC(=O)Nn1c(Cc2c(NCCC(=O)O)sc3c2CCCC3)nnc1SCc1nnc(S)n1N,6212.0,nM,Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation counting
CHEMBL1802849,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCC1CC1,600.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802850,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NC1CCCC1,1700.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802851,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCO,1300.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802852,COCCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,100000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802853,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCCO,4500.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802854,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCCCCO,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802855,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCN1CCOCC1,4000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1179821,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCN,910.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802856,CC(=O)NC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802857,CCOC(=O)C(=O)NC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803067,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCc1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803068,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCc1ccc2c(c1)OCO2,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803069,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1Nc1ccccc1,4300.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803070,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1Nc1ccc(O)cc1,1600.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803071,COc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2C)cc1,700.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803072,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1Nc1ccc2c(c1)OCO2,5800.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803073,CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1Nc1ccc2c(c1)OCCO2,1200.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803079,CCCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1,7300.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803082,CCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1,2400.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803083,O=C1NC(NCC2CC2)=N/C1=C\c1ccc2c(c1)OCO2,4700.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803084,Cc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1803085,O=C1NC(Nc2ccc(O)cc2)=N/C1=C\c1ccc2c(c1)OCO2,1700.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802355,COc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802356,O=C1NC(Nc2ccc3c(c2)OCO3)=N/C1=C\c1ccc2c(c1)OCO2,3000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802357,O=C1NC(Nc2ccc3c(c2)OCCO3)=N/C1=C\c1ccc2c(c1)OCO2,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802358,O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2,410.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802410,Nc1ncc(I)c(-c2c[nH]c3c(N)cccc23)n1,660.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802409,Nc1ccc2c(-c3nc(N)ncc3I)c[nH]c2c1,6200.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802408,Nc1ccc2[nH]cc(-c3nc(N)ncc3I)c2c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802407,Nc1ncc(I)c(-c2c[nH]c3cccc(N)c23)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802406,Nc1ncc(I)c(-c2c[nH]c3ccccc23)n1,1400.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802405,Nc1ncc(I)c(-c2c[nH]c3c([N+](=O)[O-])cccc23)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802404,Nc1ncc(I)c(-c2c[nH]c3cc([N+](=O)[O-])ccc23)n1,1600.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802403,Nc1ncc(I)c(-c2c[nH]c3ccc([N+](=O)[O-])cc23)n1,1600.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802402,Nc1ncc(I)c(-c2c[nH]c3cccc([N+](=O)[O-])c23)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802401,Nc1nccc(-c2c[nH]c3c([N+](=O)[O-])cccc23)n1,6300.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802400,Nc1nccc(-c2c[nH]c3cc([N+](=O)[O-])ccc23)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802399,COc1cccc(-c2cnc(N)nc2-c2c[nH]c3c(Br)cccc23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802398,COc1cccc(-c2cnc(N)nc2-c2c[nH]c3cc(Br)ccc23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802397,COc1cccc(-c2cnc(N)nc2-c2c[nH]c3ccc(Br)cc23)c1,7600.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802396,COc1cccc(-c2cnc(N)nc2-c2c[nH]c3cccc(Br)c23)c1,6000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802395,Nc1ncc(-c2ccc(C(F)(F)F)cc2)c(-c2c[nH]c3c(Br)cccc23)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802394,Nc1ncc(-c2ccc(C(F)(F)F)cc2)c(-c2c[nH]c3cc(Br)ccc23)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802393,Nc1ncc(-c2ccc(C(F)(F)F)cc2)c(-c2c[nH]c3ccc(Br)cc23)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802392,Nc1ncc(-c2ccc(C(F)(F)F)cc2)c(-c2c[nH]c3cccc(Br)c23)n1,4700.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802391,CC(=O)Nc1ccc(-c2cnc(N)nc2-c2c[nH]c3c(Br)cccc23)cc1,7500.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802390,CC(=O)Nc1ccc(-c2cnc(N)nc2-c2c[nH]c3cc(Br)ccc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802389,CC(=O)Nc1ccc(-c2cnc(N)nc2-c2c[nH]c3ccc(Br)cc23)cc1,6800.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802972,CC(=O)Nc1ccc(-c2cnc(N)nc2-c2c[nH]c3cccc(Br)c23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802971,CC(=O)c1ccc(-c2cnc(N)nc2-c2c[nH]c3c(Br)cccc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802970,CC(=O)c1ccc(-c2cnc(N)nc2-c2c[nH]c3cc(Br)ccc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802969,CC(=O)c1ccc(-c2cnc(N)nc2-c2c[nH]c3ccc(Br)cc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802968,CC(=O)c1ccc(-c2cnc(N)nc2-c2c[nH]c3cccc(Br)c23)cc1,7000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802967,Nc1ncc(I)c(-c2c[nH]c3c(Br)cccc23)n1,2100.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802966,Nc1ncc(I)c(-c2c[nH]c3cc(Br)ccc23)n1,680.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802965,Nc1ncc(I)c(-c2c[nH]c3ccc(Br)cc23)n1,1800.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802964,Nc1ncc(I)c(-c2c[nH]c3cccc(Br)c23)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802963,Nc1nccc(-c2c[nH]c3c(Br)cccc23)n1,3100.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802962,Nc1nccc(-c2c[nH]c3cccc(Br)c23)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using Histone H1 and [gamma32]-ATP after 30 mins by scintillation counting
CHEMBL1802841,CNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,18000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802842,CCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,16000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802843,CCCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,3000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802844,CC(C)NC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,1800.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802845,CCCCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,3300.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802846,CC(C)CNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,3100.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802847,CC(C)CCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,2000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1802848,C=CCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C,1600.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL1824539,COc1ccc(CNC(=O)Nc2cc(C#N)ccn2)cc1,100000000.0,nM,Inhibition of human CDK5/p35 activity using Ser/Thr 12 peptide as substrate by FRET assay
CHEMBL1824540,COc1ccc(CNC(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)cc1,100000000.0,nM,Inhibition of human CDK5/p35 activity using Ser/Thr 12 peptide as substrate by FRET assay
CHEMBL1824334,COc1ccc(CNC(=O)Nc2cc(-c3nnn[nH]3)ccn2)cc1,100000000.0,nM,Inhibition of human CDK5/p35 activity using Ser/Thr 12 peptide as substrate by FRET assay
CHEMBL1824332,COc1ccc(CNC(=O)Nc2nc3ccc(-c4nnn[nH]4)cc3s2)cc1,26400000.0,nM,Inhibition of human CDK5/p35 activity using Ser/Thr 12 peptide as substrate by FRET assay
CHEMBL479170,Oc1ccc(-c2cncc(-c3cc4cc(O)ccc4[nH]3)c2)cc1,1500.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910190,N#Cc1ccc(-c2cncc(-c3cc4cc(O)ccc4[nH]3)c2)cc1,5300.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910191,CS(=O)(=O)c1ccc(-c2cncc(-c3cc4cc(O)ccc4[nH]3)c2)cc1,1800.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910192,Oc1ccc(-c2cncc(-c3cc4cc(O)ccc4[nH]3)n2)cc1,1500.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910193,N#Cc1ccc(-c2cncc(-c3cc4cc(O)ccc4[nH]3)n2)cc1,4400.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910194,CS(=O)(=O)c1ccc(-c2cncc(-c3cc4cc(O)ccc4[nH]3)n2)cc1,6300.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910195,Oc1ccc(-c2cncc(-c3cc4ccc(O)cc4[nH]3)c2)cc1,160.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910196,N#Cc1ccc(-c2cncc(-c3cc4ccc(O)cc4[nH]3)c2)cc1,900.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910197,CS(=O)(=O)c1ccc(-c2cncc(-c3cc4ccc(O)cc4[nH]3)c2)cc1,380.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910198,Oc1ccc(-c2cncc(-c3cc4ccc(O)cc4[nH]3)n2)cc1,1500.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910199,N#Cc1ccc(-c2cncc(-c3cc4ccc(O)cc4[nH]3)n2)cc1,5400.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910200,CS(=O)(=O)c1ccc(-c2cncc(-c3cc4ccc(O)cc4[nH]3)n2)cc1,2600.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910201,Oc1ccc(-c2ccnc(-c3cc4cc(O)ccc4[nH]3)c2)cc1,360.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1910377,Oc1ccc(-c2ccnc(-c3cc4ccc(O)cc4[nH]3)c2)cc1,830.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [33P-gamma]-ATP after 30 mins by scintillation counting
CHEMBL1929238,CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O,30000.0,nM,Inhibition of CDK5/p25
CHEMBL1947117,O=c1oc2ccc(O)cc2c2c1[nH]c1cc3c(cc12)OCO3,16000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947116,COc1ccc(-c2ccc3c(c2)[nH]c2c(=O)oc4ccc(O)cc4c23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947115,Cc1ccc2c(c1)[nH]c1c(=O)oc3ccc(O)cc3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947114,O=c1oc2ccc(O)cc2c2c1[nH]c1cc(O)ccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947113,O=c1oc2ccc(O)cc2c2c1[nH]c1ccc(C(F)(F)F)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947112,O=c1oc2ccc(O)cc2c2c1[nH]c1ccc(F)cc12,8400.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947111,O=c1oc2cc(O)c(O)cc2c2c1[nH]c1ccc(O)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947110,O=c1oc2ccc(O)cc2c2c1[nH]c1ccc(O)cc12,720.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947109,O=c1oc2ccc(O)cc2c2c1[nH]c1cccc(-c3ccc(O)cc3)c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947108,O=c1oc2ccc(O)cc2c2c1[nH]c1cccc(C(F)(F)F)c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1944663,CCCOc1cccc2[nH]c3c(=O)oc4ccc(O)cc4c3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947107,Cc1cccc2[nH]c3c(=O)oc4ccc(O)cc4c3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947106,COc1cccc2[nH]c3c(=O)oc4ccc(O)cc4c3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1947105,O=c1oc2ccc(O)cc2c2c1[nH]c1ccccc12,2700.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1946918,O=c1oc2cc(O)ccc2c2c1[nH]c1cc(O)ccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1946916,O=c1oc2cc(O)ccc2c2c1[nH]c1ccccc12,4700.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1946915,O=c1oc2ccccc2c2c1[nH]c1cccc(-c3ccc(O)cc3)c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1946914,COc1cccc2oc(=O)c3[nH]c4ccccc4c3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL1946913,O=c1oc2ccccc2c2c1[nH]c1ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins by scintillation counting
CHEMBL489967,CN1CCCCC1c1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,1700.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL2029614,CN1CCCC[C@@H]1c1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,950.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL2029615,CN1CCCC[C@H]1c1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,50.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL523951,O=c1cc(-c2ccccc2)oc2c(C3CCCCN3)c(O)cc(O)c12,5500.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL2029616,COc1cc(O)c(C2CCCCN2)c2oc(-c3ccccc3)cc(=O)c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL490159,COc1cc(O)c(C2CCCCN2C)c2oc(-c3ccccc3)cc(=O)c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL2029617,CN1CCCC1c1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,90.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL2029618,CN1CCC[C@@H]1c1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,570.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL2029619,CN1CCC[C@H]1c1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,40.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL2029620,O=c1cc(-c2ccccc2)oc2c(C3CCCN3)c(O)cc(O)c12,1100.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL2029621,CCCCCC(NC)c1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,520.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL2029622,CCCCC[C@@H](NC)c1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,270.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL2029623,CCCCC[C@H](NC)c1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,2100.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by scintillation counting
CHEMBL460472,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1,100000.0,nM,Inhibition of CDK5/p25
CHEMBL2031893,COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC,100000.0,nM,Inhibition of CDK5/p25
CHEMBL393545,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1cccn21,2100.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL2041749,Cc1ccc2[nH]c3c(c4c(n5cccc35)C(=O)NC4=O)c2c1,7500.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL2041912,COc1ccc2[nH]c3c(c4c(n5cccc35)C(=O)NC4=O)c2c1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL239698,O=C1NC(=O)c2c1c1c3cc(O)ccc3[nH]c1c1cccn21,2600.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL2041914,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1nccc21,4000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL2041915,Cc1ccc2[nH]c3c(c4c(c5ccnn53)C(=O)NC4=O)c2c1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL2041916,COc1ccc2[nH]c3c(c4c(c5ccnn53)C(=O)NC4=O)c2c1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL2041917,O=C1NC(=O)c2c1c1c3cc(O)ccc3[nH]c1n1nccc21,510.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL2041918,O=C1NC(=O)c2c1c1[nH]ncc1c1[nH]c3ccccc3c21,910.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL2041919,Cc1ccc2[nH]c3c4cn[nH]c4c4c(c3c2c1)C(=O)NC4=O,310.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL2064520,COC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2064531,c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2064532,N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2064533,N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2064515,N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2064534,N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2064535,N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2064536,N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2064537,COCC1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2064538,COC[C@@H]1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2064539,COC[C@H]1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1,100000.0,nM,Inhibition of human recombinant CDK5/p35 by FRET assay
CHEMBL2069711,NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1,551.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069712,NS(=O)(=O)c1cc(-c2nc3ccc(F)cc3s2)cs1,331.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069713,NS(=O)(=O)c1cc(-c2nc3ccc(Cl)cc3s2)cs1,355.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069714,Cc1ccc2nc(-c3csc(S(N)(=O)=O)c3)sc2c1,1260.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069715,NS(=O)(=O)c1cc(-c2nc3ccc([N+](=O)[O-])cc3s2)cs1,1272.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069716,CC(=O)c1ccc2nc(-c3csc(S(N)(=O)=O)c3)sc2c1,6312.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069717,O=S(=O)(NO)c1cc(-c2nc3ccccc3s2)cs1,7415.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069718,O=S(=O)(NCCF)c1cc(-c2nc3ccccc3s2)cs1,10000.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069719,O=S(=O)(Nc1nccs1)c1cc(-c2nc3ccccc3s2)cs1,1764.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069720,Cc1nc(NS(=O)(=O)c2cc(-c3nc4ccccc4s3)cs2)sc1C,8220.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069721,CCOC(=O)Cc1csc(NS(=O)(=O)c2cc(-c3nc4ccccc4s3)cs2)n1,5088.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069722,O=S(=O)(NCc1ccccn1)c1cc(-c2nc3ccccc3s2)cs1,5472.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069723,Cc1ccnc(NS(=O)(=O)c2cc(-c3nc4ccccc4s3)cs2)c1,8274.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069724,O=S(=O)(Nc1ncccc1O)c1cc(-c2nc3ccccc3s2)cs1,9936.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069725,O=S(=O)(Nc1ccc(N2CCOCC2)nc1)c1cc(-c2nc3ccccc3s2)cs1,7704.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069726,O=S(=O)(c1cc(-c2nc3ccccc3s2)cs1)N1CCC[C@@H]1CO,8880.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069727,NS(=O)(=O)c1cc(-c2nc3ccc(F)c(Cl)c3s2)cs1,672.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2069728,NS(=O)(=O)c1cc(-c2nc3cccc(-c4ccc(F)cc4)c3s2)cs1,6780.0,nM,Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay
CHEMBL2089032,CC(C)n1cnc2c(NCc3ccc(-c4ccccn4)cc3)nc(NC[C@@H](O)CO)nc21,190.0,nM,Inhibition of human recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL2089033,CC(C)n1cnc2c(NCc3ccc(-c4ccccn4)cc3)nc(N[C@@H]3CCC[C@H](O)[C@@H]3O)nc21,270.0,nM,Inhibition of human recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL2089034,CC(C)n1cnc2c(NCc3ccc(-c4ccccn4)cc3)nc(N3C[C@H](O)C[C@H]3CO)nc21,610.0,nM,Inhibition of human recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL2089035,CC(C)n1cnc2c(NCc3ccc(-c4ccccn4)cc3)nc(NCC[C@H](O)CO)nc21,820.0,nM,Inhibition of human recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL2089036,CC(C)[C@H](N)C(=O)OC[C@H](O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1.Cl,180.0,nM,Inhibition of human recombinant CDK5/p25 expressed in Escherichia coli
CHEMBL2088657,Cc1n[nH]c(=O)c2[nH]c3ccc(Br)cc3c12,,,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088658,Cc1n[nH]c(=O)c2[nH]c3ccc(F)cc3c12,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088659,COc1ccc2[nH]c3c(=O)[nH]nc(C)c3c2c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088660,Cc1n[nH]c(=O)c2c1c1cc(Br)ccc1n2Cc1ccc([N+](=O)[O-])cc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088661,Cc1n[nH]c(=O)c2c1c1cc(Br)ccc1n2Cc1cccc([N+](=O)[O-])c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088662,Cc1n[nH]c(=O)c2c1c1cc(Br)ccc1n2Cc1ccc(C#N)cc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088663,Cc1n[nH]c(=O)c2c1c1cc(Br)ccc1n2Cc1cccc(C#N)c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088664,COc1ccc(Cn2c3ccc(Br)cc3c3c(C)n[nH]c(=O)c32)cc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088665,COc1cccc(Cn2c3ccc(Br)cc3c3c(C)n[nH]c(=O)c32)c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088666,Cc1n[nH]c(=O)c2c1c1cc(F)ccc1n2Cc1ccc([N+](=O)[O-])cc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088667,Cc1n[nH]c(=O)c2c1c1cc(F)ccc1n2Cc1cccc([N+](=O)[O-])c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088668,Cc1n[nH]c(=O)c2c1c1cc(F)ccc1n2Cc1ccc(C#N)cc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088669,Cc1n[nH]c(=O)c2c1c1cc(F)ccc1n2Cc1cccc(C#N)c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088670,COc1ccc(Cn2c3ccc(F)cc3c3c(C)n[nH]c(=O)c32)cc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088671,COc1cccc(Cn2c3ccc(F)cc3c3c(C)n[nH]c(=O)c32)c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088672,COc1ccc2c(c1)c1c(C)n[nH]c(=O)c1n2Cc1ccc([N+](=O)[O-])cc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088673,COc1ccc2c(c1)c1c(C)n[nH]c(=O)c1n2Cc1cccc([N+](=O)[O-])c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088674,COc1ccc2c(c1)c1c(C)n[nH]c(=O)c1n2Cc1ccc(C#N)cc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088675,COc1ccc2c(c1)c1c(C)n[nH]c(=O)c1n2Cc1cccc(C#N)c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088676,COc1ccc(Cn2c3ccc(OC)cc3c3c(C)n[nH]c(=O)c32)cc1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2088677,COc1cccc(Cn2c3ccc(OC)cc3c3c(C)n[nH]c(=O)c32)c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL573339,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,,,Inhibition of human recombinant CDK5/P25 using myelin basic protein substrate
CHEMBL2153517,COc1cc(Nc2ncnc3c2sc2ccccc23)cc(OC)c1OC,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153516,COc1cc(Nc2ncnc3c2sc2ccccc23)cc(OC)c1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153515,COc1ccc(Nc2ncnc3c2sc2ccccc23)cc1OC,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153412,COc1ccc(Nc2ncnc3c2sc2ccccc23)cc1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153411,c1ccc(Nc2ncnc3c2sc2ccccc23)cc1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL1836358,Nc1ncnc2c1sc1ccccc12,5200.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153518,c1ccc2c(c1)sc1c(Nc3ccc4c(c3)OCO4)ncnc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153519,c1ccc2c(c1)sc1c(Nc3ccc4c(c3)OCCO4)ncnc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153520,Fc1cc(Br)ccc1Nc1ncnc2c1sc1ccccc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153521,O=[N+]([O-])c1cc(Nc2ncnc3c2sc2ccccc23)ccc1O,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL457313,Nc1ncnc2c1sc1ncccc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153522,c1ccc(Nc2ncnc3c2sc2ncccc23)cc1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153523,COc1ccc(Nc2ncnc3c2sc2ncccc23)cc1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153524,COc1ccc(Nc2ncnc3c2sc2ncccc23)cc1OC,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153525,COc1cc(Nc2ncnc3c2sc2ncccc23)cc(OC)c1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153526,COc1cc(Nc2ncnc3c2sc2ncccc23)cc(OC)c1OC,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153527,c1cnc2sc3c(Nc4ccc5c(c4)OCO5)ncnc3c2c1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153528,c1cnc2sc3c(Nc4ccc5c(c4)OCCO5)ncnc3c2c1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153529,Fc1cc(Br)ccc1Nc1ncnc2c1sc1ncccc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153530,O=[N+]([O-])c1cc(Nc2ncnc3c2sc2ncccc23)ccc1O,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153531,Nc1ncnc2c1sc1cccnc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153532,c1ccc(Nc2ncnc3c2sc2cccnc23)cc1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153533,COc1ccc(Nc2ncnc3c2sc2cccnc23)cc1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153534,COc1ccc(Nc2ncnc3c2sc2cccnc23)cc1OC,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153535,COc1cc(Nc2ncnc3c2sc2cccnc23)cc(OC)c1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153536,COc1cc(Nc2ncnc3c2sc2cccnc23)cc(OC)c1OC,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153537,c1cnc2c(c1)sc1c(Nc3ccc4c(c3)OCO4)ncnc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153538,c1cnc2c(c1)sc1c(Nc3ccc4c(c3)OCCO4)ncnc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153539,Fc1cc(Br)ccc1Nc1ncnc2c1sc1cccnc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153540,O=[N+]([O-])c1cc(Nc2ncnc3c2sc2cccnc23)ccc1O,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153541,Nc1ncnc2c1sc1nccnc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153542,c1ccc(Nc2ncnc3c2sc2nccnc23)cc1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153543,COc1ccc(Nc2ncnc3c2sc2nccnc23)cc1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153544,COc1ccc(Nc2ncnc3c2sc2nccnc23)cc1OC,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153545,COc1cc(Nc2ncnc3c2sc2nccnc23)cc(OC)c1,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153546,COc1cc(Nc2ncnc3c2sc2nccnc23)cc(OC)c1OC,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153547,c1cnc2c(n1)sc1c(Nc3ccc4c(c3)OCO4)ncnc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153548,c1cnc2c(n1)sc1c(Nc3ccc4c(c3)OCCO4)ncnc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153549,Fc1cc(Br)ccc1Nc1ncnc2c1sc1nccnc12,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL2153550,O=[N+]([O-])c1cc(Nc2ncnc3c2sc2nccnc23)ccc1O,10000.0,nM,Inhibition of human recombinant GST-tagged CDK5/p25 expressed in Escherichia coli using histone H1 as substrate and [gamma32P]ATP after 30 mins by scintillation counting
CHEMBL230194,Nc1nc2c(-c3ccc[nH]3)nccc2[nH]1,70000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-32P] ATP after 30 mins by scintillation counting
CHEMBL2153260,Nc1nc2c(-c3ccco3)nccc2[nH]1,34000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-32P] ATP after 30 mins by scintillation counting
CHEMBL2153261,Nc1nc2c(-c3cccs3)nccc2[nH]1,43000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-32P] ATP after 30 mins by scintillation counting
CHEMBL2153263,Nc1nc2c(-c3ccsc3)nccc2[nH]1,11000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-32P] ATP after 30 mins by scintillation counting
CHEMBL2153264,Nc1nc2c(-c3ccccn3)nccc2[nH]1,6000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-32P] ATP after 30 mins by scintillation counting
CHEMBL2153265,Nc1nc2c(-c3cccnc3)nccc2[nH]1,60000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-32P] ATP after 30 mins by scintillation counting
CHEMBL2153267,Nc1nc2c(-c3ccccc3)nccc2[nH]1,40000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-32P] ATP after 30 mins by scintillation counting
CHEMBL2180845,O=C(Nc1ccc(O)cn1)Nc1cccc2c1C1CCCCN1C2=O,1300.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180844,O=C(Nc1cccc2c1C1CCCCN1C2=O)Nc1ncccc1O,37.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180843,O=C(Nc1ccc(-c2ccccc2)cn1)Nc1cccc2c1C1CCCCN1C2=O,4000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180859,O=C(Nc1cccc(N2CCCCC2)n1)Nc1cccc2c1C1CCCCN1C2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180858,COc1cccnc1NC(=O)Nc1cccc2c1C1CCCCN1C2=O,590.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180857,O=C(Nc1cccc2c1C1CCCCN1C2=O)Nc1nc(Cl)c(Cl)c(Cl)c1Cl,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180856,O=C(Nc1cccc2c1C1CCCCN1C2=O)Nc1ncc(F)cc1F,260.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180855,O=C(Nc1cccc(F)n1)Nc1cccc2c1C1CCCCN1C2=O,90.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180854,O=C(Nc1cc(Br)ccn1)Nc1cccc2c1C1CCCCN1C2=O,25.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180853,O=C(Nc1ccc(Br)cn1)Nc1cccc2c1C1CCCCN1C2=O,130.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180852,O=C(Nc1cccc(Br)n1)Nc1cccc2c1C1CCCCN1C2=O,40.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180851,O=C(Nc1cc(O)c2ccccc2n1)Nc1cccc2c1C1CCCCN1C2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180850,O=C(Nc1ccc2cccc(O)c2n1)Nc1cccc2c1C1CCCCN1C2=O,700.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180849,O=C(Nc1cc2ccccc2cn1)Nc1cccc2c1C1CCCCN1C2=O,68.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180848,O=C(Nc1nc2ccccc2s1)Nc1cccc2c1C1CCCCN1C2=O,16000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180847,O=C(Nc1cc(-c2ccccc2)on1)Nc1cccc2c1C1CCCCN1C2=O,1500.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180846,Cc1cc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)no1,2700.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180870,Cn1ccc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)n1,510.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180869,O=C(Nc1cc[nH]n1)Nc1cccc2c1C1CCCCN1C2=O,170.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180868,O=C(Nc1csc(-c2ccncc2)n1)Nc1cccc2c1C1CCCCN1C2=O,1700.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180867,Cc1nc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)cs1,530.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180866,O=C(Nc1cscn1)Nc1cccc2c1C1CCCCN1C2=O,430.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180865,O=C(Nc1ccncn1)Nc1cccc2c1C1CCCCN1C2=O,1500.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180864,O=C(Nc1ncccn1)Nc1cccc2c1C1CCCCN1C2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180863,O=C(Nc1cnccn1)Nc1cccc2c1C1CCCCN1C2=O,70.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180862,O=C(Nc1ccccn1)Nc1cccc2c1C1CCCCN1C2=O,80.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180861,O=C(Nc1ccccc1)Nc1cccc2c1C1CCCCN1C2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2180860,O=C(Nc1cccc2c1C1CCCCN1C2=O)NC1CCCCC1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate and [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL2234213,CCOc1ccc(S(=O)(=O)N2CCN(c3ccccc3)CC2)cc1-c1nc2ncccc2c(=O)[nH]1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234212,CCOc1ccc(S(=O)(=O)N2CCOCC2)cc1-c1nc2ncccc2c(=O)[nH]1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234211,O=c1[nH]cnc2c(-c3ccc(Br)cc3)n[nH]c12,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234269,O=c1[nH]cnc2c(-c3ccccc3)n[nH]c12,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234268,CCOC(=O)c1[nH]nc(-c2ccc(Br)cc2)c1N,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234220,CCOC(=O)c1[nH]nc(-c2ccc(Cl)cc2)c1N,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234219,CCOC(=O)c1[nH]nc(-c2ccc(Cl)cc2)c1/N=N/c1ccccc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234218,CCOC(=O)c1[nH]nc(-c2ccc(F)cc2)c1/N=N/c1ccccc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234217,O=C1NN=C(c2ccc(Br)cc2)/C(=N/Nc2ccccc2)C1=O,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234216,O=C1NN=C(c2ccccc2)/C(=N/Nc2ccccc2)C1=O,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234215,CCOC(=O)C(=O)/C(=N\Nc1ccccc1)C(=O)c1ccc(Cl)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2234214,CCOC(=O)C(=O)/C(=N\Nc1ccccc1)C(=O)c1ccccc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone H1 as substrate and [gamma-33P]-ATP after 10 min
CHEMBL2262602,O=C(O)/C(Br)=C/c1cn(-c2ccccc2)nc1-c1ccc(Br)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262601,Cc1nn(-c2ccccc2)c(C)c1/C=C(\Br)C(=O)O,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262600,O=C(O)/C(Br)=C/c1ccc(Cl)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262599,Cc1nn(-c2ccccc2)c(C)c1/C=C(\I)c1nc2ccccc2[nH]c1=O,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262598,O=c1[nH]c2ccccc2nc1/C(I)=C/c1ccc(Cl)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262597,O=c1[nH]c2ccccc2nc1/C(I)=C/c1ccccc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262596,O=c1[nH]c2ccccc2nc1/C(Cl)=C/c1ccc(Cl)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262595,O=C(COC1=C(Br)C(c2ccccc2)OC1=O)NCc1ccccc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262594,Cc1nn(-c2ccccc2)c(C)c1C1OC(=O)C(O)=C1I,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262593,COc1ccc(C2OC(=O)C(O)=C2I)cc1OC,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262592,O=C1OC(c2ccc(Cl)cc2)C(I)=C1O,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262591,O=C1OC(c2ccccc2)C(I)=C1O,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262590,Cc1nn(-c2ccccc2)c(C)c1C1OC(=O)C(O)=C1Cl,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262589,O=C1OC(c2cn(-c3ccccc3)nc2-c2ccc(Br)cc2)C(Br)=C1O,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262588,COc1ccc(-c2nn(-c3ccccc3)cc2C2OC(=O)C(O)=C2Br)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262782,O=C1OC(c2cn(-c3ccccc3)nc2-c2ccccc2)C(Br)=C1O,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262781,Cc1nn(-c2ccccc2)c(C)c1C1OC(=O)C(O)=C1Br,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262780,O=C1OC(c2ccc(Cl)cc2)C(Br)=C1O,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262779,O=C1OC(c2ccccc2)C(Br)=C1O,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262605,O=C(O)C(=O)/C=C/c1cn(-c2ccccc2)nc1-c1ccc(Br)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262604,COc1ccc(-c2nn(-c3ccccc3)cc2/C=C/C(=O)C(=O)O)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2262603,O=C(O)C(=O)/C=C/c1cn(-c2ccccc2)nc1-c1ccccc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL2295951,CC(C)n1cnc2c(Nc3ccc(-c4cncnc4)cc3)nc(Cl)nc21,2100.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295941,CC(C)CC[C@H](O)Nc1nc(Nc2cccc(-c3ncccn3)c2)c2ncn(C(C)C)c2n1,2000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295959,CC(C)n1cnc2c(Nc3cccc(-c4ncccn4)c3)nc(Cl)nc21,1300.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295942,CC(C)n1cnc2c(Nc3cccc(-c4cncnc4)c3)nc(Cl)nc21,1000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295950,CC(C)C[C@H](O)Nc1nc(Nc2ccc(-c3ncccn3)cc2)c2ncn(C(C)C)c2n1,1000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295938,CC(C)C[C@H](O)Nc1nc(Nc2cccc(-c3ncccn3)c2)c2ncn(C(C)C)c2n1,900.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295940,CC(O)C(O)Nc1nc(Nc2cccc(-c3ncccn3)c2)c2ncn(C(C)C)c2n1,620.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295956,CC(C)CC[C@H](O)Nc1nc(Nc2ccc(-c3cncnc3)cc2)c2ncn(C(C)C)c2n1,540.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295936,CCC[C@H](O)Nc1nc(Nc2cccc(-c3ncccn3)c2)c2ncn(C(C)C)c2n1,500.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295955,CC(C)C[C@H](O)Nc1nc(Nc2ccc(-c3cncnc3)cc2)c2ncn(C(C)C)c2n1,480.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295944,CCC[C@H](O)Nc1nc(Nc2cccc(-c3cncnc3)c2)c2ncn(C(C)C)c2n1,300.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295948,CCC[C@H](O)Nc1nc(Nc2ccc(-c3ncccn3)cc2)c2ncn(C(C)C)c2n1,270.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295960,CCC[C@@H](O)Nc1nc(Nc2cccc(-c3ncccn3)c2)c2ncn(C(C)C)c2n1,200.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295953,CCC[C@H](O)Nc1nc(Nc2ccc(-c3cncnc3)cc2)c2ncn(C(C)C)c2n1,200.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295957,CC(C)n1cnc2c(Nc3ccc(-c4cncnc4)cc3)nc(NC(O)CCO)nc21,190.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295946,CC(C)C(O)Nc1nc(Nc2cccc(-c3cncnc3)c2)c2ncn(C(C)C)c2n1,110.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295939,CC(C)C(O)Nc1nc(Nc2cccc(-c3ncccn3)c2)c2ncn(C(C)C)c2n1,110.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295958,CC(C)C(O)Nc1nc(Nc2ccc(-c3cncnc3)cc2)c2ncn(C(C)C)c2n1,110.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295947,CCC[C@@H](O)Nc1nc(Nc2ccc(-c3ncccn3)cc2)c2ncn(C(C)C)c2n1,100.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295949,CC(C)C[C@@H](O)Nc1nc(Nc2ccc(-c3ncccn3)cc2)c2ncn(C(C)C)c2n1,83.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295943,CCC[C@@H](O)Nc1nc(Nc2cccc(-c3cncnc3)c2)c2ncn(C(C)C)c2n1,70.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295952,CCC[C@@H](O)Nc1nc(Nc2ccc(-c3cncnc3)cc2)c2ncn(C(C)C)c2n1,60.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295945,CC(C)C[C@@H](O)Nc1nc(Nc2cccc(-c3cncnc3)c2)c2ncn(C(C)C)c2n1,52.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295937,CC(C)C[C@@H](O)Nc1nc(Nc2cccc(-c3ncccn3)c2)c2ncn(C(C)C)c2n1,50.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL2295954,CC(C)C[C@@H](O)Nc1nc(Nc2ccc(-c3cncnc3)cc2)c2ncn(C(C)C)c2n1,20.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 and [gamma33P]ATP as substrate after 30 min by scintillation counting
CHEMBL215919,CC[C@H](CO)Nc1nc(Nc2cccc(-c3ccccn3)c2)c2ncn(C(C)C)c2n1,80.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314434,CC(C)n1cnc2c(Nc3ccnnc3)nc(C(C)(C)CO)nc21,100.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2311568,CC(C)n1c(C(CO)CO)nc2c(Nc3ccnnc3)ncnc21,200.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314433,CC(C)[C@@H](CO)Nc1nc(Nc2ccnnc2)c2ncn(C(C)C)c2n1,230.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314436,CC(C)[C@H](CO)Nc1nc(Nc2ccnnc2)c2ncn(C(C)C)c2n1,41.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314435,CC[C@@H](CO)Nc1nc(Nc2ccnnc2)c2ncn(C(C)C)c2n1,42.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314437,CC[C@H](CO)Nc1nc(Nc2ccnnc2)c2ncn(C(C)C)c2n1,60.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314438,CC(C)n1cnc2c(Nc3ccnnc3)nc(Cl)nc21,3000.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314439,CC(C)n1cnc2c(Nc3cnccn3)nc(Cc3cnccn3)nc21,13000.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314440,CC(C)n1c(Nc2cncc(C(C)(C)CO)n2)nc2cncnc21,3000.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314441,CC(C)[C@H](CO)Nc1cncc(Nc2nc3cncnc3n2C(C)C)n1,300.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314442,CC[C@H](CO)Nc1cncc(Nc2nc3cncnc3n2C(C)C)n1,900.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314443,CC(C)n1cnc2c(Nc3cnccn3)nc(Cl)nc21,12000.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314444,CC(C)n1c(C(CO)CO)nc2c(Nc3cncnc3)ncnc21,300.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314445,CC(C)n1cnc2c(Nc3cncnc3)nc(C(C)(C)CO)nc21,180.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314446,CC(C)[C@@H](CO)Nc1nc(Nc2cncnc2)c2ncn(C(C)C)c2n1,370.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314447,CC(C)[C@H](CO)Nc1nc(Nc2cncnc2)c2ncn(C(C)C)c2n1,38.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314448,CC[C@@H](CO)Nc1nc(Nc2cncnc2)c2ncn(C(C)C)c2n1,76.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314449,CC[C@H](CO)Nc1nc(Nc2cncnc2)c2ncn(C(C)C)c2n1,42.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314450,CC(C)n1cnc2c(Nc3cncnc3)nc(Nc3cncnc3)nc21,360.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314451,CC(C)n1cnc2c(Nc3cncnc3)nc(Cl)nc21,2800.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314452,CC(C)n1cnc2c(Nc3ccncn3)nc(C(C)(C)CO)nc21,3200.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314453,CC(C)n1c(C(CO)CO)nc2c(Nc3ccncn3)ncnc21,8500.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314454,CC(C)[C@@H](CO)Nc1nc(Nc2ccncn2)c2ncn(C(C)C)c2n1,3200.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314455,CC(C)[C@H](CO)Nc1nc(Nc2ccncn2)c2ncn(C(C)C)c2n1,730.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314457,CC[C@@H](CO)Nc1nc(Nc2ccncn2)c2ncn(C(C)C)c2n1,4800.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314456,CC[C@H](CO)Nc1nc(Nc2ccncn2)c2ncn(C(C)C)c2n1,1800.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314458,CC(C)n1cnc2c(Nc3ccncn3)nc(Cl)nc21,10000.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314459,CC(C)[C@@H](CO)Nc1nc(Nc2ncccn2)c2ncn(C(C)C)c2n1,10000.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314460,CC(C)[C@H](CO)Nc1nc(Nc2ncccn2)c2ncn(C(C)C)c2n1,10000.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314461,CC[C@@H](CO)Nc1nc(Nc2ncccn2)c2ncn(C(C)C)c2n1,11000.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314463,CC[C@H](CO)Nc1nc(Nc2ncccn2)c2ncn(C(C)C)c2n1,10000.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314462,CC(C)n1cnc2c(Nc3ncccn3)nc(Cl)nc21,10000.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314465,CC(C)[C@@H](CO)Nc1nc(Nc2ccncc2)c2ncn(C(C)C)c2n1,200.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314464,CC(C)[C@H](CO)Nc1nc(Nc2ccncc2)c2ncn(C(C)C)c2n1,21.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314467,CC[C@@H](CO)Nc1nc(Nc2ccncc2)c2ncn(C(C)C)c2n1,50.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314466,CC[C@H](CO)Nc1nc(Nc2ccncc2)c2ncn(C(C)C)c2n1,17.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314469,CC(C)n1cnc2c(Nc3ccncc3)nc(Cl)nc21,7400.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314468,CC(C)n1c(C(CO)CO)nc2c(Nc3cccnc3)ncnc21,300.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314470,CC(C)[C@@H](CO)Nc1nc(Nc2cccnc2)c2ncn(C(C)C)c2n1,300.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314471,CC(C)[C@H](CO)Nc1nc(Nc2cccnc2)c2ncn(C(C)C)c2n1,22.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314472,CC[C@@H](CO)Nc1nc(Nc2cccnc2)c2ncn(C(C)C)c2n1,90.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314473,CC[C@H](CO)Nc1nc(Nc2cccnc2)c2ncn(C(C)C)c2n1,25.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314474,CC(C)n1cnc2c(Nc3cccnc3)nc(Cl)nc21,1100.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314475,CC(C)[C@@H](CO)Nc1nc(Nc2ccccn2)c2ncn(C(C)C)c2n1,1900.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314476,CC(C)[C@H](CO)Nc1nc(Nc2ccccn2)c2ncn(C(C)C)c2n1,1100.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314477,CC[C@@H](CO)Nc1nc(Nc2ccccn2)c2ncn(C(C)C)c2n1,4100.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314478,CC[C@H](CO)Nc1nc(Nc2ccccn2)c2ncn(C(C)C)c2n1,2300.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314479,CC(C)n1cnc2c(Nc3ccccn3)nc(Cl)nc21,2100.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313884,COc1ccc2c(c1)sc1c(Nc3ccc(N(C)C)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313927,COc1ccc2c(c1)sc1c(Nc3cccc(C(F)(F)F)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313926,COc1ccc2c(c1)sc1c(Nc3ccc(C#N)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313925,COc1ccc(Nc2ncnc3c2sc2cc(OC)ccc23)c(F)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313924,COc1ccc2c(c1)sc1c(Nc3ccc(Br)cc3F)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313923,COc1ccc2c(c1)sc1c(Nc3ccc(F)cc3F)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313922,COc1ccc2c(c1)sc1c(Nc3ccc(Cl)cc3F)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313921,COc1ccc2c(c1)sc1c(Nc3ccc(F)c(Cl)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313920,COc1ccc2c(c1)sc1c(Nc3ccc(Cl)cc3Cl)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313919,COc1ccc2c(c1)sc1c(Nc3cc(Cl)cc(Cl)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313918,COc1ccc2c(c1)sc1c(Nc3ccc(Cl)c(Cl)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313917,COc1ccc2c(c1)sc1c(Nc3ccccc3Cl)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313916,COc1ccc2c(c1)sc1c(Nc3cccc(Cl)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313915,COc1ccc2c(c1)sc1c(Nc3ccc(Cl)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313914,COc1ccc2c(c1)sc1c(Nc3ccc(Br)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313913,COc1ccc2c(c1)sc1c(Nc3ccc(F)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313912,COc1ccc2c(c1)sc1c(Nc3ccc4c(c3)OCCO4)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313911,COc1ccc2c(c1)sc1c(Nc3ccc4c(c3)OCO4)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313910,COc1ccc2c(c1)sc1c(Nc3cc(OC)c(OC)c(OC)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313909,COc1cc(Nc2ncnc3c2sc2cc(OC)ccc23)cc(OC)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313908,COc1ccc2c(c1)sc1c(Nc3ccc(OC)c(OC)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313907,COc1ccc(Nc2ncnc3c2sc2cc(OC)ccc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313906,COc1ccc2c(c1)sc1c(Nc3cccc(C)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313905,COc1ccc2c(c1)sc1c(Nc3ccc(C)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313904,COc1ccc2c(c1)sc1c(Nc3ccccc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313903,COc1ccc2c(c1)sc1c(N)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313902,COc1ccc2c(c1)oc1c(Nc3ccc(N(C)C)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313901,COc1ccc2c(c1)oc1c(Nc3cccc(C(F)(F)F)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313900,COc1ccc2c(c1)oc1c(Nc3ccc(C#N)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313899,COc1ccc(Nc2ncnc3c2oc2cc(OC)ccc23)c(F)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313898,COc1ccc2c(c1)oc1c(Nc3ccc(Br)cc3F)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313897,COc1ccc2c(c1)oc1c(Nc3ccc(F)cc3F)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313896,COc1ccc2c(c1)oc1c(Nc3ccc(Cl)cc3F)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313895,COc1ccc2c(c1)oc1c(Nc3ccc(F)c(Cl)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313894,COc1ccc2c(c1)oc1c(Nc3ccc(Cl)cc3Cl)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313893,COc1ccc2c(c1)oc1c(Nc3cc(Cl)cc(Cl)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313892,COc1ccc2c(c1)oc1c(Nc3ccc(Cl)c(Cl)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313891,COc1ccc2c(c1)oc1c(Nc3ccccc3Cl)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313890,COc1ccc2c(c1)oc1c(Nc3cccc(Cl)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313889,COc1ccc2c(c1)oc1c(Nc3ccc(Cl)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313888,COc1ccc2c(c1)oc1c(Nc3ccc(Br)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313887,COc1ccc2c(c1)oc1c(Nc3ccc(F)cc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313886,COc1ccc2c(c1)oc1c(Nc3ccc4c(c3)OCCO4)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2313885,COc1ccc2c(c1)oc1c(Nc3ccc4c(c3)OCO4)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314170,COc1ccc2c(c1)oc1c(Nc3cc(OC)c(OC)c(OC)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314169,COc1cc(Cc2cccc3c2oc2cc(OC)ccc23)cc(OC)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314168,COc1ccc2c(c1)oc1c(Nc3ccc(OC)c(OC)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314167,COc1ccc(Nc2ncnc3c2oc2cc(OC)ccc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314166,COc1ccc2c(c1)oc1c(Nc3cccc(C)c3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314165,COc1ccc2c(c1)oc1c(Nc3ccc(C)cc3)cccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314164,COc1ccc2c(c1)oc1c(Nc3ccccc3)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2314163,COc1ccc2c(c1)oc1c(N)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting
CHEMBL2333365,Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F,10000.0,nM,Inhibition of CDK5/P25 (unknown origin)
CHEMBL2347578,CC[C@H](CO)Nc1nc(NCc2cc(F)ccc2O)c2ncn(C(C)C)c2n1,240.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2347577,CC[C@@H](Nc1nc(NCc2cc(F)ccc2O)c2ncn(C(C)C)c2n1)C(C)O,67.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2347575,CC[C@@H](Nc1nc(NCc2cc(Cl)ccc2O)c2ncn(C(C)C)c2n1)C(C)O,71.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2347574,CC(C)n1cnc2c(NCc3cc(Cl)ccc3O)nc(NCC(C)(C)O)nc21,69.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2349194,CC[C@H](CO)Nc1nc(NCc2cc(Cl)ccc2O)c2ncn(C(C)C)c2n1,150.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2349193,CC(C)n1cnc2c(NCc3cc(Cl)ccc3O)nc(NC3CCC(N)CC3)nc21,125.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2349192,CC(C)n1cnc2c(NCc3cc(Cl)ccc3O)nc(NC3CCC(O)CC3)nc21,550.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2347584,CC(C)CNc1nc(NCc2ccccc2O)c2ncn(C(C)C)c2n1,2360.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2347583,CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCC(C)(C)O)nc21,4485.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2347582,CC(C)[C@H](Nc1nc(NCc2ccccc2N)c2ncn(C(C)C)c2n1)C(C)(C)O,675.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2347581,CC(C)n1cnc2c(NCc3ccccc3N)nc(NCCC(C)(C)O)nc21,5000.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2347580,CC(C)n1cnc2c(NCc3ccccc3N)nc(NCC(C)(C)O)nc21,740.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL1094304,CC[C@H](CO)Nc1nc(NCc2ccccc2O)c2ncn(C(C)C)c2n1,270.0,nM,Inhibition of CDK5/P35 (unknown origin) using histone H1 as substrate
CHEMBL2348725,O=C(Nc1n[nH]c(=O)c2ccccc12)c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348724,Nc1n[nH]c(=O)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348723,CC(C)C(=O)Nc1n[nH]c(=O)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348745,CC(=O)Nc1n[nH]c(=O)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348744,O=C(Cc1ccccc1)Nc1n[nH]c(=O)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348743,CCCCCC(=O)Nc1n[nH]c(=O)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348742,CC(C)C(=O)N(C(=O)C(C)C)c1n[nH]c(=O)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348741,CC(=O)N(C(C)=O)c1n[nH]c(=O)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348740,O=C(Cc1ccccc1)Nc1nnc(Cl)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348739,O=C(Cc1ccccc1)N(C(=O)Cc1ccccc1)c1nnc(Cl)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348738,CCCCCC(=O)N(C(=O)CCCCC)c1nnc(Cl)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348737,O=C(Nc1cc(-c2ccccc2)c(=O)[nH]n1)c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348736,O=C(Nc1cc(-c2ccccc2)c(Cl)nn1)c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348735,Nc1cc(-c2ccccc2)c(=O)[nH]n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348734,CC(=O)Nc1cc(-c2ccccc2)c(=O)[nH]n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348733,Nc1n[nH]c(=O)cc1-c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348732,CC(=O)Nc1n[nH]c(=O)cc1-c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348731,CN1CCC(Nc2n[nH]c(=O)c3ccccc23)CC1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348730,O=c1[nH]nc(NCCN2CCCCC2)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348729,CCCNc1n[nH]c(=O)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348728,O=c1[nH]nc(NCc2ccccc2)c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348727,CN1CCC(Nc2cc(-c3ccccc3)c(=O)[nH]n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348726,O=c1cc(-c2ccccc2)c(NCCN2CCCCC2)n[nH]1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348750,O=c1[nH]nc(NCCN2CCCCC2)cc1-c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348749,CCCNc1n[nH]c(=O)cc1-c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348748,CCCNc1cc(-c2ccccc2)c(=O)[nH]n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348747,O=c1cc(-c2ccccc2)c(NCc2ccccc2)n[nH]1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2348746,O=c1[nH]nc(NCc2ccccc2)cc1-c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL2377825,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccccc1[N+](=O)[O-],1.5,nM,Inhibition of CDK5/P25 (unknown origin)-mediated phosphorylation of peptide substrate incubated for 15 mins prior to substrate addition measured after 90 mins by P33-radiolabeled assay
CHEMBL2402946,NC1CCC(Nc2nc(NCc3ccc(-c4ccccc4O)nc3)c3ncn(C4CCCC4)c3n2)CC1,18.7,nM,Inhibition of CDK5/p35 (unknown origin) using histone H1 as substrate
CHEMBL2417913,O=C1c2c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)cc2OC1(O)Cc1ccc(O)cc1,50000.0,nM,Inhibition of CDK5/p25 (unknown origin)-mediated incorporation of gamma33P into substrate after 20 mins by scintillation counting analysis in presence of 33P-ATP
CHEMBL2417912,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c21,24330.0,nM,Inhibition of CDK5/p25 (unknown origin)-mediated incorporation of gamma33P into substrate after 20 mins by scintillation counting analysis in presence of 33P-ATP
CHEMBL593229,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)cc(O)c21,4810.0,nM,Inhibition of CDK5/p25 (unknown origin)-mediated incorporation of gamma33P into substrate after 20 mins by scintillation counting analysis in presence of 33P-ATP
CHEMBL1208973,O=c1cc(-c2ccc(O)cc2)oc2c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c(O)cc(O)c12,9290.0,nM,Inhibition of CDK5/p25 (unknown origin) after 30 mins by SDS-PAGE analysis
CHEMBL251254,O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,10280.0,nM,Inhibition of CDK5/p25 (unknown origin) after 30 mins by SDS-PAGE analysis
CHEMBL2425487,COc1cc(C)c(-c2c3c4cc(OC)c(O)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O,10000.0,nM,Inhibition of recombinant CDK5/p25 (unknown origin) expressed in Escherichia coli using [gamma-33P]ATP after 30 mins
CHEMBL301226,COc1ccc(-c2c3c4cc(OC)c(O)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O,25.0,nM,Inhibition of recombinant CDK5/p25 (unknown origin) expressed in Escherichia coli using [gamma-33P]ATP after 30 mins
CHEMBL2425904,N#C/N=[N+](\[O-])c1c(N)nc(Nc2ccc(S(=O)(=O)NCCO)cc2)nc1OCC1CCCCC1,560.0,nM,Inhibition of CDK5/P25 (unknown origin)
CHEMBL2425903,CNS(=O)(=O)c1ccc(Nc2nc(N)c(/[N+]([O-])=N/C#N)c(OCC3CCCCC3)n2)cc1,775.0,nM,Inhibition of CDK5/P25 (unknown origin)
CHEMBL2425902,Cc1ccc(S(=O)(=O)/N=[N+](\[O-])c2c(N)nc(N)nc2OCC2CCCCC2)cc1,,,Inhibition of CDK5/P25 (unknown origin)
CHEMBL2425901,NC(=O)/N=[N+](\[O-])c1c(N)nc(N)nc1OCC1CCCCC1,,,Inhibition of CDK5/P25 (unknown origin)
CHEMBL2425900,N#C/N=[N+](\[O-])c1c(N)nc(N)nc1OCC1CCCCC1,,,Inhibition of CDK5/P25 (unknown origin)
CHEMBL303958,Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1,,,Inhibition of CDK5/P25 (unknown origin)
CHEMBL3091793,c1nc(Nc2ccc3c(c2)OCO3)c2oc3cc(-c4ccc5c(c4)OCO5)cnc3c2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091806,Fc1ccc(Nc2ncnc3c2oc2cc(-c4ccc5c(c4)OCO5)cnc23)cc1Cl,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091805,Clc1ccc(Nc2ncnc3c2oc2cc(-c4ccc5c(c4)OCO5)cnc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091804,Clc1ccc(Nc2ncnc3c2oc2cc(-c4ccc5c(c4)OCO5)cnc23)cc1Cl,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091803,COc1cc(Nc2ncnc3c2oc2cc(-c4ccc5c(c4)OCO5)cnc23)cc(OC)c1OC,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091802,COc1ccc(Nc2ncnc3c2oc2cc(-c4ccc5c(c4)OCO5)cnc23)cc1OC,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091801,COc1ccc(Nc2ncnc3c2oc2cc(-c4ccc5c(c4)OCO5)cnc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091800,Cc1ccc(Nc2ncnc3c2oc2cc(-c4ccc5c(c4)OCO5)cnc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091799,c1ccc(Nc2ncnc3c2oc2cc(-c4ccc5c(c4)OCO5)cnc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091798,Nc1ncnc2c1oc1cc(-c3ccc4c(c3)OCO4)cnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091797,Nc1ncnc2c1oc1cc(-c3ccc(Cl)cc3Cl)cnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091795,Nc1ncnc2c1oc1cc(-c3ccc(Cl)c(Cl)c3)cnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091794,Nc1ncnc2c1oc1cc(-c3cccc(Cl)c3)cnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091819,COc1ccc(-c2cnc3c(c2)oc2c(N)ncnc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091818,Cc1ccc(-c2cnc3c(c2)oc2c(N)ncnc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091817,Nc1ncnc2c1oc1cc(-c3ccccc3)cnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091816,Fc1cc(Br)ccc1Nc1ncnc2c1oc1cccnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091815,Fc1ccc(Nc2ncnc3c2oc2cccnc23)cc1Cl,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091814,C1=COc2cc(Nc3ncnc4c3oc3cccnc34)ccc2O1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091813,c1cnc2c(c1)oc1c(Nc3ccc4c(c3)OCO4)ncnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091812,COc1cc(Nc2ncnc3c2oc2cccnc23)cc(OC)c1OC,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091811,COc1cc(Nc2ncnc3c2oc2cccnc23)cc(OC)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091810,COc1ccc(Nc2ncnc3c2oc2cccnc23)cc1OC,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091809,COc1ccc(Nc2ncnc3c2oc2cccnc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091808,c1ccc(Nc2ncnc3c2oc2cccnc23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3091807,Nc1ncnc2c1oc1cccnc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3092864,NCCOCCOCCOc1ccc(NC2=N/C(=C\c3ccccc3)C(=O)N2)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL3092863,NCCOCCOCCOCCOc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL3092862,NCCOCCOCCOc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL3092861,NCCOCCOCCO,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL3092860,O=C1NC(Nc2ccccc2)=N/C1=C\c1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]-ATP after 30 mins by scintillation counting
CHEMBL1719330,COc1cc2ncnc(Nc3ccc(OC(F)(F)F)cc3)c2cc1OC,10000.0,nM,inhibition of human recombinant CDK5/p25 using histone H1 as substrate by scintillation counting in presence of [gamma-33P]ATP
CHEMBL1277433,COc1cc2ncnc(Nc3ccc(C(F)(F)F)cc3)c2cc1OC,10000.0,nM,inhibition of human recombinant CDK5/p25 using histone H1 as substrate by scintillation counting in presence of [gamma-33P]ATP
CHEMBL301018,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC,10000.0,nM,inhibition of human recombinant CDK5/p25 using histone H1 as substrate by scintillation counting in presence of [gamma-33P]ATP
CHEMBL1761927,COc1cc2ncnc(Nc3ccc(NC(C)=O)cc3)c2cc1OC,10000.0,nM,inhibition of human recombinant CDK5/p25 using histone H1 as substrate by scintillation counting in presence of [gamma-33P]ATP
CHEMBL1191611,COc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1,10000.0,nM,inhibition of human recombinant CDK5/p25 using histone H1 as substrate by scintillation counting in presence of [gamma-33P]ATP
CHEMBL100714,COc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1OC,10000.0,nM,inhibition of human recombinant CDK5/p25 using histone H1 as substrate by scintillation counting in presence of [gamma-33P]ATP
CHEMBL3127769,COc1cc2ncnc(Nc3ccc(C(C)=O)cc3)c2cc1OC,10000.0,nM,inhibition of human recombinant CDK5/p25 using histone H1 as substrate by scintillation counting in presence of [gamma-33P]ATP
CHEMBL3127768,COc1cc2ncnc(Nc3ccc(C)c(C)c3)c2cc1OC,10000.0,nM,inhibition of human recombinant CDK5/p25 using histone H1 as substrate by scintillation counting in presence of [gamma-33P]ATP
CHEMBL316064,COc1cc2ncnc(Nc3cccc(C(F)(F)F)c3)c2cc1OC,10000.0,nM,inhibition of human recombinant CDK5/p25 using histone H1 as substrate by scintillation counting in presence of [gamma-33P]ATP
CHEMBL94191,COc1cc2ncnc(Nc3ccccc3)c2cc1OC,10000.0,nM,inhibition of human recombinant CDK5/p25 using histone H1 as substrate by scintillation counting in presence of [gamma-33P]ATP
CHEMBL602937,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,20000.0,nM,Inhibition of CDK5/p-35 (unknown origin)
CHEMBL3291229,O=C1NCC(O)Cn2c1cc1ccccc12,,,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291230,Cc1c2n(c3ccccc13)CC(O)CNC2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291231,N#Cc1c2n(c3ccccc13)CC(O)CNC2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291232,O=C1NCC(O)Cn2c1c(-c1ccccc1)c1ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291233,CCCC#Cc1c2n(c3ccccc13)CC(O)CNC2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291234,COC(=O)/C=C/c1c2n(c3ccccc13)CC(O)CNC2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3286445,CCCCCc1c2n(c3ccccc13)CC(O)CNC2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291235,O=C1NCC(O)Cc2c1[nH]c1ccccc21,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291236,Cn1c2c(c3ccccc31)CC(O)CNC2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3290949,O=C1NCC(O)Cn2c1c(I)c1ccccc12,430.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3290950,COc1cccc2c1c(I)c1n2CC(O)CNC1=O,2900.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291223,COc1ccc2c(c1)c(I)c1n2CC(O)CNC1=O,23000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291224,COc1ccc2c(I)c3n(c2c1)CC(O)CNC3=O,730.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291225,O=C1NCC(O)Cn2c1c(I)c1ccc(OCc3ccccc3)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291226,O=C1NCC(O)Cn2c1c(Br)c1ccccc12,5500.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291227,COc1ccc2c(Br)c3n(c2c1)CC(O)CNC3=O,1000.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3291228,O=C1NCC(O)Cn2c1c(I)c1ccc(O)cc12,400.0,nM,Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysis
CHEMBL3289596,O=C1Cc2c([nH]c3c(/C=C/C(=O)c4ccccc4)cccc23)-c2cccnc2N1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL3289600,O=C(/C=C/c1cccc2c3c([nH]c12)-c1cccnc1NC(=O)C3)Nc1ccccc1,10000.0,nM,Inhibition of human recombinant CDK5/p25
CHEMBL3338893,COc1ccc(Nc2cc(-c3ccncc3)n[nH]c2=O)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL3338892,COc1ccc(Nc2cc(-c3ccco3)n[nH]c2=O)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL3338891,COc1ccc(Nc2cc(-c3ccc(OC)cc3)n[nH]c2=O)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL3338890,COc1ccc(Nc2cc(-c3ccccc3)n[nH]c2=O)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL3338889,COc1ccc(Nc2cc(C)n[nH]c2=O)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL3338888,COc1ccc2[nH]c3c(=O)[nH]nc(-c4ccco4)c3c2c1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL3338887,COc1ccc2[nH]c3c(=O)[nH]nc(-c4ccc(C(F)(F)F)cc4)c3c2c1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL3338886,COc1ccc(-c2n[nH]c(=O)c3[nH]c4ccc(OC)cc4c23)cc1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL3408810,Nc1ncnc2c1sc1nc(-c3ccc(Cl)cc3Cl)ccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408809,Nc1ncnc2c1sc1ncc(-c3cncnc3)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408808,Nc1ncnc2c1sc1ncc(-c3cccs3)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408807,Nc1ncnc2c1sc1ncc(-c3ccc4c(c3)OCO4)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408806,Nc1ncnc2c1sc1ncc(-c3ccc([N+](=O)[O-])cc3)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408805,Nc1ncnc2c1sc1ncc(-c3ccc(Br)cc3)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408804,COc1ccc(-c2cnc3sc4c(N)ncnc4c3c2)c(F)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408803,Nc1ncnc2c1sc1ncc(-c3ccc(F)cc3Cl)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408802,Nc1ncnc2c1sc1ncc(-c3ccc(Cl)cc3F)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408801,Nc1ncnc2c1sc1ncc(-c3ccc(F)cc3F)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408800,Nc1ncnc2c1sc1ncc(-c3ccc(C(F)(F)F)cc3)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408799,Nc1ncnc2c1sc1ncc(-c3ccc(Cl)cc3Cl)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408798,Nc1ncnc2c1sc1ncc(-c3ccc(Cl)c(Cl)c3)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408797,Nc1ncnc2c1sc1ncc(-c3cccc(Cl)c3)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408796,Nc1ncnc2c1sc1ncc(-c3ccc(Cl)cc3)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408795,COc1ccc(-c2cnc3sc4c(N)ncnc4c3c2)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3408794,Cc1ccc(-c2cnc3sc4c(N)ncnc4c3c2)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL507635,Nc1ncnc2c1sc1ncc(-c3ccccc3)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP
CHEMBL3609746,O=C(Nc1ccc(Br)cn1)Nc1cccc2c1C1CC3(CCN1C2=O)SCCS3,7300.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609745,O=C(Nc1cccc(Br)n1)Nc1cccc2c1C1CC3(CCN1C2=O)SCCS3,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609744,CO[C@@H]1CCN2C(=O)c3cccc(NC(=O)Nc4cc(C)ccn4)c3[C@@H]2C1,320.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609675,CO[C@@H]1CCN2C(=O)c3cccc(NC(=O)Nc4cnc(C)cn4)c3[C@@H]2C1,320.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609674,Cc1cnc(NC(=O)Nc2cccc3c2C2CC4(CCN2C3=O)SCCS4)cn1,220.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609673,CO[C@@H]1CCN2C(=O)c3cccc(NC(=O)Nc4ccn(C)n4)c3[C@@H]2C1,2300.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609672,Cn1ccc(NC(=O)Nc2cccc3c2C2CC4(CCN2C3=O)SCCS4)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609671,Cc1cccnc1NC(=O)Nc1cccc2c1[C@@H]1C[C@H](O)CCN1C2=O,630.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609670,Cc1cccnc1NC(=O)Nc1cccc2c1C1CC(=O)CCN1C2=O,,,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609669,CO[C@@H]1CCN2C(=O)c3cccc(NC(=O)Nc4ncccc4C)c3[C@@H]2C1,1100.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609668,Cc1cccnc1NC(=O)Nc1cccc2c1C1CC3(CCN1C2=O)OCCO3,3100.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609667,COc1cc(NC(=O)Nc2cccc3c2[C@@H]2C[C@H](O)CCN2C3=O)nc2ccccc12,4900.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609666,COc1cc(NC(=O)Nc2cccc3c2C2CC(=O)CCN2C3=O)nc2ccccc12,,,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609665,COc1cc(NC(=O)Nc2cccc3c2[C@@H]2C[C@H](OC)CCN2C3=O)nc2ccccc12,8500.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609664,COc1cc(NC(=O)Nc2cccc3c2C2CC4(CCN2C3=O)SCCS4)nc2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609663,COc1cc(NC(=O)Nc2cccc3c2C2CC4(CCN2C3=O)OCCO4)nc2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609662,Cc1cccc(NC(=O)Nc2cccc3c2[C@@H]2C[C@H](O)CCN2C3=O)n1,1000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609661,Cc1cccc(NC(=O)Nc2cccc3c2C2CC(=O)CCN2C3=O)n1,,,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609660,CO[C@@H]1CCN2C(=O)c3cccc(NC(=O)Nc4cccc(C)n4)c3[C@@H]2C1,4300.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609659,Cc1cccc(NC(=O)Nc2cccc3c2C2CC4(CCN2C3=O)SCCS4)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609658,Cc1cccc(NC(=O)Nc2cccc3c2C2CC4(CCN2C3=O)OCCO4)n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609657,O=C(Nc1cnccn1)Nc1cccc2c1[C@@H]1C[C@H](O)CCN1C2=O,84.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609656,O=C1CCN2C(=O)c3cccc(NC(=O)Nc4cnccn4)c3C2C1,3600.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609655,CO[C@@H]1CCN2C(=O)c3cccc(NC(=O)Nc4cnccn4)c3[C@@H]2C1,480.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609654,O=C(Nc1cnccn1)Nc1cccc2c1C1CC3(CCN1C2=O)SCCS3,150.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609569,O=C(Nc1cnccn1)Nc1cccc2c1C1CC3(CCN1C2=O)OCCO3,7100.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609568,O=C(Nc1ccccn1)Nc1cccc2c1[C@@H]1C[C@H](O)CCN1C2=O,2100.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609567,O=C1CCN2C(=O)c3cccc(NC(=O)Nc4ccccn4)c3C2C1,1600.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609566,CO[C@@H]1CCN2C(=O)c3cccc(NC(=O)Nc4ccccn4)c3[C@@H]2C1,550.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609565,O=C(Nc1ccccn1)Nc1cccc2c1C1CC3(CCN1C2=O)SCCS3,240.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3609564,O=C(Nc1ccccn1)Nc1cccc2c1C1CC3(CCN1C2=O)OCCO3,11000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 substrate and ATP
CHEMBL3735260,CN1CCN(c2ccc3nc(-c4cccc5c4OCO5)c(-c4ccncc4)n3c2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735184,CC1CN(c2ccc3nc(-c4cccc5c4OCO5)c(-c4ccncc4)n3n2)CC(C)N1C,,,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735309,c1cc2c(c(-c3nc4cccnn4c3-c3ccncc3)c1)OCO2,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3734959,CN1CCN(c2ccc3nc(-c4cccc5c4OCO5)c(-c4ccccc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735077,CN1CCN(c2ccc3nc(-c4cccc5c4OCO5)c(-c4cccnc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735368,CN1CCN(c2ccc3nc(-c4cccc(C(=O)N5CCOCC5)c4)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3734840,CN1CCN(c2ccc3nc(-c4ccc(C(=O)N5CCOCC5)cc4)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3736271,CN1CCN(c2ccc3nc(-c4ccc(-c5ccccc5)s4)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735315,CN1CCN(c2ccc3nc(-c4cccc(-c5ccsc5)c4)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735817,CN1CCN(c2ccc3nc(-c4cccc(-c5cccs5)c4)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3736408,CN1CCN(c2ccc3nc(-c4cccc(-c5ccccc5)c4)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735025,CN1CCN(c2ccc3nc(-c4ccc(-c5ccccc5)cc4)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735563,CCOc1ccc2c(-c3nc4ccc(N5CCN(C)CC5)nn4c3-c3ccncc3)cccc2c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3736103,COc1ccc2c(-c3nc4ccc(N5CCN(C)CC5)nn4c3-c3ccncc3)cccc2c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735482,CN1CCN(c2ccc3nc(-c4cccc5ccccc45)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3734983,CN1CCN(c2ccc3nc(-c4ccc5ncsc5c4)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735428,CN1CCN(c2ccc3nc(-c4ccc5c(c4)OCCO5)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735582,CN1CCN(c2ccc3nc(-c4cccc5c4OCCO5)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735590,CN1CCN(c2ccc3nc(-c4ccc5c(c4)OCO5)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735196,CN1CCN(c2ccc3nc(-c4cccc5c4OCO5)c(-c4ccncc4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3735836,COc1cccc(-c2nc3ccc(N4CCN(C)CC4)nn3c2-c2ccncc2)c1,10000.0,nM,Inhibition of human recombinant CDK5/P25 expressed in Escherichia coli using histone H1 substrate after 30 mins by scintillation and luminescence counting method in presence of [gamma-33P]ATP
CHEMBL3741589,O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1,10000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL3745885,Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21,10000.0,nM,Inhibition of human CDK5/p25 using histone H1 as substrate
CHEMBL3763161,c1cnc2[nH]c(-c3cnnn3CCCc3c[nH]c4ncccc34)cc2c1,10700.0,nM,Inhibition of CDK5/p35NCK (unknown origin) using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL3301610,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,405.0,nM,Inhibition of CDK5/p35NCK (unknown origin) using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL3263773,COc1ccccc1-c1cc(Nc2cccc(CS(N)(=O)=O)c2)ncn1,4960.0,nM,Inhibition of CDK5/p35NCK (unknown origin) using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL3785571,Cc1cccnc1NC(=O)Nc1cccc2c1C1CCCCN1C2=O,96.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3786657,COC(=O)c1cccnc1NC(=O)Nc1cccc2c1C1CCCCN1C2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3787480,Cc1ccnc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)c1,40.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3787512,O=C(Nc1cc(CO)ccn1)Nc1cccc2c1C1CCCCN1C2=O,41.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3787081,COCc1ccnc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)c1,410.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3786276,O=C(Nc1cc(CN2CCOCC2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,67.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3787557,CN1CCN(Cc2ccnc(NC(=O)Nc3cccc4c3C3CCCCN3C4=O)c2)CC1,130.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3786430,O=C(Nc1cc(CN2CCCCC2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,120.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3785575,Cc1ccc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)nc1,44.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3785408,Cc1cccc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)n1,35.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3786624,O=Cc1cccc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)n1,25.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3787093,COC(=O)c1cccc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)n1,320.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3786332,O=C(Nc1cccc(CO)n1)Nc1cccc2c1C1CCCCN1C2=O,160.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3785804,COCc1cccc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)n1,1200.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3785573,O=C(Nc1cccc(CN2CCOCC2)n1)Nc1cccc2c1C1CCCCN1C2=O,1800.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3785596,CN1CCN(Cc2cccc(NC(=O)Nc3cccc4c3C3CCCCN3C4=O)n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3786745,O=C(Nc1cccc(CN2CCCCC2)n1)Nc1cccc2c1C1CCCCN1C2=O,760.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3787061,O=C(Nc1cccc(CN2CCCC2)n1)Nc1cccc2c1C1CCCCN1C2=O,5100.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3787584,CCN(CC)Cc1cccc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)n1,3100.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3786536,Cc1cnc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)cn1,23.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3785771,Cc1nccnc1NC(=O)Nc1cccc2c1C1CCCCN1C2=O,160.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3787033,Cc1cncc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)n1,810.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3787135,O=C(Nc1ccc2ccccc2n1)Nc1cccc2c1C1CCCCN1C2=O,400.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3785795,COc1cc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)nc2ccccc12,150.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3787292,O=C(Nc1cc(CF)ccn1)Nc1cccc2c1C1CCCCN1C2=O,43.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate
CHEMBL3823532,Nc1ncc2cc3cnccc3c([N+](=O)[O-])c2n1,10000.0,nM,Inhibition of GST-tagged human recombinant CDK5/p25 expressed in Escherichia coli using histone H1 as substrate incubated for 30 mins in presence of [gamma-33 ATP] by liquid scintillation counting analysis
CHEMBL3823483,Nc1ncc2cc3cnccc3c(N)c2n1,4800.0,nM,Inhibition of GST-tagged human recombinant CDK5/p25 expressed in Escherichia coli using histone H1 as substrate incubated for 30 mins in presence of [gamma-33 ATP] by liquid scintillation counting analysis
CHEMBL3823505,Nc1ncc2cc3cnccc3cc2n1,10000.0,nM,Inhibition of GST-tagged human recombinant CDK5/p25 expressed in Escherichia coli using histone H1 as substrate incubated for 30 mins in presence of [gamma-33 ATP] by liquid scintillation counting analysis
CHEMBL3961341,COc1cc(F)ccc1-c1ccnc(NC(=O)[C@@H]2CC[C@H](NC(C)=O)C2)c1,913.0,nM,Inhibition of recombinant human His/GST-tagged CDK5/p35 expressed in baculovirus infected Sf9 insect cells using Rb-CTF as substrate after 80 mins in presence of [33P]ATP by microbeta scintillation counting analysis
CHEMBL3545083,COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1,2.0,nM,Inhibition of CDK5/p35 (unknown origin)
CHEMBL3919811,CN(C)CCOc1ccc(Nc2cc(-n3cnc4ccccc43)ncn2)nc1,610.0,nM,Inhibition of recombinant full-length human N-terminal His6-tagged CDK5/recombinant full-length human N-terminal GST-tagged p35 expressed in baculovirus infected insect Sf21 cells using histone H1 as substrate in presence of [gamma-33P]-ATP after 40 mins by scintillation counting analysis
CHEMBL3753955,N#C/C(=C\c1cccnc1)c1c[nH]c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884241,N#C/C(=C\c1ccccn1)c1c[nH]c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885092,N#C/C(=C\c1ccncc1)c1c[nH]c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884027,N#C/C(=C\c1ccccc1)c1c[nH]c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3753782,COc1cccc2[nH]cc(/C(C#N)=C/c3cccnc3)c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3754608,COc1ccc2[nH]cc(/C(C#N)=C/c3cccnc3)c2c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3753970,COc1ccc2c(/C(C#N)=C/c3cccnc3)c[nH]c2c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3751934,COc1cccc2c(/C(C#N)=C/c3cccnc3)c[nH]c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3753668,N#C/C(=C\c1cccnc1)c1c[nH]c2ncccc12,130.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884086,N#C/C(=C\c1cccnc1)c1c[nH]c2ccc(F)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885043,N#C/C(=C\c1cccnc1)c1c[nH]c2ccc(Cl)cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883943,COc1cncc(/C=C(\C#N)c2c[nH]c3ccc(OC)cc23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884570,COc1ccc2c(/C(C#N)=C/c3cccnc3)c[nH]c2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885315,COc1cncc(/C=C(\C#N)c2c[nH]c3cc(OC)ccc23)c1,,,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884764,COc1ccc2[nH]cc(/C(C#N)=C(\N)c3cccnc3)c2c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883356,N#C/C(=C/c1cccnc1)c1c[nH]c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883764,N#Cc1cc2cnccc2c2[nH]c3ccccc3c12,800.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885267,N#Cc1cc2cccnc2c2[nH]c3ccccc3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883580,N#Cc1cc2ncccc2c2[nH]c3ccccc3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885482,N#Cc1cc2ccccn2c2nc3ccccc3c1-2,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883820,N#Cc1cc2ccncc2c2[nH]c3ccccc3c12,6000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884113,Nc1nc2ccccc2c2cc3cnccc3cc12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883541,N#Cc1cc2ccccc2c2[nH]c3ccccc3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884250,COc1cccc2[nH]c3c4ccncc4cc(C#N)c3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883639,COc1ccc2[nH]c3c4ccncc4cc(C#N)c3c2c1,800.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883660,COc1ccc2c(c1)[nH]c1c3ccncc3cc(C#N)c21,440.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885431,COc1cccc2c1[nH]c1c3ccncc3cc(C#N)c21,460.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884015,N#Cc1cc2cnccc2c2[nH]c3ncccc3c12,780.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883414,N#Cc1cc2cnccc2c2[nH]c3ccc(F)cc3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883458,N#Cc1cc2cnccc2c2[nH]c3ccc(Cl)cc3c12,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884932,COc1ccc2[nH]c3c4c(OC)cncc4cc(C#N)c3c2c1,930.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885316,COc1ccc2c(n1)[nH]c1c3ccncc3cc(C#N)c21,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884821,COc1ccc2c(c1)[nH]c1c3c(OC)cncc3cc(C#N)c21,6400.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884861,COc1ccc2c(c1)[nH]c1c3ccncc3cc(C(N)=O)c21,4500.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884627,COc1cccc2c1[nH]c1c3ccncc3cc(C(N)=O)c21,9000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884583,COc1ccc2c(c1)[nH]c1c3c(OC)cncc3cc(C(N)=O)c21,1600.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885328,COc1ccc2c(c1)[nH]c1c3ccncc3cc(CN)c21,5600.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885360,COc1ccc2c(c1)[nH]c1c3ccncc3cc(CNC(C)=O)c21,6000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884845,COc1ccc2c(c1)[nH]c1c3ccncc3cc(CN(C)C)c21,5400.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885021,COc1ccc2[nH]cc3c2c1C(C)NC(c1cccnc1)=C3C#N,6400.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885036,COc1ccc2[nH]c3c(=O)[nH]c(-c4cccnc4)c(C#N)c3c2c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885335,COc1ccc2[nH]cc(-c3cc4cnccc4cc3NC(C)=O)c2c1,8000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883813,COc1ccc2cc(-c3ccncc3)[nH]c2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3883448,COc1ccc2c(-c3ccncc3)c[nH]c2n1,7000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884031,COc1ccc2c(CC#N)c(-c3ccncc3)[nH]c2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3885333,COc1ccc2[nH]cc(/C(C#N)=C/c3cnccc3C)c2c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate after 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis
CHEMBL3884319,CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21,658.0,nM,Inhibition of human recombinant full length GST/His-tagged CDK5/P25 expressed in baculovirus expression system
CHEMBL492244,CN1CCN(CCO/N=C2C(=C3/C(=O)Nc4cc(Br)ccc43)/Nc3ccccc3/2)CC1.Cl,500.0,nM,Inhibition of recombinant human N-terminal GST-tagged CDK5 (M1 to P292 residues)/p35NCK (M1 to R307 residues) expressed in baculovirus infected sf9 cells using RB-CTF as substrate by filter binding assay
CHEMBL4065204,COc1cc2ncnc(Nc3cc(-c4ccccc4)n(-c4ccccc4)n3)c2cc1OC,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Escherichia coli using histone H1 as substrate after 30 mins in presence of ATP by scintillation counting method
CHEMBL4081787,COc1ccc(-c2cc(Nc3ncnc4cc(OC)c(OC)cc34)n[nH]2)cc1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Escherichia coli using histone H1 as substrate after 30 mins in presence of ATP by scintillation counting method
CHEMBL4099804,COc1cc2ncnc(Nc3cc(-c4ccc(Cl)cc4)[nH]n3)c2cc1OC,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Escherichia coli using histone H1 as substrate after 30 mins in presence of ATP by scintillation counting method
CHEMBL4105091,COc1cc2ncnc(Nc3cc(-c4ccc(F)cc4)[nH]n3)c2cc1OC,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Escherichia coli using histone H1 as substrate after 30 mins in presence of ATP by scintillation counting method
CHEMBL4080858,COc1cc2ncnc(Nc3cc(-c4ccccc4)[nH]n3)c2cc1OC,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Escherichia coli using histone H1 as substrate after 30 mins in presence of ATP by scintillation counting method
CHEMBL4097381,COc1cc2ncnc(Nc3n[nH]cc3C#N)c2cc1OC,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Escherichia coli using histone H1 as substrate after 30 mins in presence of ATP by scintillation counting method
CHEMBL4070204,COc1cc2ncnc(Nc3cc(O)[nH]n3)c2cc1OC,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Escherichia coli using histone H1 as substrate after 30 mins in presence of ATP by scintillation counting method
CHEMBL4099677,Fc1ccc2ncc(-c3cccc(C(F)(F)F)c3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4081668,O=Cc1cccc(-c2cnc3ccc(F)nn23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4091942,Clc1ccc2ncc(-c3ccc4[nH]ccc4c3)n2n1,6700.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4076906,Clc1ccc2ncc(-c3cccnc3)n2n1,4700.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4070065,FC(F)(F)c1cccc(-c2cnc3ccc(Cl)nn23)c1,4700.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4097256,FC(F)(F)c1cccc(/C=C/c2cnc3ccc(Cl)nn23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4061394,Clc1cccc(-c2cnc3ccc(Cl)nn23)c1,6800.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4089542,Nc1cccc(-c2cnc3ccc(Cl)nn23)c1,29000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4087260,Nc1ccc(Cl)cc1-c1cnc2ccc(Cl)nn12,71000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4076448,O=Cc1cccc(-c2cnc3ccc(Cl)nn23)c1,820.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4077159,O/N=C/c1cccc(-c2cnc3ccc(Cl)nn23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4093231,CC[C@@H](CO)NC(=O)c1cccc(-c2cnc3ccc(Cl)nn23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4075820,CC[C@H](CO)NC(=O)c1cccc(-c2cnc3ccc(Cl)nn23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4085467,FC(F)(F)c1ccc(-c2cnc3ccc(Cl)nn23)cc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4090770,CC[C@@H](CO)Nc1ccc2ncc(-c3ccc4[nH]ccc4c3)n2n1,3100.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4062820,CC[C@@H](CO)Nc1ccc2ncc(-c3cc4ccccc4[nH]3)n2n1,1200.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4082981,CC[C@@H](CO)Nc1ccc2ncc(-c3cc4cc(Br)ccc4[nH]3)n2n1,8300.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4100956,CC[C@@H](CO)Nc1ccc2ncc(-c3cccnc3)n2n1,1700.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4086402,CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(C(F)(F)F)c3)n2n1,50000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4104296,CC[C@@H](CO)Nc1ccc2ncc(-c3ccc(C(F)(F)F)cc3)n2n1,7100.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4080844,CC[C@@H](CO)Nc1ccc2ncc(/C=C/c3cccc(C(F)(F)F)c3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4105084,CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(Cl)c3)n2n1,610.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4088717,CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(N)c3)n2n1,3800.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4067477,CC[C@@H](CO)Nc1ccc2ncc(-c3cc(Cl)ccc3N)n2n1,17000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4061526,CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(NC(C)=O)c3)n2n1,190.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4089652,CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(SC)c3)n2n1,820.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4070189,CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(S(C)(=O)=O)c3)n2n1,890.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4097368,CC[C@@H](CO)Nc1ccc2ncc(-c3ccsc3)n2n1,590.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4092047,CC[C@@H](CO)Nc1ccc2ncc(-c3ccnc(SC)n3)n2n1,2200.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4071234,CC[C@@H](CO)Nc1ccc2ncc(-c3ccnc([S+](C)[O-])n3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4062683,CC[C@@H](CO)Nc1ccc2ncc(-c3ccnc(S(C)(=O)=O)n3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4084364,CC[C@@H](CO)Nc1ccc2ncc(-c3ccnc(N)n3)n2n1,5100.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4071322,CCOC(=O)c1cccc(-c2cnc3ccc(N[C@@H](CC)CO)nn23)c1,1100.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4092117,CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(C(=O)O)c3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4093104,CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(C=O)c3)n2n1,480.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4065432,CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(/C=N/O)c3)n2n1,1000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4070227,CC[C@@H](CO)/N=C/c1cccc(-c2cnc3ccc(N[C@@H](CC)CO)nn23)c1,590.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4071413,CC[C@@H](CO)NC(=O)c1cccc(-c2cnc3ccc(N[C@@H](CC)CO)nn23)c1,6100.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4098237,CC[C@H](CO)NC(=O)c1cccc(-c2cnc3ccc(N[C@@H](CC)CO)nn23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4074132,CC(C)[C@@H](CO)Nc1ccc2ncc(-c3cccnc3)n2n1,1400.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4083948,CCOC(=O)Nc1ccc2ncc(-c3cccnc3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4075509,CCOC(=O)Nc1ccc2ncc(-c3cccc(Cl)c3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4074499,CC(=O)Nc1cccc(Nc2ccc3ncc(-c4cccc(Cl)c4)n3n2)c1,390.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4071013,OCCN1CCN(c2ccc3ncc(-c4cccc(Cl)c4)n3n2)CC1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4064988,Clc1cccc(-c2cnc3ccc(N4CCC(N5CCCCC5)CC4)nn23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4092673,CC[C@@H](CO)N(C(C)=O)c1ccc2ncc(-c3cccc(NC(C)=O)c3)n2n1,1100.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4102871,CC(=O)Nc1cccc(Nc2ccc3ncc(-c4cccc(NC(C)=O)c4)n3n2)c1,220.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4084919,CC[C@H](CO)/N=C/c1cccc(-c2cnc3ccc(N[C@H](CC)CO)nn23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4076663,CC[C@H](CO)NC(=O)c1cccc(-c2cnc3ccc(N[C@H](CC)CO)nn23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4079343,CC[C@@H](CO)NC(=O)c1cccc(-c2cnc3ccc(N[C@H](CC)CO)nn23)c1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4079347,COc1ccc2ncc(-c3ccc4[nH]ccc4c3)n2n1,5100.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4098107,COc1ccc2ncc(-c3cccc(C(F)(F)F)c3)n2n1,18000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4063254,COc1ccc2ncc(-c3ccc(C(F)(F)F)cc3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4091127,COc1ccc2ncc(/C=C/c3cccc(C(F)(F)F)c3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4067420,COc1ccc2ncc(-c3ccnc(SC)n3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4062568,COc1ccc2ncc(-c3ccnc([S+](C)[O-])n3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4077125,COc1ccc2ncc(-c3ccnc(N)n3)n2n1,10000.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4072506,COc1ccc2ncc(-c3cccc(/C=N/O)c3)n2n1,1800.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4090223,CSc1ccc2ncc(-c3ccc4[nH]ccc4c3)n2n1,4200.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4069158,CSc1ccc2ncc(-c3cccc(C(F)(F)F)c3)n2n1,750.0,nM,Inhibition of human recombinant CDK5/p25 after 30 mins by [gamma-33P]ATP based scintillation counting analysis
CHEMBL4098255,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NCc5ccc(F)c(F)c5)ncnc43)C2)n1,13.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4081756,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NCc5cccc(Br)c5)ncnc43)C2)n1,4.8,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4103221,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NCc5cccc(Cl)c5)ncnc43)C2)n1,2.3,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4091107,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NCc5ccc(F)cc5)ncnc43)C2)n1,30.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4070146,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NCc5cccc(F)c5)ncnc43)C2)n1,6.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4105016,O=C(N[C@H]1C[C@@H](n2cnc3c(NCc4cccnc4)ncnc32)C1)c1cccc(-c2ccccc2)n1,31.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4087174,O=C(N[C@H]1C[C@@H](n2cnc3c(NCc4cccnc4)ncnc32)C1)c1cccc(C(F)(F)F)n1,23.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4067424,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NCc5cccnc5)ncnc43)C2)n1,10.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4076545,CC(=O)N[C@H]1CC[C@H](Nc2ncnc3c2ncn3[C@H]2C[C@@H](NC(=O)c3cccc(C)n3)C2)CC1,30.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4092920,CC(=O)N[C@H]1CC[C@@H](Nc2ncnc3c2ncn3[C@H]2C[C@@H](NC(=O)c3cccc(C)n3)C2)CC1,27.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4070922,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NC5CCNC5)ncnc43)C2)n1,1000.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4097273,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NC5CCN(C(=O)OC(C)(C)C)C5)ncnc43)C2)n1,500.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4087130,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(N[C@H]5CC[C@H](O)CC5)ncnc43)C2)n1,500.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4104979,CC(=O)N1CCC(Nc2ncnc3c2ncn3[C@H]2C[C@@H](NC(=O)c3cccc(C)n3)C2)CC1,179.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4082514,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NC5CCN(C)CC5)ncnc43)C2)n1,1000.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4059822,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NC5CCNCC5)ncnc43)C2)n1,162.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4082490,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NC5CCN(C(=O)OC(C)(C)C)CC5)ncnc43)C2)n1,66.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4072013,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NCC5CCNCC5)ncnc43)C2)n1,71.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4098980,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NCC5CCN(C(=O)OC(C)(C)C)CC5)ncnc43)C2)n1,90.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4063385,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NCC5CCCCC5)ncnc43)C2)n1,25.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4067461,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(NCc5ccc(Cl)c(Cl)c5)ncnc43)C2)n1,34.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4094891,COc1cccc(Nc2ncnc3c2ncn3[C@H]2C[C@@H](NC(=O)c3cccc(C)n3)C2)c1,67.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4101443,Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc4c(Nc5ccncc5)ncnc43)C2)n1,1000.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4091242,COc1ccc(Nc2ncnc3c2ncn3[C@H]2C[C@@H](NC(=O)c3cccc(C)n3)C2)cc1OC,94.0,nM,Inhibition of CDK5/p35 (unknown origin) using ULingt-4E-BP as substrate after 1 hr in presence of ATP by fluorescence assay
CHEMBL4079206,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(/C=C/c4c(Cl)cccc4Cl)oc23)[C@H](O)C1,15.5,nM,Inhibition of CDK5/cyclin p25 (unknown origin) after 30 mins in presence of [33P]-gamma-ATP by filter binding assay
CHEMBL4128587,NC(=O)c1c(O)cc(O)c2c1oc1c(=O)[nH]cnc12,10000.0,nM,Inhibition of human CDK5/p25
CHEMBL4129279,NC(=O)c1c(O)cc(O)c2c1oc1c(=O)[nH]c(=O)[nH]c12,10000.0,nM,Inhibition of human CDK5/p25
CHEMBL4127885,NC(=O)c1c(O)cc(O)c2c1oc1c(N)ncnc12,10000.0,nM,Inhibition of human CDK5/p25
CHEMBL475816,CC(=O)C1=C(O)C=C2Oc3c(C(N)=O)c(O)cc(O)c3[C@]2(C)C1=O,5600.0,nM,Inhibition of human CDK5/p25
CHEMBL4210771,CC(C)c1n[nH]c2c(NCc3ccccc3)nc(NC3CCCCC3N)nc12,440.0,nM,Inhibition of recombinant human full length N-terminal GST/His6-tagged CDK5 (M1 to P292 residues)/N-terminal His6-tagged p25NCK (A104 to R307 residues) expressed in Sf9 insect cells
CHEMBL4205015,CC(C)c1n[nH]c2c(NCc3ccccc3)nc(NC3CCC(N)CC3)nc12,1600.0,nM,Inhibition of recombinant human full length N-terminal GST/His6-tagged CDK5 (M1 to P292 residues)/N-terminal His6-tagged p25NCK (A104 to R307 residues) expressed in Sf9 insect cells
CHEMBL4241699,O=C(O)CCCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4244860,N#CCCCCCn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4243080,O=C1C2=C(C(=O)N1O)c1cn(c3ccccc13)CCCCCCn1cc2c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4238883,CCn1cc(C2=C(c3cn(C(C)C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4239321,CC(C)n1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4249393,CC(C)n1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4240779,Cn1cc(C2=C(c3cn(CCCCCC(=O)O)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4245590,Cn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4246062,CCn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4241803,Cn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4242235,Cn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4238093,O=C1C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ncccc23)C(=O)N1O,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL52851,Cn1cc(C2=C(c3cn(C)c4ncccc34)C(=O)NC2=O)c2ccccc21,800.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4238971,N#CCCCCCn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)NC2=O)c2ccccc21,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 expressed in bacteria using histone H1 as substrate in presence of [gamma-33P]ATP
CHEMBL4281048,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,4640.0,nM,Inhibition of recombinant full length His/GST-tagged human CDK5/p25 expressed in baculovirus expression system
CHEMBL4284209,CC(C)c1cnn2c(NCc3ccc(-c4ccccn4)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12,50.0,nM,Inhibition of recombinant human CDK5/p25 after 30 mins in presence of [gamma-33P] by scintillation counting method
CHEMBL4448494,Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C,98.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL393929,O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1,2480.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL367625,CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,26.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL80713,COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,419.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL1802728,CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,8800.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL1276446,O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1,7.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL411491,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1,738.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL3545110,CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,20000.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL3115681,CN1CCN(c2ccc(Nc3ncc4cc(C#N)c(=O)n(C5CCCC5)c4n3)cc2)CC1,272.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL268368,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21,936.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL1331734,COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12,20000.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL290904,Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,20000.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL2028998,CCNc1cc(N[C@H]2CC[C@H](O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1,10000.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL477064,CCCOc1cnc(CN/C=C2\C(=O)NC(=O)c3ccc(I)cc32)cc1O,1200.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL64758,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21,154.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL261720,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,0.2,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL310840,CCCCOc1c(C(=O)c2c(F)cc(C)cc2F)c[nH]c2nncc1-2,258.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL300389,OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1,10.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL265964,Nc1cc(Nc2ccc(S(N)(=O)=O)cc2)ncn1,4400.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL298445,Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1,188.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL259389,Nc1n[nH]c2nc3ccccc3nc12,13700.0,nM,Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay
CHEMBL4482864,COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1,300.0,nM,Inhibition of recombinant full length human GST/His-tagged CDK5/p25 expressed in baculovirus expression system
CHEMBL4439395,O=C(Cc1ccc(-c2ccccc2)cc1)Nc1cc(C2CCC2)[nH]n1,23.0,nM,Inhibition of CDK5/p35 (unknown origin) in presence of ATP
CHEMBL4452422,O=C(Nc1cccc(OC[C@H]2CCCN2)n1)Nc1csc(-c2ccncc2)n1,10.0,nM,Inhibition of CDK5/p25 (unknown origin) using histone-h1 as substrate measured after 10 mins in presence of [gamma33P]AT
CHEMBL4438748,CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1,10000.0,nM,Inhibition of recombinant full length human CDK5/p25 using histone H1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis
CHEMBL4540226,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(SCCN)nc12,15.0,nM,Inhibition of recombinant human full-length N-terminal GST-His6 fused CDK5 (M1 to P292 residues)/N-terminal His6-tagged p25 (A104 to R307 residues) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate measured in presence of [gamma-33P]ATP
CHEMBL4475474,C#Cc1cccc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)n1,80.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4445964,C#Cc1ccc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)nc1,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4515295,C#CCCc1ccnc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)c1,70.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4483607,C#Cc1ccnc(NC(=O)Nc2cccc3c2[C@@H]2CCCCN2C3=O)c1,50.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4463060,C#Cc1ccnc(NC(=O)Nc2cccc3c2[C@H]2CCCCN2C3=O)c1,18.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4566076,C#Cc1ccnc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)c1,68.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4518977,c1ccc2c(NCCn3ccnn3)c3c(nc2c1)CCCC3,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4583414,O=C(Nc1cc(COCc2cn(CCNc3ccnc4ccccc34)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,240.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4459540,O=C(Nc1cc(COCc2cn(CCNc3ccncc3)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,200.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4531222,O=C(Nc1cc(COCc2cn(CCCc3ccccc3)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,260.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4537142,Cn1cc(COCc2ccnc(NC(=O)Nc3cccc4c3C3CCCCN3C4=O)c2)nn1,250.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4444585,C#CCN(C)Cc1ccnc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)c1,90.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4435354,C#CCOCc1ccnc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)c1,150.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL95,Nc1c2c(nc3ccccc13)CCCC2,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4537026,O=C(Nc1cccc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)n1)Nc1cccc2c1C1CCCCN1C2=O,3100.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4583650,O=C(Nc1ccc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)cn1)Nc1cccc2c1C1CCCCN1C2=O,10000.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4443468,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1[C@@H]1CCCCN1C2=O,1100.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4443989,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1[C@H]1CCCCN1C2=O,500.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4559936,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,800.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4593316,O=C(Nc1cc(CCc2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,800.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4446287,CN(Cc1ccnc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)c1)Cc1cn(CCNc2c3c(nc4ccccc24)CCCC3)nn1,310.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4516356,O=C(Nc1cc(COCc2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,300.0,nM,Inhibition of human recombinant CDK5/p25 using histone H1 as substrate in presence of [gamma-33P]ATP incubated for 30 mins by liquid scintillation counting assay
CHEMBL4434651,c1ccc(Nc2ncc3c(n2)CCCC3)cc1,1760.0,nM,Inhibition of recombinant full length N-terminal GST tagged human CDK5/p25 expressed in baculovirus infected sf9 cells using histone H1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay
CHEMBL4564126,Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21,5000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL4569508,O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1,19.0,nM,Inhibition of full-length recombinant human GST and His-tagged CDK5/P25 expressed in baculovirus expression system by Z'-LYTE assay
CHEMBL4550702,Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1,10.0,nM,Inhibition of full-length recombinant human GST and His-tagged CDK5/P25 expressed in baculovirus expression system by Z'-LYTE assay
CHEMBL4568087,Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1,4.4,nM,Inhibition of full-length recombinant human GST and His-tagged CDK5/P25 expressed in baculovirus expression system by Z'-LYTE assay
CHEMBL4552628,Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12,61.0,nM,Inhibition of full-length recombinant human GST and His-tagged CDK5/P25 expressed in baculovirus expression system by Z'-LYTE assay
CHEMBL4634634,C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C,100000.0,nM,Inhibition of recombinant full length human GST/His-tagged CDK5/p25 expressed in baculovirus expression system using serine/threonine-12 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay
CHEMBL4647764,C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1,1130.0,nM,Inhibition of recombinant human full-length GST/His-tagged CDK5/p25 expressed in baculovirus expression system using FRET-labeled Ser/Thr 12 as substrate measured after 1 hr by Z'-lyte assay
CHEMBL4782409,CN1CC[C@@H](c2c(OP(=O)(O)O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO,210.0,nM,Inhibition of N-terminal His6-tagged thrombin cleavage site-fused human CDK5 (M1 to P292 residues)/p35 (M1 to R307 residues) expressed in baculovirus infected Sf9 insect cells
CHEMBL4286578,COc1cc(F)ccc1-c1ncnc(Nc2cccc(CS(C)(=N)=O)c2)n1,890.0,nM,Inhibition of N-terminal GST-tagged human CDK5/N-terminal GST-tagged p35
CHEMBL4764481,Nc1nc(N[C@H]2C[C@@H]3CC[C@H]2C3)sc1C(=O)c1ccccc1[N+](=O)[O-],159.0,nM,Inhibition of CDK5/p35 (unknown origin)
CHEMBL4790926,CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6[nH]5)cc4)oc23)CC1,121.0,nM,Inhibition of human CDK5/p25 in presence of ATP by ADP-glo luminescent assay
CHEMBL4787876,CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc(-c6ccccc6)c[nH]5)cc4)oc23)CC1,195.0,nM,Inhibition of human CDK5/p25 in presence of ATP by ADP-glo luminescent assay
CHEMBL4781618,CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4)oc23)CC1,284.0,nM,Inhibition of human CDK5/p25 in presence of ATP by ADP-glo luminescent assay
CHEMBL4793858,CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6[nH]5)cc4Cl)oc23)CC1,550.0,nM,Inhibition of human CDK5/p25 in presence of ATP by ADP-glo luminescent assay
CHEMBL4788045,CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4Cl)oc23)CC1,1093.0,nM,Inhibition of human CDK5/p25 in presence of ATP by ADP-glo luminescent assay
CHEMBL4788347,COc1cc(F)ccc1-c1nc(Nc2ccc3c(N4CCOCC4)c(C(C)=O)c(=O)oc3c2)ncc1F,1261.0,nM,Inhibition of CDK5/p25 (unknown origin) preincubated for 20 mins followed by ATP addition and measured after 120 mins in presence of [33P-gamma] ATP by hotspot kinase assay
CHEMBL4776698,CCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1,10000.0,nM,Inhibition of human recombinant CDK5/p25 expressed in bacterial expression using histone H1 as substrate by ADP-glo assay
CHEMBL4796622,CCCCNc1nc2cc([N+](=O)[O-])ccc2s1,10000.0,nM,Inhibition of human recombinant CDK5/p25 expressed in bacterial expression using histone H1 as substrate by ADP-glo assay
CHEMBL3634367,CN(C)c1nccn2c(-c3ccncc3)c(-c3ccc(F)cc3)nc12,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of ATP measured after 30 mins by ADP-Glo assay
CHEMBL4860515,CN(C)c1nccn2c(-c3cccnc3)c(-c3ccc(F)cc3)nc12,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of ATP measured after 30 mins by ADP-Glo assay
CHEMBL4848621,CN(C)c1nccn2c(-c3cncnc3)c(-c3ccc(F)cc3)nc12,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of ATP measured after 30 mins by ADP-Glo assay
CHEMBL4871059,CN(C)c1nccn2c(-c3cnc(N)nc3)c(-c3ccc(F)cc3)nc12,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of ATP measured after 30 mins by ADP-Glo assay
CHEMBL4866187,CN(C)c1nccn2c(-c3ccc4[nH]ncc4c3)c(-c3ccc(F)cc3)nc12,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of ATP measured after 30 mins by ADP-Glo assay
CHEMBL4861720,CN(C)c1nccn2c(-c3cnn(C)c3)c(-c3ccc(F)cc3)nc12,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of ATP measured after 30 mins by ADP-Glo assay
CHEMBL4875029,CSc1nccc(-c2c(-c3ccccc3)nc3c(Cl)nccn23)n1,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of [gamma-33P]ATP by radiometric assay
CHEMBL4872681,CSc1nccc(-c2c(-c3ccccc3)nc3c(N(C)C)nccn23)n1,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of [gamma-33P]ATP by radiometric assay
CHEMBL4860872,CN(C)c1nccn2c(-c3ccnc(N)n3)c(-c3ccccc3)nc12,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of [gamma-33P]ATP by radiometric assay
CHEMBL4851634,CSc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of [gamma-33P]ATP by radiometric assay
CHEMBL4875986,CSc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N(C)C)nccn23)n1,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of [gamma-33P]ATP by radiometric assay
CHEMBL4870529,CN(C)c1nccn2c(-c3ccnc(N)n3)c(-c3ccc(F)cc3)nc12,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of [gamma-33P]ATP by radiometric assay
CHEMBL4877608,CSc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N)nccn23)n1,1000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of [gamma-33P]ATP by radiometric assay
CHEMBL4853288,Nc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N)nccn23)n1,10000.0,nM,Inhibition of human recombinant CDK5/ p25 expressed in bacterial expression system using histone H1 as substrate in presence of [gamma-33P]ATP by radiometric assay
CHEMBL4848734,CC(=O)c1c(N2CCOCC2)c2ccc(Nc3nccc(-c4ccc5nn(C)c(C(C)C)c5c4)n3)cc2oc1=O,9.0,nM,Inhibition of human CDK5/p25 using histone H1 as substrate incubated for 2 hrs by [gamma-33P]-ATP assay
CHEMBL4856177,CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C,14.7,nM,Inhibition of human CDK5/p25 using histone H1 as substrate incubated for 2 hrs by [gamma-33P]-ATP assay
CHEMBL4869775,CCOC(=O)c1cccc(Nc2cc3nc(SC4CCNCC4)ccc3cn2)c1,10.0,nM,Inhibition of full length human CDK5 (1 to 292 residues)/p25 expressed in baculovirus expression system using FL peptide 29 as a substrate preincubated for 30 mins followed by substrate addition incubated for 60 mins in the presence of ATP by mobility shift assay
CHEMBL4861166,CN1CCC(N(CC(=O)O)c2ccc3cnc(Nc4cccc(S(N)(=O)=O)c4)cc3n2)CC1,10.0,nM,Inhibition of full length human CDK5 (1 to 292 residues)/p25 expressed in baculovirus expression system using FL peptide 29 as a substrate preincubated for 30 mins followed by substrate addition incubated for 60 mins in the presence of ATP by mobility shift assay
CHEMBL4878160,CN1CCC(C(=O)c2ccc3cnc(Nc4ccc(-n5cccn5)cc4F)cc3n2)CC1,10.0,nM,Inhibition of full length human CDK5 (1 to 292 residues)/p25 expressed in baculovirus expression system using FL peptide 29 as a substrate preincubated for 30 mins followed by substrate addition incubated for 60 mins in the presence of ATP by mobility shift assay
CHEMBL4875691,CN1CCC(S(=O)(=O)c2ccc3cnc(Nc4ccc(N5CCCS5(=O)=O)cc4)cc3n2)CC1,10.0,nM,Inhibition of full length human CDK5 (1 to 292 residues)/p25 expressed in baculovirus expression system using FL peptide 29 as a substrate preincubated for 30 mins followed by substrate addition incubated for 60 mins in the presence of ATP by mobility shift assay
CHEMBL4876976,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccc(S(C)(=O)=O)cc4)cc3n2)CC1,10.0,nM,Inhibition of full length human CDK5 (1 to 292 residues)/p25 expressed in baculovirus expression system using FL peptide 29 as a substrate preincubated for 30 mins followed by substrate addition incubated for 60 mins in the presence of ATP by mobility shift assay
CHEMBL4874874,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cccc(C(N)=O)c4)cc3n2)CC1,10.0,nM,Inhibition of full length human CDK5 (1 to 292 residues)/p25 expressed in baculovirus expression system using FL peptide 29 as a substrate preincubated for 30 mins followed by substrate addition incubated for 60 mins in the presence of ATP by mobility shift assay
CHEMBL5088480,OCc1ccn(-c2ccc(Nc3cc4nc(OC5CCNCC5)ccc4cn3)c(F)c2)n1,16.0,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5094131,OCc1ccn(-c2ccc(Nc3cc4nc(NC5CCNCC5)ccc4cn3)c(F)c2)n1,11.0,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5094209,OCc1ccn(-c2ccc(Nc3cc4nc(CC5CCNCC5)ccc4cn3)c(F)c2)n1,48.0,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5093797,O=C(O)CN(c1ccc2cnc(Nc3ccc(-n4ccc(CO)n4)cc3F)cc2n1)C1CCNCC1,26.0,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5082140,C[C@](O)(c1ccc2cnc(Nc3ccc(-n4ccc(CO)n4)cc3F)cc2n1)C1CCNCC1,3.6,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5093640,CN1CCC(Oc2ccc3cnc(Nc4ccc(-n5ccc(CO)n5)cc4F)cc3n2)CC1,3.9,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5093012,CN1CCC(N(CC(=O)O)c2ccc3cnc(Nc4ccc(-n5ccc(CO)n5)cc4F)cc3n2)CC1,4.5,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5092400,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccc(-n5ccc(CO)n5)cc4F)cc3n2)CC1,1.0,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5079772,C[C@H](c1ccc2cnc(Nc3ccc(-n4ccc(CO)n4)cc3F)cc2n1)C1CCN(C)CC1,4.3,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5076000,CN1CCC([C@@H](O)c2ccc3cnc(Nc4ccc(-n5ccc(CO)n5)cc4F)cc3n2)CC1,5.9,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5081712,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccccc4)cc3n2)CC1,0.6,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5077125,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccccc4F)cc3n2)CC1,1.1,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5078762,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccc(-n5cccn5)cc4F)cc3n2)CC1,0.8,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5077138,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccc(S(C)(=O)=O)cc4F)cc3n2)CC1,0.6,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5075328,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccc(-c5cccc(C#N)c5)cc4F)cc3n2)CC1,0.2,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5088315,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccc(-c5cccn(C)c5=O)cc4F)cc3n2)CC1,2.8,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5078596,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cccc(N5CCOCC5)c4)cc3n2)CC1,1.4,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5080866,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cc(N5CCOCC5)ccc4F)cc3n2)CC1,1.8,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5079342,CC(=O)N1CCN(c2ccc(F)c(Nc3cc4nc([C@](C)(O)C5CCN(C)CC5)ccc4cn3)c2)CC1,2.7,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5074832,CCc1ccc(F)c(Nc2cc3nc([C@](C)(O)C4CCN(C)CC4)ccc3cn2)c1,0.6,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5094270,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cc(C(F)(F)F)ccc4F)cc3n2)CC1,1.2,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5080351,CC(C)Oc1ccc(F)c(Nc2cc3nc([C@](C)(O)C4CCN(C)CC4)ccc3cn2)c1,0.6,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5078192,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cc(N5CCOCC5)ncc4F)cc3n2)CC1,3.2,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5080566,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cc(N5CCOCC5)c(C#N)cc4F)cc3n2)CC1,2.0,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5086711,C#Cc1cc(F)c(Nc2cc3nc([C@](C)(O)C4CCN(C)CC4)ccc3cn2)cc1N1CCOCC1,644.0,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5086375,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccc(C#N)cc4F)cc3n2)CC1,0.8,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5091792,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cc(N5CCCC5)ncc4F)cc3n2)CC1,0.9,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5080123,CC(C)Nc1cc(Nc2cc3nc([C@](C)(O)C4CCN(C)CC4)ccc3cn2)c(F)cn1,6.3,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5083778,CC(C)Oc1cc(Nc2cc3nc([C@](C)(O)C4CCN(C)CC4)ccc3cn2)c(F)cn1,1.2,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5084882,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cc(OC5CCC5)ncc4F)cc3n2)CC1,3.0,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5088595,CCc1cc(Nc2cc3nc([C@](C)(O)C4CCN(C)CC4)ccc3cn2)c(F)cn1,0.9,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5090019,CC(C)c1cc(Nc2cc3nc([C@](C)(O)C4CCN(C)CC4)ccc3cn2)c(F)cn1,0.8,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5084200,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cc(C(F)(F)F)ncc4F)cc3n2)CC1,2.3,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5080361,CC(C)c1cc(Nc2cc3nc([C@](C)(O)C4CCN(C)CC4)ccc3cn2)c(F)cc1C#N,1.0,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5070707,CC(C)Oc1cc(Nc2cc3nc([C@](C)(O)C4CCN(C)CC4)ccc3cn2)c(F)cc1C#N,2.2,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5087911,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cc(C(F)(F)F)c(C#N)cc4F)cc3n2)CC1,2.2,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5077028,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cc(N5CC6CCC(C5)O6)c(C#N)cc4F)cc3n2)CC1,0.8,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL5080813,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4cc(C(N)=O)ncc4F)cc3n2)CC1,4.4,nM,Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method
CHEMBL4650328,Nc1nccc(-c2ccc(O)c(-c3ccnc(N)n3)n2)n1,2.4,nM,Inhibition of CDK5/p35 (unknown origin)
CHEMBL216543,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O,100.0,nM,Inhibition of CDK5/p35 (unknown origin)
CHEMBL1208600,O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2C1=O,65.0,nM,Inhibition of CDK5/p35 (unknown origin)
CHEMBL5199235,CN1C(=O)/C(=C2\Nc3ccccc3\C2=N/O)c2ccccc21,100000.0,nM,Inhibition of GST-fused CDK5/p25 (unknown origin)
CHEMBL1092509,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccccc2/C1=N\O,33000.0,nM,Inhibition of GST-fused CDK5/p25 (unknown origin)
CHEMBL5179617,Cc1nc2c(F)cc(-c3nc(Nc4nccc(Sc5cnc(N6CCC7(CC6)CO[C@@H](C)[C@H]7N)cn5)c4Cl)ncc3F)cc2n1C(C)C,540.0,nM,Inhibition of recombinant full length N-terminal GST/His6-fusion tagged human CDK5/P25 expressed in Sf9 insect cells incubated for 20 mins followed by [33P]gamma-ATP addition and measured after 2 hrs by radiometric HotSpot Kinase assay
CHEMBL5178368,CCCNc1ccc2ncc(-c3ccc4[nH]ncc4c3)n2n1,41.0,nM,Inhibition of human recombinant CDK5/p25 expressed in bacterial expression system using histone H1 as substrate in presence of ATP at measured after 30 mins by ADP-Glo assay
CHEMBL5202522,Nc1nc(N[C@H]2CC3CCC2C3)sc1C(=O)c1ccccc1[N+](=O)[O-],159.0,nM,Inhibition of CDK5/p35 (unknown origin)
CHEMBL255465,NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1,112.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL512682,O=C1NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1,7000.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL480350,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)c(Br)c32)N1,56.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL1233473,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Cl)c(Cl)c32)N1,62.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5271328,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]cc(Br)c32)N1,79.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5267995,CC(=O)NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)c(Br)c32)N1,533.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5272265,CCNC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)c(Br)c32)N1,9120.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5277152,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c4ccc(Br)cc4c32)N1,213.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5281583,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c4ccc(Cl)cc4c32)N1,191.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5285766,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c4ccc(F)cc4c32)N1,177.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL481333,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c4ccccc4c32)N1,177.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5267075,O=C1NCC/C(=N\Nc2ccccn2)c2c1[nH]c(Br)c2Br,10400.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5280645,O=C1NCC/C(=N\Nc2ccc(Cl)cn2)c2c1[nH]c1ccc(F)cc21,75.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5265856,O=C1NCC/C(=N\Nc2cccnc2)c2c1[nH]c1ccc(F)cc21,12.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5272006,O=C1NCC/C(=N\Nc2cccnc2Cl)c2c1[nH]c1ccc(F)cc21,12.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL5276637,N=C1NC(=O)C(=C2CCNC(=O)c3[nH]c(Br)cc32)N1,160.0,nM,Inhibition of CDK5/p25 (unknown origin)
CHEMBL3298236,c1ccc(-c2ccc3[nH]ncc3c2)cc1,1797.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4283240,COc1ccc2c3ccnc(Cl)c3n(CC#N)c2c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5279705,COC1=CC2C(=O)NC3=Cc4ccc(OC)cc4C(=C1OC)C32,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL3421968,COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3cnccc23)n1,1058.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL1614713,c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4784318,CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1,3960.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL1230165,O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL3894571,COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4292553,Oc1ccc(-c2cnc3[nH]cc(-c4ccc(F)cc4)c3c2)cc1O,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4647659,CC(C)Oc1ccc(F)c(-c2cnc(N)c(C(=O)Nc3cnccc3N3CCC[C@@H](C(=O)O)C3)n2)c1,470.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5081787,O=C1N=C(Nc2c(Cl)cccc2Cl)S/C1=C\c1ccc2nccnc2c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5093741,CN1Cc2nn(C)c(C#N)c2-c2cnc3[nH]cc(c3c2)-c2cn(nc2C(F)(F)F)CCCC1=O,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5086263,CN1Cc2nn(C)c(C#N)c2-c2cnc3[nH]c(F)c(c3c2)-c2cn(nc2C(F)(F)F)CCCC1=O,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL1236620,CCOC(=O)c1c(/C(C#N)=C\N)c2ccc(Cl)c(Cl)c2n1C,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4873449,Oc1ccc(-c2n[nH]c3ncc(-c4ccc(O)c(O)c4)cc23)cc1,38.4,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5273528,CCNc1cc(Nc2ccc(C(=O)N3CCC(N4CCOCC4)CC3)cc2OC)nc2[nH]cc(C(F)(F)F)c12,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5283849,O=C1NC(NC2CCCCCC2)=N/C1=C\c1ccc2ncsc2c1,4620.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5091238,O=C1NC(NC23CC4CC(CC(C4)C2)C3)=N/C1=C\c1ccc2ncsc2c1,243.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4297639,CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5cncc(-c6cccc(F)c6)c5[nH]4)c3c2)c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL393525,Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(Br)cn12,24.5,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4441878,Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1C(C)C,273.2,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5070553,Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CC(F)(F)F,413.6,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5289681,CC(C)CN1CCC(C(=O)Nc2cc3cc(-c4cnn(C)c4)ccc3cn2)CC1,1027.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5285332,Cn1cc(-c2ccc3cnc(NC(=O)C4CCN(S(C)(=O)=O)CC4)cc3c2)cn1,1791.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5280761,O=C1Nc2cc(S(=O)(=O)Cc3c(Cl)cccc3Cl)ccc2S/C1=C\c1ccc(O)c([N+](=O)[O-])c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5272336,Cc1cc(C(=O)NC2Nc3cccc(C)c3N2[C@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL1682931,CC(=O)c1nccc2c1[nH]c1ccccc12,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL1997924,c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1,101.1,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL418971,CC(C)(c1ccc(O)cc1)c1ccc(O)cc1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL790,N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4637319,Cc1cccc(N(C)c2nccc(-c3cnn4ncccc34)n2)c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4848254,CN(C)c1nccc(-c2cnn3ncccc23)n1,9672.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5286716,COc1ccc2nc3c(CO)cc(OC)cc3c(SC[C@H]3CCNC3)c2c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4783398,Cc1ccc(-n2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)c([N+](=O)[O-])c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4288096,COc1ccc(/C=C2\SC(=S)NC2=O)cc1C#C[Si](C)(C)C,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL297453,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,431.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5284529,O=C(Nc1ccc2[nH]ncc2c1)c1csc(Nc2ccccc2)n1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL3185434,COc1ccc(-n2c(C)c([N+](=O)[O-])c3ccc(O)cc32)cc1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL1232500,CCN1/C(=C/C(C)=O)Sc2ccc(O)cc21,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5095897,COc1ccc2nc3ccc(OC)cc3c(SCCCN)c2c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL608533,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4754195,Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL1094636,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5286520,CCOc1ccc2nc(N3CCCN(C(=S)Nc4ccccc4F)CC3)c(C#N)cc2c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5288595,COc1ccc2sc(-c3cncc(NC(C)=O)c3)nc2c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL1173055,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL562562,COc1cc(CCc2c(O)ccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2C(C)=O)ccc1O,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL5288391,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Cc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4798421,CCN(CC)Cc1ccc(OC)c(-c2cc3c(-c4ccc(C(=O)O)c(C(C)C)c4)ccnc3[nH]2)c1,10000.0,nM,Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis
CHEMBL4213175,COc1ccncc1NC(=O)c1ccnc(NC(=O)C2CC2)c1,50000.0,nM,Inhibition of CDK5/p25 (unknown origin) by Ambit kinase assay
CHEMBL5270581,O=C(Nc1cnccc1-c1ccccc1)c1ccnc(NC(=O)C2CC2)c1,50000.0,nM,Inhibition of CDK5/p25 (unknown origin) by Ambit kinase assay
CHEMBL5288565,O=C(Nc1cnccc1-c1ccc(F)cc1)c1ccnc(NC(=O)C2CC2)c1,50000.0,nM,Inhibition of CDK5/p25 (unknown origin) by Ambit kinase assay
CHEMBL5278465,O=C(Nc1cnccc1-c1ccc(Cl)cc1)c1ccnc(NC(=O)C2CC2)c1,50000.0,nM,Inhibition of CDK5/p25 (unknown origin) by Ambit kinase assay
